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ABSTRACT 
Staphylococcus species (spp.) are among the most common bacterial pathogens of humans and 
animals. The rise of antimicrobial resistance amongst this genus has significantly added to the 
threat it poses to public health. This thesis examines the epidemiology of the Staphylococcus genus 
in veterinary medicine, with particular reference to methicillin-resistant Staphylococcus aureus 
(MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP). Chapter 1 begins with 
an in-depth literature review detailing our current understanding of this fascinating genus. Due to 
its importance as a human pathogen, much research has already been conducted into the 
mechanisms of antimicrobial resistance, population structure, host adaptation markers and 
virulence factors found in S. aureus. Research into S. aureus can often be extrapolated to other 
staphylococcal species, but differences and knowledge gaps exist for staphylococci of veterinary 
significance such as S. pseudintermedius and S. felis; common pathogens of dogs and cats 
respectively. The literature review therefore compares what is known about S. aureus to that of 
other Staphylococcus spp. of veterinary importance. Chapter 2 describes how whole genome 
sequencing and in silico analysis were used to elucidate the molecular epidemiology of 
staphylococcal isolates examined in the subsequent chapters. MRSP and MRSA have been reported 
amongst animals from several countries overseas, but little is known about the epidemiology of 
these pathogens in the Australian veterinary setting. Chapters 3 and 4 consequently describe the 
first nationwide surveillance study that examined 1080 clinical Staphylococcus isolates collected 
from veterinary diagnostic laboratories across all Australian states and territories. Chapter 3 
describes the molecular epidemiology of clinical MRSA from animals in Australia and examines the 
relationship between clinical MRSA from animals and that carried by Australian veterinarians. In 
contrast to Australian companion animals, MRSA was not found in the collection of 203 S. aureus 
bovine mastitis samples. Chapter 4 examines 77 MRSP isolates collected during the surveillance 
study and describes how novel sequence types and methicillin-resistance determinants are present 
amongst Australian MRSP. To more closely examine the transmission cycle of MRSA and MRSP in 
companion animal practice, Chapter 5 describes a prospective study that investigated MRSP and 
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MRSA carriage amongst veterinary personnel, canine hospital admissions and veterinary-owned 
pet dogs and cats. MRSA carriage was found in veterinary personnel at a higher rate than what is 
reported for the general public. However, MRSA found in veterinary personnel was not reflected in 
carriage by canine patients treated by the personnel or pets owned by personnel, suggesting there 
are additional risk factors for MRSA carriage amongst veterinary personnel besides contact with 
animals carrying resistant staphylococci. Returning to isolates collected in the surveillance study, 
Chapter 6 examines genomic and phenotypic virulence factors amongst 38 S. felis isolates collected 
from cats. S. felis has traditionally been viewed as a commensal of cats and could be discounted as 
a contaminant of clinical samples. However, Chapter 6 details how it has sufficient markers of 
virulence including newly detected coagulation of feline plasma to make it a potential pathogen of 
cats. A multilocus sequence typing scheme was developed which gives an initial framework for the 
population structure of S. felis in Australian cats. A common finding of the surveillance study 
conducted here, and previous similar studies conducted elsewhere, is the predominance of a 
particular clone of MRSP, ST71, amongst clinical isolates from animals. Chapter 7 describes how 
genomic screening established that ST71 isolates from Australia are significantly more likely to carry 
qac genes than other MRSP clones. Qac genes are associated with increased biocide tolerance in 
MRSA and prior to this study, had not been reported in MRSP. Chapter 7 investigates whether qac 
genes lead to the phenotypic expression of increased biocide tolerance in MRSP. Isolates with and 
without qac genes were tested to determine their tolerance to chlorhexidine and benzalkonium 
chloride, two common veterinary biocides. Surprisingly, the presence of qac genes in MRSP isolates 
did not affect the minimum inhibitory concentration (MBC) of either biocide. However, a consistent 
finding was that protein contamination significantly increased the MBC of both biocides which is a 
pertinent reminder that biocides may be ineffective against MRSA and MRSP if used in the absence 
of effective cleaning. Taken together, the studies of this thesis paint a compelling picture of the 
epidemiology of resistant staphylococci in the Australian veterinary setting: shedding light on 
questions that had previously been unanswered and raising questions that will pave the way for 
interesting studies in the future.  
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“Rivers know this: there is no hurry. We shall get there some day.”  
― A.A. Milne   
Chapter 1  
Kate Alice Worthing thesis - March 2018   1 
Chapter 1. Introduction 
 Antimicrobial resistance and the Staphylococcus genus 
Alexander Fleming’s 1929 report of an ‘antibacterial substance’ (1) marked the start of an arms race 
between manmade antimicrobial drugs and bacterial superbugs. Since Fleming first described how he 
serendipitously killed staphylococci with penicillin (1), the Staphylococcus genus, with its arsenal of 
virulence factors and refined host adaptation, has been a key target of antimicrobial drug 
development. Despite their close association with humans and animals as resident flora, 
Staphylococcus spp. are among the most common bacterial pathogens. They are adept at creating 
opportunistic infections that continually challenge clinicians, compounded by the ongoing emergence 
of antimicrobial resistance. The following thesis will explore the epidemiology of this important 
pathogen in veterinary medicine, with particular reference to antimicrobial-resistant staphylococci in 
Australian animals. 
Staphylococcus spp. are Gram-positive, catalase-positive, facultatively anaerobic bacterial cocci that 
are generally viewed as commensals, with skin and mucous membrane carriage being common 
amongst healthy humans and animals (2-8). Staphylococcus spp. are typically adapted to one or two 
host species. Humans are naturally carriers of S. aureus (2), while S. pseudintermedius is considered a 
commensal in dogs (3, 5), and cats are the natural host of S. felis (9, 10). Molecular studies have 
suggested a genetic basis for this host-specificity (11) and host specific markers are thought to exist. 
These markers mostly pertain to evasion of the host immune system (11-15). The coagulase test, which 
detects the presence of clotting within plasma, has traditionally been used to delineate pathogenic 
from less pathogenic staphylococcal species (16). Although coagulase-negative staphylococci are 
regarded as less pathogenic, their role as significant opportunistic pathogens in  
Staphylococci in Australian Animals 
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humans was clearly demonstrated when a large multi-centre study found coagulase-negative 
staphylococci to be the foremost cause (31%) of nosocomial bloodstream infections in the USA (17). 
Coagulase-negative staphylococci are also common pathogens in bovine mastitis (18) and they are 
accordingly now considered potential veterinary pathogens. 
Over 50 Staphylococcus spp. have been identified (19) and while Staphylococcus aureus is considered 
the chief coagulase-positive spp. in human medicine, several other Staphylococcus spp. are potential 
pathogens for both humans and animals (6, 20-26). Staphylococci are generally found in one or two 
host species, but asymptomatic carriage and infection can occur across the species divide (27-35). In 
veterinary medicine, Staphylococcus spp. are responsible for a wide range of diseases including canine 
pyoderma, bovine mastitis and pyogenic infections in virtually every body system of any mammal, 
reflecting their role as opportunistic pathogens that capitalise on host compromise to allow tissue 
invasion (36, 37). While staphylococcal infections were once relatively simple to treat with the 
provision of systemic or topical antimicrobials, management of staphylococcal infections has been 
greatly complicated by the rise of antimicrobial resistance in both human and veterinary medicine (38-
40).  
This literature review introduces the key themes of this thesis, focusing on the veterinary 
staphylococcal species investigated within the thesis, the virulence factors that allow Staphylococcus 
spp. to create disease and the epidemiology of antimicrobial-resistant staphylococci in veterinary 
medicine.  
 Staphylococcus spp. of veterinary significance 
1.2.1 Staphylococcus aureus  
In 1881, Alexander Ogston (41) published a report with several elegant hand-drawn diagrams in which 
‘micrococcus’, a round micro-organism, could be observed in samples from various purulent infection 
sites in humans. Ogston isolated this round micro-organism from 65 of 85 human abscesses and found 
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that when purulent discharge from these abscesses was injected into mice and guinea pigs, the animals 
developed similar abscesses from which the organism could also be isolated (41). Having fulfilled 
Koch’s postulates, Ogston concluded that while ‘micrococcus’ (later renamed Staphylococcus aureus) 
could be an ‘innocent organism’, it could also ‘under suitable conditions… give rise to blood-poisoning, 
to acute inflammation, and to suppuration’ (41). Staphylococcus aureus was thus the first 
staphylococcal species to be described, and clinical reports have appeared in the literature since the 
late 19th century (41-43).  
A defining feature of S. aureus is its gold pigmentation, which is due to carotenoid pigments that 
actually confer a survival advantage by acting as antioxidants against neutrophil oxidative burst (44). 
S. aureus is a commensal of the skin and mucous membranes of humans, with the anterior nares being 
the most common site of carriage (8). Carriage rates vary between study populations but a median 
nasal carriage rate of 37.2% amongst the general human population was reported in a meta-analysis 
that examined 18 studies (45). It is a common pathogen of both humans and animals and, true to the 
first report by Ogston (41), can cause suppurative disease in any organ (46).  
Although S. aureus can potentially cause disease in any animal, it is a particularly prevalent and 
economically important pathogen in bovine mastitis (47-49). It is also a common cause of wound 
infections in companion animals (dogs, cats and horses) (35) and can be carried asymptomatically by 
pigs (32, 50). Due to its significance as a human pathogen, the scientific literature and general media 
often debate the extent to which animals are a reservoir for S. aureus infections in humans (32, 51-
53). To aid rational debate about the subject, several studies have focussed on determining markers 
to differentiate human-adapted from livestock-adapted strains S. aureus (15, 54). To further 
investigate the epidemiology of S. aureus at the human-animal interface, Chapter 3 examines the 
phylogeny and variety of host adaptation markers amongst a collection of methicillin-resistant 
Staphylococcus aureus (MRSA) isolated from Australian animals and veterinarians and Chapter 5 
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describes a screening study of veterinarians and their pets for concurrent carriage of MRSA and 
methicillin-resistant Staphylococcus pseudintermedius (MRSP).  
1.2.2 Staphylococcus pseudintermedius  
Hajek et al. (1976) (6) first described S. intermedius as a newly identified coagulase-positive species 
that had previously been misidentified as S. aureus. This new species could be differentiated from S. 
aureus phenotypically because it was unpigmented, did not produce acetoin and did not ferment 
maltose (6).  Several surveys then reported that S. intermedius was the predominant Staphylococcus 
spp. in dogs and cats (3, 5, 36). Two decades later, Devriese et al. (20) found a cluster of four isolates 
from a dog, cat, horse and parrot that were distinct from other isolates previously described as S. 
intermedius. DNA-DNA hybridisation confirmed that the four isolates represented a novel species 
called S. pseudintermedius – so named because of its close phylogenetic relationship to S. intermedius. 
It was also closely related to S. delphini, a coagulase-positive species originally isolated from dolphins 
(55). Sasaki et al. (56) also used DNA-DNA hybridisation to confirm the status of S. pseudintermedius 
as a novel species, closely related to S. intermedius and S. delphini, and recommended that the three 
species be grouped as ‘Staphylococcus intermedius group (SIG)’ because they could only be 
differentiated through advanced phenotypic tests and molecular tests such as DNA-DNA hybridisation. 
Sasaki et al. (56) analysed 117 isolates previously described as S. intermedius and found that all isolates 
from dogs, cats and humans were in fact S. pseudintermedius. Bannoehr et al. (57) then used 
multilocus sequence typing (MLST) to analyse 99 isolates previously described as S. intermedius and 
confirmed that S. pseudintermedius, not S. intermedius, was the most common cause of canine 
pyoderma. As a result, subsequent studies generally refer to SIG isolates from dogs as S. 
pseudintermedius and it can be assumed that most, if not all, older articles that refer to S. intermedius 
from dogs are in fact discussing S. pseudintermedius.  
Staphylococcus pseudintermedius is normal flora of the skin and mucous membrane for most dogs and 
some cats (3-5, 58). The high frequency of S. pseudintermedius carriage by dogs is similar to carriage 
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of S. aureus in healthy humans (2), although S. pseudintermedius carriage in dogs is more frequent 
than S. aureus carriage in humans (58). As well as being the most common Staphylococcus spp. isolated 
from healthy dogs, S. pseudintermedius is also the most common cause of staphylococcal infections in 
dogs (59, 60). A wide range of canine diseases are caused by S. pseudintermedius, but most studies 
concur that the skin is the most common site of S. pseudintermedius infection (particularly pyoderma), 
followed in various frequencies by otitis externa, cystitis, surgical site infections, and infections in the 
skeletal, reproductive and respiratory systems (22, 59-64). It is also an occasional zoonotic pathogen 
(30, 65, 66). 
Although it can cause disease in humans, S. pseudintermedius is generally thought to be canine host-
adapted. Simou et al. (67) provided evidence of host-specificity towards dogs by showing that S. 
pseudintermedius bound to a significantly higher percentage of canine corneocytes than human 
corneocytes, whereas S. aureus bound to significantly more human than canine corneocytes. While S. 
pseudintermedius is a common and important pathogen of dogs in its own right, the occurrence of 
methicillin-resistance amongst S. pseudintermedius has increased in significance firstly due to 
increased complexity in treating such infections in animals and secondly as a potential public health 
threat for humans. Chapter 4 outlines the epidemiology of S. pseudintermedius in Australia, focussing 
on the molecular epidemiology of clinical MRSP from dogs and cats. Chapter 5 discusses carriage of 
MRSP by Australian dogs while Chapter 7 describes investigations into biocide tolerance amongst 
veterinary-derived S. pseudintermedius isolates. 
1.2.3 Staphylococcus felis   
While S. pseudintermedius is the most common staphylococcal pathogen of dogs and is occasionally 
found in cats, S. felis is the resident staphylococcal species of cats. It was first identified as a new 
species in 1989, when Igimi et al. (68) characterised a group of 39 previously unidentified isolates of 
coagulase-negative staphylococci from cats and concluded that S. felis, a newly identified species, was 
the most common species amongst cats. The isolates had come from a range of clinical syndromes in 
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cats including otitis externa, cystitis, abscesses and other skin infections. The isolates were coagulase-
negative when tested on rabbit plasma, and were weakly haemolytic on sheep blood agar.  Previously, 
Devriese et al. (69) had examined 112 specimens from both healthy and diseased cats and concluded 
that S. sciuri was the most common staphylococcal species in cats. In the paper that first described S. 
felis, Igimi et al. (68) noted that S. felis was phenotypically similar to another coagulase-negative 
species, S. simulans, but the two could be differentiated by DNA-DNA hybridisation. Igimi et al. (70) 
subsequently examined a larger collection of 93 clinical specimens and found that S. felis was indeed 
the most commonly isolated species of Staphylococcus from cats. More recent studies have confirmed 
that S. felis, not S. simulans or S. sciuri, is the most common Staphylococcus spp. carried on the skin 
(9) and in the saliva (10) of healthy cats. It is also becoming increasingly recognised as a common 
pathogen of the feline urinary tract (71, 72), ear canals (73) and skin (74). Apart from the handful of 
studies described above (71-74), the literature on S. felis is scant. Consequently, Chapter 6 examines 
the molecular epidemiology and potential virulence factors of a collection of clinical S. felis isolates 
from Australian cats. 
 Virulence factors of Staphylococcus spp. 
Detailed knowledge of the pathogenesis of staphylococcal infections is somewhat restricted, but 
investigation into virulence factors has provided important links between Staphylococcus spp., host 
immune responses and disease states. Staphylococcal infections are initiated when the skin or mucosal 
barrier is physically breached, or local defences are otherwise overwhelmed and the bacteria are 
allowed to penetrate into deeper tissues. Infections are typically characterised by pus formation due 
to enzymatic tissue liquefaction (46) and a propensity towards chronicity which is aided by intracellular 
survival (75). The majority of research into specific staphylococcal virulence factors relates to S. aureus, 
due to its importance as a human pathogen. There is nevertheless a growing body of evidence that 
other Staphylococcus spp. have virulence factors that are either homologous to those described in S. 
aureus, or unique to the different staphylococcal species. Staphylococcal virulence factors are 
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generally divided into four categories: exoenzymes, exotoxins, adhesins and others (76, 77). This can 
be more broadly divided into cell wall and membrane components and secreted virulence factors. 
1.3.1 Cell wall and membrane components 
The Gram-positive cell wall of Staphylococcus is composed of a thick peptidoglycan layer interwoven 
with teichoic acids, transmembrane lipoteichoic acids and proteins (78, 79). Each component of the 
staphylococcal cell can play a dual role in cell functioning and virulence. The functions of cell wall 
components include evading host immune defences (80, 81), aiding adhesion to host tissues (82, 83), 
conferring antimicrobial resistance (84), surviving in adverse conditions (85) and modulating the host 
inflammatory response (86, 87). One example of a cell wall-associated protein with several functions 
is staphylococcal autolysin (Atl), which functions as an autolytic enzyme during bacterial cell division 
but can also facilitate binding to host tissues (88, 89). The staphylococcal protein A (SpA) is a cell wall-
associated protein that is well conserved in the Staphylococcus genome, although it demonstrates 
sequence variation (90). SpA, encoded by the spa gene, is involved with non-host specific binding to 
IgG from a range of animal species (91, 92). Binding of SpA to host IgG helps Staphylococcus evade 
host defences by interfering with complement fixation and phagocytosis (81). The reliable presence of 
the spa gene in the Staphylococcus genome has proven useful to researchers, as spa typing is now a 
common way of classifying S. aureus (93) and S. pseudintermedius (90). Clumping factor is another cell 
wall-associated protein that plays a role in adhesion and host specificity by mediating binding to host 
fibrinogen (94, 95). Clumping factor A (CfA) is thought to aid adherence to host cells (96) and may play 
a role in host specificity, as genetic analysis can divide S. aureus isolates into human and bovine groups 
based on CfA gene expression (97). The presence or absence of clumping factor is the basis of the slide 
agglutination test, which is a common phenotypic method of differentiating Staphylococcus isolates.  
Some Staphylococcus spp. isolates produce biofilm, a particularly important virulence factor for 
surgical implant infections. Biofilm is characterised by clumps of bacteria bound together by a matrix 
of peptides and polysaccharide adhesion molecules (98). Christensen et al. (99) found that S. 
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epidermidis isolates that made biofilm were significantly more likely to cause intravenous catheter 
infections in mice than those without biofilm production. Tojo et al.  (100) further demonstrated that 
an integral part of biofilm is a capsular polysaccharide adhesin molecule. This adhesin facilitates cell 
to cell contact between bacteria, which allows formation of the large bacterial clusters that 
characterise a biofilm (101). In addition to aiding cell tocell adhesion in biofilms, capsular 
polysaccharides help evade host immunity by protecting against phagocytosis by neutrophils (102). 
Biofilm production appears to be an essential virulence factor for implant infections by coagulase-
negative species such as Staphylococcus epidermidis (99, 103, 104), but studies have shown that S. 
aureus (103) and S. pseudintermedius also readily produce biofilm (105). Bacterial cells deep within 
the biofilm are less metabolically active, so staphylococcal biofilms can be intrinsically resistant to 
antimicrobials simply because the bacteria are not undergoing the cell division that is required for 
some antimicrobials to be effective (98). Given that biofilm production is a multifactorial process, it is 
not surprising that there are several genes and cell wall-associated proteins involved. Biofilm-
associated surface protein, encoded by the bap gene, is one such protein that facilitates staphylococcal 
adhesion to inert surfaces and intercellular adhesion (106). The ica operon is also involved in several 
aspects of biofilm production, particularly in the production of the glucosaminoglycan-based matrix 
(107). In addition to biofilm production, many Staphylococcus spp. are resistant to lysozyme (108), 
which is a bactericidal enzyme intended to attack the peptidoglycan layer of the bacterial cell wall and 
is produced by polymorphonuclear cell granules, intestinal cells and bodily secretions of mammalian 
hosts (109-111). Bera et al. (80) found that O-acetylation of the peptidoglycan layer, aided by a 
membrane-bound protein called OatA, was the major determinant of lysozyme resistance in S. aureus. 
Several of the aforementioned cell wall-associated proteins can be antigenic, but staphylococci can 
counter this by producing an extracellular polysaccharide capsule that masks surface antigens and thus 
aids in evasion of host immunity (112). The capsule of other bacterial species is thought to impede 
phagocytosis and this is likely true for Staphylococcus spp. too, although variation within and between 
studies has made this difficult to prove (113). Capsular serotyping was initially used as a potential 
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measure of virulence amongst S. aureus isolates (114, 115), but this is not a common procedure due 
to the variable effects of culture conditions on capsule production.  
Studies investigating staphylococcal virulence factors give the best insight into staphylococcal disease 
when both phenotype and genotype are examined. Nevertheless, genome screening for genes that 
encode putative virulence factors is a useful place to start (76, 77, 116). In Chapter 6, a collection of S. 
felis isolates from cats were screened for genetic markers of biofilm formation, lysozyme resistance 
and capsule production. 
1.3.2 Secreted virulence factors 
Exotoxins are bacterial products (generally proteins) that damage or kill host cells while exoenzymes 
are extracellularly secreted enzymes that degrade host tissues for the purpose of bacterial digestion. 
Staphylococcal exotoxins include haemolysins, cytotoxins, exfoliative toxins and enterotoxins. 
Exfoliative toxins are generally involved in dermatoses such as impetigo and exudative dermatitis. One 
example of an exfoliative toxin is EXI in S. pseudintermedius, which is encoded by the exi gene. The EXI 
toxin of S. pseudintermedius causes host-specific degradation of canine desmoglein 1 (Dsg1), which is 
a desmosomal adhesion molecule of mammalian skin (117). Desmoglein breakdown causes epidermal 
splitting and this manifests as blister formation. Degradation of Dsg1 by homologous exfoliative toxins 
has been demonstrated in S. pseudintermedius bullous impetigo in dogs (117), S. hyicus exudative 
epidermitis in pigs (118) and S. aureus scalded skin syndrome in humans (119).  
Compared to exfoliative toxins, staphylococcal enterotoxins are generally less host specific in their 
activity. Enterotoxins are so named because they induce emesis in humans after oral ingestion (120). 
Some staphylococcal enterotoxins are also described as superantigens because they can activate T-
lymphocytes, causing massive cytokine release that is far in excess of what would be induced by a 
normal antigen (121-124). In addition to their role as superantigens in diseases such as toxic shock 
syndrome, enterotoxins are frequently associated with human food poisoning outbreaks caused by S. 
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aureus (125). Dairy products are a major source of staphylococcal enterotoxin in human food 
poisoning outbreaks (125, 126), so it is not surprising that most veterinary studies into enterotoxins 
relate to bovine mastitis.  In contrast to their emetic effects in humans, enterotoxins are thought to 
play an immunomodulatory role in bovine mastitis by disrupting T lymphocytes (127). This T 
lymphocyte disruption may aid in the intracellular survival that is intrinsic to the pathogenesis of 
staphylococcal mastitis (127). Rall et al. (128) found that the gene encoding staphylococcal enterotoxin 
A (sea) was the most common enterotoxin gene in a herd that included clinically healthy cows and 
cows with mastitis in Brazil. Despite the sea gene being uniformly present in Staphylococcus isolates 
from all cows, isolates from cows with mastitis were more likely to produce the sea toxin than isolates 
from healthy cows, further indicating that sea expression and enterotoxin production play a role in 
mastitis pathogenesis. In Chapter 3, a human-derived sea gene sequence was used as one of the 
markers of host adaptation in a collection of MRSA from humans and animals. 
Haemolysins are toxic to both leucocytes and erythrocytes while bicomponent leukocidins/leukotoxins 
such as Panton-Valentine leukocidin mainly target leucocytes and epithelial cells (129, 130). The 
presence of haemolysin can usually be detected by visible haemolysis on blood agar plates, making 
haemolysis detection a useful phenotypic test in differentiating haemolytic from non-haemolytic 
staphylococcal species. Leukocidins cause cell death by adhering to host cells and creating pores in 
their cell membrane (131). Panton-Valentine leukocidin (PVL) is produced by some S. aureus isolates 
from animals and humans but it does not appear to be produced by any other Staphylococcus spp. 
(56, 132, 133). While PVL is uncommon in S. aureus strains overall, it is very commonly found in those 
strains associated with primary necrotic skin lesions in adult humans and community-acquired 
necrotising pneumonia in children (129). PVL has been found in clinical MRSA isolates from companion 
animals and transmission of a PVL-positive MRSA strain has been demonstrated between a healthy 
dog and its owner who had recurrent skin infections (134). Due to its association with serious 
infections in immune-competent humans, PVL is thought to be an important virulence factor, so 
epidemiological investigations often include PVL screening in their categorization of S. aureus isolates 
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(56, 133). The MRSA isolates examined in Chapters 3 and 5 were consequently screened for PVL and 
other leukotoxins while S. felis isolates in Chapter 6 were screened for leukotoxin homologues. 
Coagulase is a pro-inflammatory enzyme that activates host prothrombin and causes clotting of host 
plasma and is implicated in abscess formation by S. aureus (16, 135). Coagulase production is variable 
amongst staphylococcal species and is generally associated with heightened virulence (16, 136). 
Whether an isolate was positive for coagulase or not was once considered the major determinant of 
its pathogenicity but it is now widely accepted that both coagulase-positive and -negative species can 
be pathogenic (17, 68). S. felis is a coagulase-negative species of cats that has received very little 
attention in the literature despite its predominance in feline clinical disease. Chapter 6 investigates 
several virulence factors in S. felis including coagulase production, and found that feline host-specific 
coagulase activity can be present amongst S. felis isolates.  
 Methicillin-resistance in Staphylococcus spp. 
The sheer speed at which bacteria can replicate and mutate has meant that the discovery of novel 
antimicrobials is inevitably met with a bacterial counterattack using mechanisms that confer 
antimicrobial resistance. Patients treated in early penicillin trials showed seemingly miraculous 
recoveries (137) and the use of penicillin to treat war wounds undoubtedly reduced mortalities in the 
second half of World War II (138). However, shortly after penicillin began to be used on a mass scale 
in 1944, penicillin-resistant strains of S. aureus were reported (139). As a β-lactam, penicillin kills 
bacteria by disrupting the layering of peptidoglycans during cell wall synthesis (140). Kirby (139) found 
that the mode of staphylococcal β-lactam resistance was due to a mobile genetic element which has 
since been characterised as the plasmid-encoded enzyme,  β-lactamase (141).  
To circumvent β-lactamase producing staphylococci, methicillin was introduced into human medicine 
around 1960 (142) as a novel β–lactam antimicrobial. Due to a modified structure compared to 
penicillin, methicillin is stable against enzymatic degradation by β-lactamase (142). Just as penicillin 
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resistance was reported shortly after it began to be used clinically, the introduction of methicillin into 
human hospitals was closely followed by reports of phenotypic methicillin-resistance amongst clinical 
S. aureus isolates (38). It was another two decades before Hartman and Tomasz (143) found that 
methicillin-resistance was conferred by a modified penicillin binding protein (penicillin binding protein 
2a (PBP2a)) that had low binding affinity to methicillin and other β-lactams. PBP2a is a functional 
protein involved in crosslinking of the peptidoglycan cell wall, but has decreased affinity to all β-
lactams so that it can continue to perform its function even in the presence of β-lactams (144, 145). 
PBP2a is encoded by the mecA gene and its homologues (146, 147). Mec genes are carried in a mobile 
genetic element called the staphylococcal cassette chromosome mec (SCCmec) (148, 149). SCCmec 
cassettes can harbour other resistance genes (150), which is one reason why methicillin-resistant 
isolates are often multidrug-resistant (151). The original source of the mecA gene was likely a naturally 
occurring homologous gene amongst the ubiquitous coagulase-negative species, S. sciuri, which 
moved into coagulase-positive species via horizontal gene transfer (152, 153). Antimicrobial use in 
human and veterinary medicine, particularly in food producing animals, then selected for mecA 
positive isolates, leading to a dramatic rise in the prevalence of methicillin-resistant staphylococci 
(152, 154).  
Since the early reports of methicillin-resistance amongst S. aureus isolates, the frequency of MRSA has 
steadily increased in human and veterinary medicine. Prevalence rates of MRSA now vary between 
epidemiological settings, making it difficult to draw direct comparisons between studies. For example, 
one study reported that in 2016 the rate of MRSA amongst S. aureus bacteraemia in Australian human 
hospitals ranged from 11% in Tasmania to 47.4% in the Northern Territory (155) while a 2015 study 
reported a 38% MRSA prevalence amongst S. aureus bacteraemia cases in Taiwan (156). The difference 
in prevalence is multifactorial and is likely influenced by varying study methodologies, geographic 
variations in antimicrobial use, population density and the dominant strains of MRSA that are 
circulating within a community. Although prevalence rates of MRSA in human medicine vary, a 
common finding is that the presence of methicillin-resistance amongst S. aureus infections is always 
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associated with significantly higher mortality compared to methicillin-susceptible infections (155, 
157). Unlike human medicine, it is not yet clear whether methicillin-resistance amongst S. aureus 
infections in animals has a negative impact upon their survival. Nevertheless, the public health 
significance of MRSA amongst companion and food producing animals is the source of much debate. 
MRSA was first reported in bovine mastitis in the 1970’s (158) and it continues to be detected at low 
frequencies in surveillance studies overseas (18, 159, 160). Similar Australian surveillance studies are 
lacking, and the unique restrictions on antimicrobial usage in Australian food producing animals (161) 
means that the results of overseas studies cannot be applied to an Australian setting. In addition to 
being a bovine mastitis pathogen, MRSA is a common cause of wound infections in companion animals 
(35). To establish a baseline for future epidemiological studies into MRSA in the Australian veterinary 
setting, Chapter 3 describes the first nationwide surveillance study that examined the frequency of 
MRSA in clinical isolates from Australian animals. The prevalence of methicillin-resistant S. 
pseudintermedius (MRSP) was first reported in the late 1990’s  (38) and, like S. aureus, the prevalence 
of methicillin-resistance amongst S. pseudintermedius has risen steadily since that time. The frequency 
of MRSP similarly varies between reports (59, 162-165), but frequencies of up to 60% of canine S. 
pseudintermedius pyoderma cases have been reported outside Australia (166). Chapter 4 describes 
the first Australian surveillance study into MRSP amongst clinical veterinary isolates. 
Today, methicillin is not used as a therapeutic because of its acid intolerance, instability in storage 
(167), and its parenteral-only administration (168). However, ‘methicillin-resistance’ has remained as 
a term used to describe bacteria with resistance to β–lactams conferred by mecA and its homologues. 
It was recognised soon after the discovery of methicillin-resistance that test conditions such as 
temperature and antimicrobial disk choice could affect the ability of phenotypic tests to detect 
methicillin-resistance (169-171). Oxacillin disks were found to be more stable than methicillin (172), 
and oxacillin is now used as a proxy to detect methicillin-resistant in S. pseudintermedius and several 
other staphylococcal species (173, 174). However, oxacillin is unreliable for S. aureus disk diffusion 
testing because is a poor inducer of mecA mediated resistance and it can fail to recognise phenotypic 
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resistance in heterogeneous MRSA populations that contain mecA-positive and -negative isolates (175, 
176). Cefoxitin is consequently used to detect methicillin-resistance in S. aureus (173, 174, 176). 
Methicillin-resistance can still be heterogeneously expressed, so gold standard diagnosis requires 
identification of the mecA gene and homologues (40) or demonstration of the PBP2a protein by latex 
agglutination (171).  Beyond clinical diagnosis, useful epidemiological information is gleaned by strain 
typing, as described in Section 1.5. 
 Diagnosis and characterisation of Staphylococcus spp. 
Identification of Staphylococcus infections to a genus level is not difficult, as the organism grows well 
in a range of conditions. Genus identification is readily achieved with basic phenotypic tests such as 
Gram staining and the catalase test, as outlined in Section 2.2. Identification to the species level is 
more challenging and requires a range of more advanced phenotypic tests or more costly but more 
accurate molecular tests such as matrix assisted laser desorption ionisation- time of flight mass 
spectrometry (MALDI-TOF MS), outlined below.  
1.5.1 Matrix-assisted laser desorption/ionisation- time of flight (MALDI-TOF MS) mass 
spectrometry 
Matrix assisted laser desorption ionisation- time of flight mass spectrometry (MALDI-TOF MS) is a 
relatively simple molecular method of characterizing Staphylococcus isolates to the genus and species 
level (177-179).  This technique analyses the protein constituents of the cell wall of each isolate and 
produces a unique dendrogram based on the size and ‘time of flight’ of protein particles when they 
are hit with a laser (177). Only a small amount of sample is needed (one colony) and samples can be 
applied directly from an agar plate. It is a quick and accurate method of differentiation between similar 
Staphylococcus spp. (for example, the SIG members) (178). Due to its speed, accuracy and relative cost 
effectiveness, MALDI-TOF MS was used to confirm the species of most of the isolates examined in this 
thesis. 
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1.5.2 Strain typing 
As molecular technology and bioinformatics have advanced, so too has the degree of discrimination 
that can be achieved within staphylococcal species. Defining a staphylococcal isolate to its strain or 
‘clone’ level provides useful information about the possible epidemiological origin of the isolate. This 
information is useful both on a broad scale, such as national and international surveillance studies 
which track movement of important pathogens around the world, and on smaller scales such as clinical 
settings where infection control may be improved if the origin of the isolate is known. Several methods 
of strain typing Staphylococcus have been developed, as outlined below. 
 Pulsed field gel electrophoresis 
Gel electrophoresis is a common technique in molecular biology where fragments of DNA, RNA or 
protein are run across an electrically charged gel. The distance that each fragment moves through the 
gel is governed by its size and electric charge, so that smaller fragments typically move further than 
large fragments. Pulsed field gel electrophoresis (PFGE) was once a major tool in investigating 
outbreaks of staphylococcal related disease (180, 181). The high discriminatory ability of PFGE allowed 
researchers to detect minute changes in the Staphylococcus genome which allows tracking of strains 
within outbreak settings. The downside of PFGE is that it requires multiple technical steps that can be 
performed several different ways, making it difficult to directly compare results between laboratories 
and thus hindering efforts to track epidemic strains across different geographic areas. Furthermore, 
the lack of a standardised protocol for S. pseudintermedius makes it difficult to compare results 
between laboratories. Given its limited utility for epidemiological studies, particularly for S. 
pseudintermedius, PFGE was not used as a typing method for any of the studies in this thesis. 
 Multilocus sequence typing 
Multilocus sequence typing (MLST) was first described in 1998 (182) as a more convenient and 
transferable mode of characterising bacterial isolates than PFGE. MLST uses gene sequencing to 
compare the alleles of short fragments of several highly conserved genes. A curated online database 
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is used to designate an isolate as a particular allelic profile or ‘sequence type’ based on its allele pattern 
for each gene (182). Suitable genes for MLST schemes are those that are highly conserved and 
therefore reliably present in every isolate but which demonstrate enough allelic variability that isolates 
may be differentiated based on their allelic profile for the set of genes (182, 183). The use of 
sequencing allows comparison between laboratories because sequence types can be grouped on 
computer, stored as a file and subsequently compared across the internet (182, 183).  The output of 
MLST has been variably referred to as allelic profile, sequence type, strain or clone but from herein 
this thesis will refer to the output of MLST as sequence type or clone.  
MLST provides investigators with useful epidemiological information because clusters of closely 
related strains can be identified and inferences made about which strains predominate in an outbreak 
situation or particular geographic area (57, 183, 184). The first MLST scheme for S. aureus was 
developed in 2000 (183) and schemes have since been developed for S. pseudintermedius (57, 185) 
and S. epidermidis (186). The epidemiological utility of MLST was exemplified when Perreten et al. 
(184) used MLST to analyse MRSP isolates from around the world and identified two major strains of 
MRSP: ST71 in Europe and ST68 in USA.  The strains were geographically separate and genotypically 
different, yet the isolates all had methicillin-resistance conferred by mecA gene, indicating that mecA 
acquisition occurred simultaneously in at least two geographically separate clones. These clones then 
spread widely across each region. The changes in house keeper gene alleles as detected by MLST 
accumulate slower than the changes in protein expression detected by PFGE (183). Therefore PFGE 
remains useful to analyse microvariations in active outbreak investigation, whereas MLST is useful in 
assessing macrovariations across larger epidemiological investigations (57, 184, 187). MLST was used 
as a typing methods for several studies in this thesis, as outlined in Chapters 3, 4, 5 and 6. 
1.5.2.2.1 Spa typing 
Spa typing is a single locus typing method that compares alleles of the ubiquitous staphylococcal 
protein A gene. First developed for S. aureus in 2004 (187), spa typing has overtaken PFGE as a highly 
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discriminatory method of typing S. aureus (93). A separate spa typing protocol has also been 
developed for S. pseudintermedius (90). Both protocols analyse polymorphisms of region X of the spa 
gene. With only one gene analysed and a computerised output, spa typing is less time consuming and 
easier to interpret than PFGE. It has similar (90) or lower discriminatory ability than PFGE (184) but 
higher discriminatory ability than MLST, in that isolates from a single MLST sequence type can have 
different spa types (90). Like MLST, its computerised format makes it easier to compare results across 
studies than PFGE (62). Although many S. pseudintermedius isolates can be typed this way, not all S. 
pseudintermedius lineages contain a homologue of the spa gene and thus cannot be typed using this 
method (188). Consequently, in Chapters 3, 4 and 5, spa typing of isolates was complemented by a 
second highly discriminatory typing method, dru typing. 
 Direct repeat unit (dru) typing 
Most MRSA and many MRSP isolates harbour a cluster of 40 base pair (bp) direct repeat sequences 
within the SCCmec cassette, termed the direct repeat unit (dru) (189). Analysis of dru sequence 
variation was the basis of a PCR-based typing method reported by Goering et al. (190) in 2008. The 
authors examined 104 closely related clinical MRSA isolates from human hospitals that had previously 
been divided into just two PFGE types. Dru typing further discriminated 25 dru types amongst the 104 
isolates, highlighting the epidemiological utility of dru typing in a hospital setting where analysis of 
microvariation is integral to outbreak investigation (190). One advantage that dru typing has over spa 
typing is that dru types are carried within the SCCmec cassette, so the same dru typing method can be 
applied to any staphylococcal species that harbours a mec cassette. As a result, an online database 
exists that can be used to type any SCCmec-positive isolate, provided that researchers have obtained 
the dru sequence by PCR or whole genome sequencing. However, like the spa gene, not all isolates 
harbour a direct repeat unit (190). Consequently, Chapters 3, 4 and 5 used both spa and dru typing as 
discriminatory typing methods to more accurately characterise isolates that could not be typed by one 
of the two methods.  
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 SCCmec typing 
SCCmec typing provides information about the genetic origin of an isolate’s methicillin-resistance and 
its ecological niche. Methicillin-resistance is conferred by an apparently unique mobile genetic 
element that carries the mecA gene, called the staphylococcal cassette chromosome (SCCmec) (148, 
149). As well as carrying the mecA gene, SCCmec carries regulatory genes called cassette chromosome 
recombinase genes (ccr) that enable transfer of the element between bacteria (148), although their 
exact role in SCCmec transmission is yet to be determined. SCCmec typing uses DNA sequencing to 
analyse polymorphisms in the mec and ccr genes (191, 192).  In 2009, the International Working Group 
on the Classification of the Staphylococcal Cassette Chromosome Elements (IWG-SCC) described eight 
recognised SCCmec types in MRSA (193). As typing and PCR methods develop, more SCCmec types are 
being discovered and there are currently at least 10 recognised SCCmec types (194).  
Most MRSP isolates of animal origin can be SCCmec typed using the same methodology as described 
for MRSA of human origin, but occasionally the isolates cannot be typed because of unrecognised 
combinations of mec and ccr genes (184, 191, 192, 195).  Similar to MLST, it appears that SCCmec types 
may vary according to geographic location. SCCmec type V was the most common MRSP in dogs in 
USA (195), while types II and III were most common in Europe (184). The utility of SCCmec typing in 
public health epidemiology was shown when researchers in Korea SCCmec typed MRSA from bovine 
mastitis isolates and compared these to the SCCmec types from an outbreak community acquired 
MRSA (CA-MRSA) in humans (160). They found the two populations had different SCCmec types, 
thereby showing that the mastitis milk was not likely to be the source of the CA-MRSA outbreak. 
Although the SCCmec element was initially thought to be the only method of widespread mecA 
acquisition in staphylococci, Perreten et al. (188) found pseudo-SCCmec elements in several MRSP 
isolates. The pseudo-SCCmec element of MRSP ST45 described by Perreten et al. (2013) contains the 
mecA gene positioned adjacent to orfX, which is universally located close to SCCmec insertion sites, 
but does not contain any recombinase genes. This suggests that ccr genes are not an integral part in 
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all mobile genetic elements that confer methicillin-resistance(196). As recombinase genes comprise 
one of the key components of SCCmec typing outlined by the IWG-SCC (193), SCCmec elements 
without ccr genes cannot be typed using traditional SCCmec methods. As a result, several pseudo-
SCCmec elements have now been reported (188, 197, 198) and it is clear that mec acquisition is not 
yet fully understood. Nevertheless, SCCmec typing can yield useful epidemiological information and 
was therefore used in several studies in this thesis. Chapter 4 outlines the diversity of SCCmec 
elements amongst Australian MRSP and describes a novel pseudo-SCCmec element in a cluster of 
MRSP from Melbourne, Victoria. 
 Transmission of staphylococci in veterinary medicine 
With the rise in methicillin-resistance amongst human and veterinary-associated staphylococci, there 
has been increased focus on the role that animals play in the transmission of resistant bacteria. More 
research has been conducted into the epidemiology of S. aureus and MRSA in humans than 
Staphylococcus spp. in the veterinary setting, and it is unclear to what extent the epidemiology of 
veterinary staphylococci mirrors the situation in human medicine. Around 30% of humans carry S. 
aureus (45) and these patients are generally more likely to develop nosocomial staphylococcal 
bacteraemia than patients who are not S. aureus carriers (199). Furthermore, patients who carry MRSA 
are more likely to develop nosocomial infections such as MRSA bacteraemia and surgical site infections 
than patients who harbour methicillin-susceptible S. aureus (MSSA) (199, 200). Isolates from infections 
are generally identical to that carried by the patient, suggesting that at least some nosocomial S. 
aureus and MRSA infections are endogenous (201, 202).  
Analogous to MRSA carriage being a risk factor for development of certain nosocomial infections in 
humans, MRSP carriage was recently identified as a risk factor for development of post-operative 
infections in 549 canine patients undergoing tibial plateau levelling osteotomy surgery  (203). The dru 
types of MRSP from infection sites were almost always the same as those carried by each dog pre-
operatively, again suggesting that the infections were endogenous  (203). Other risk factors for MRSP 
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infections include a history of antibiotic use, chronic skin disease, prolonged hospitalisation and 
frequent vet visits (204-206). By far the most common pathogen in dogs is S. pseudintermedius, but 
infections with S. aureus do occur (60, 207). Soares Magalhaes et al. (207) found that prolonged 
hospitalisation and antibiotic use increased the likelihood of a S. aureus infection being methicillin-
resistant. In addition, they found that contact with a human who had been unwell in the last two 
months also increased the risk of an MRSA infection. Dogs have been shown to share S. aureus clones 
with their owners, and are more likely to carry S. aureus if their owner is a health care worker (208). 
Most studies find that MRSA infections in companion animals are likely of human origin (209, 210), 
but there is also evidence to suggest that zoonotic transfer of MRSA and MRSP can also occur from 
animals to humans. A recurrent MRSA surgical site infection in a diabetic human patient was only 
eradicated once MRSA carriage in a pet dog was eliminated by treatment with vancomycin nasal 
ointment (52). Contact with pigs is a clear risk factor for MRSA carriage in piggery workers and pig 
veterinarians (211, 212). Veterinarians treating dogs, cats and horses are also at increased risk of MRSA 
and MRSP carriage compared to pet owners and veterinarians who don’t treat these animals  (29, 213-
215). It is not yet known if contact with animals alone or additional risk factors are responsible for the 
increased rate of MRSA and MRSP carriage seen in companion animal veterinarians. In this context, 
Chapter 5 describes a pilot study that examined MRS carriage amongst 46 veterinary personnel in 
Sydney, Australia. 
It is clear that staphylococci are shared between humans and animals, but much remains to be 
determined about staphylococcal transmission between humans and animals. Chapter 3 describes 
how MRSA carried by Australian veterinarians is related to MRSA infections in Australian animals, 
while Chapter 5 examines the transmission of MRSP and MRSA amongst the veterinary personnel, 
their pets and patients in two Sydney veterinary hospitals. In order for the true significance of MRSP 
carriage to be accurately assessed, establishing an estimate of local baseline prevalence was required. 
Therefore, Chapter 5 also describes a screening study that examined the frequency of MRSP amongst 
151 canine hospital admissions in Sydney, Australia. 
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 Biocide tolerance in antimicrobial-resistant Staphylococcus spp. 
History has repeatedly demonstrated that the development and use of new antimicrobials creates 
selection pressure, resulting in the development of new modes of antimicrobial resistance amongst 
bacteria. The inevitable effect of selection pressure has led human and animal physicians to seek 
alternative methods of infectious disease management besides antibiotics, such as topical treatment 
and infection prevention measures (216). Topical treatments such as chlorhexidine-based shampoo 
can be effective primary or adjunct treatment for various types of pyoderma involving MRSP in dogs 
without the need for systemic antimicrobials (217, 218). In light of this, recently published 
international treatment guidelines recommend anti-staphylococcal topical therapies as the treatment 
of choice for superficial or localised pyoderma involving methicillin-resistant staphylococci (219). In 
addition to their role as topical therapeutics, biocides such as chlorhexidine are also useful in curbing 
the spread of resistant infections. This is exemplified by the success of chlorhexidine-based hand 
hygiene programs in human hospitals that have been shown to significantly reduce the incidence of 
nosocomial MRSA bacteraemia (220, 221). Chlorhexidine is also recommended as a pre-operative 
patient and surgeon cleaning agent in veterinary surgical textbooks and publications (222, 223).  
Cationic biocides such as chlorhexidine and benzalkonium chloride exert their effect by disrupting the 
negatively-charged outer layers of the cell (224). Theoretically, such physical bombardment requires 
a complex counterattack from bacteria, making it unlikely that rapid genetic change such as a point 
mutation would result in phenotypic resistance to biocides. Biocides may consequently appear to be 
an attractive alternative to systemic antimicrobials because of the decreased selection pressure that 
they exert. However, newer research has questioned the overuse of biocides for a number of reasons 
including the possibility that their use may actually select for antimicrobial resistance (216, 225). Efflux 
pumps can extrude toxic substances such as biocides from the bacterial cell. The quaternary 
ammonium compound (QAC) family of proteins are a group of efflux pumps implicated in extrusion of 
cationic quaternary ammonium compounds such as benzalkonium chloride, a common veterinary 
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biocide (226, 227). QAC proteins are encoded by qac genes and these genes have been associated with 
increased in vitro tolerance to benzalkonium chloride and chlorhexidine (226, 227). The presence of 
qac genes appears to confer a selective advantage to certain MRSA clones within human hospitals 
(225), but the significance of qac genes amongst veterinary staphylococci such as MRSP was previously 
unknown. Consequently, Chapter 7 describes a study that screened 125 veterinary staphylococci for 
qac genes and investigated the in vitro efficacy of chlorhexidine and benzalkonium chlorhexidine. 
 Scope and aims of this thesis 
The high profile of Staphylococcus as a human pathogen has meant that there is already a large body 
of research into the epidemiology of staphylococcal disease. It is also a significant veterinary pathogen, 
and veterinary literature has not lagged far behind human medicine in reports focussed on 
staphylococci. Despite this large body of work, much remains to investigate in the Australian veterinary 
setting. By conducting a surveillance study in 2013, the research in this thesis first sought to establish 
baseline data about the frequency and molecular epidemiology of MRSA and MRSP in Australian 
animals, the foremost methicillin-resistant species in veterinary medicine. Given that Staphylococcus 
spp. clearly circulate between humans and animals, the studies in this thesis also sought to shed light 
on staphylococcal epidemiology at the human-animal interface. The 2013 surveillance study yielded a 
convenient collection of S. felis isolates, which afforded the opportunity for a thorough investigation 
into this little-understood pathogen of cats. As methicillin-resistant and multidrug-resistant 
staphylococci continue to emerge in veterinary medicine, we will likely need to draw on additional 
infection control measures besides systemic antimicrobials. It was consequently investigated whether 
two common veterinary biocides were still effective against veterinary MRSP and MRSA in vitro. Whole 
genome sequencing and bioinformatics were used extensively throughout all studies, producing a 
volume of typing and gene-screening data that would not have been possible just a few years before 
this thesis commenced.  
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Together, the five studies contained within this thesis aim to significantly increase the overall 
understanding of the epidemiology of staphylococci in the Australian veterinary setting and provide a 
suitable platform for ongoing studies. 
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Chapter 2. General materials and methods 
 Staphylococcus isolate acquisition and storage 
Sample collection for this thesis was undertaken in several stages and used several different 
methodologies, as outlined below.  
2.1.1 Surveillance isolate acquisition 
Veterinary diagnostic laboratories (VDLs) from all states and territories of Australia were asked to 
participate in a nationwide surveillance study into antimicrobial resistance in coagulase-positive 
Staphylococcus spp. Isolates were collected from January 2013 to January 2014 from all 22 Australian 
VDLs. VDLs were located across all Australian states and territories (Figure 2.1). Inclusion criteria for 
sample submission to the surveillance study were: a) coagulase-positive staphylococci as determined 
by the VDLs’ standard diagnostic testing and b) a clinically significant sample. ‘Clinical significance’ was 
determined by VDL microbiologists, who were asked to use their judgement of culture results (heavy 
and pure cultures) and clinical information provided by the veterinarian (animal signalment and clinical 
signs) to decide whether the staphylococcal isolate was the likely causative agent of disease for each 
submission.  
 
Chapter 2  
Kate Alice Worthing thesis - March 2018   25 
 
Laboratories were asked to test the isolates as they normally would, but to also subculture and forward 
any coagulase-positive clinically significant Staphylococcus to the research team. Refrigerated isolates 
were sent on AmiesTM Agar Gel transport swabs (Copan Diagnostics, USA) taken from 24hr culture 
plates. Apart from their post code of origin, the submitting veterinary clinics remained anonymous. 
Where available from the veterinarians’ submission sheets, the following data was recorded for each 
isolate: the animal of origin (species, breed, sex, age), body system that the swab was taken from 
(skin/soft tissue, surgical site, respiratory, ear, ocular, bone/joint, genitourinary, mammary, other) and 
the disease process as recorded by the submitting veterinarian. When the research team received 
isolates from the laboratories, they were given a unique number based on their laboratory of origin. 
The isolates were then cryopreserved as outlined in 2.1.4.1.  
2.1.2 Acquisition of methicillin-resistant S. aureus and S. pseudintermedius carriage 
isolates 
From July 2015 to April 2017, healthy veterinary personnel, their respective pets and canine hospital 
admissions were screened for asymptomatic carriage of MRSA and MRSP as outlined below. Samples 
were taken from humans and animals associated with two veterinary hospitals in Sydney, NSW, 
Australia. The first hospital was a primary accession hospital located in an inner city suburb. The second 
hospital was a tertiary referral hospital located 10km west of the first hospital.  
 Isolation of Staphylococcus spp. from healthy veterinary personnel 
Sampling of veterinary personnel and their pets (dogs and/or cats) was undertaken over a two week 
period in February 2017. Veterinary personnel included veterinarians and support staff (veterinary 
nurses, kennel hands and administrative staff). Personnel were invited to participate whether or not 
they had pets at home. Personnel were instructed to take samples from themselves in their own home 
by inserting a single sterile swab into the anterior nares. Personnel were provided with the necessary 
Figure 2-1. (pg 24) Distribution of Australian veterinary diagnostic laboratories (VDLs) that submitted 
staphylococcal isolates to this study. Red diamonds indicate VDLs. 
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sampling materials and were instructed to wear gloves during the procedure and to refrigerate 
samples after the procedure. Once collected, samples were forwarded to the researcher with 24hr for 
further processing. All swabs were collected using AmiesTM Agar Gel swabs (Copan Diagnostics, USA). 
The study was approved by the University of Sydney Human Ethics Committee (Project 2016/837). 
 Isolation of Staphylococcus spp. from healthy dogs and cats owned by veterinary 
personnel 
In addition to veterinary personnel collecting samples from themselves (see Section 2.1.2.1), they 
were also asked to collect samples from up to three of their pet dogs and/or cats. Personnel were 
instructed to take three separate swabs from their pet/s’: 1) anterior nares (large dogs) or nasal 
planum (small dogs and cats); 2) oral cavity; and 3) perineum. Personnel were provided with the 
necessary sampling materials and were instructed to wear gloves during the procedure and to 
refrigerate samples immediately after the procedure. All swabs were again collected using AmiesTM 
Agar Gel swabs (Copan Diagnostics, USA) and were sent to the researcher within 48hr of collection. 
This part of the study was approved by the University of Sydney Animal Ethics Committee (Project 
2016/1072). 
 Isolation of Staphylococcus spp. from canine hospital admissions 
Similar to veterinary-owned pet dogs, swabs were taken from the nares/nasal planum, oral cavity and 
perineum of canine hospital admissions to two veterinary hospitals in Sydney. Samples were taken 
within 10 min of admission to hospital and were taken with the owner’s written consent. Swabs were 
refrigerated and forwarded for further processing by the researcher within 72hr of collection. Sample 
collection from hospital admissions was also approved by the University of Sydney Animal Ethics 
Committee (Project 2015/866). 
2.1.3 Acquisition of Staphylococcus spp. from the veterinary hospital 
Environmental sampling from a veterinary hospital in Sydney involved two sampling periods in October 
2016 and February 2017. Both sampling expeditions occurred on a single day. AmiesTM Gel agar swabs 
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that were pre-moistened with sterile saline were used for sampling. In order to detect bacteria with 
potential higher tolerance to low levels of veterinary biocides, residual disinfectants were not 
neutralised prior to environmental sampling. To take samples, pre-moistened swabs were gently rolled 
for five seconds across the following areas: 1) patient cages (one swab each for cage latch, cage floor, 
right cage wall and cage roof (where accessible without a ladder);  2) waiting room chairs (one pooled 
swab for the seat, back and right front leg of five chairs); 3) door handles (one pooled swab for each 
of the two door handles to the following areas: consultation room (n= two rooms), treatment room, 
radiology room, pharmacy and bathroom) 4) computer keyboards and mice (one pooled swab for the 
computer equipment in two consultation rooms, treatment room and radiology room) and one mobile 
telephone owned by a veterinary staff member. Samples were refrigerated prior to further processing. 
2.1.4 Sample storage of prospectively collected samples 
Samples collected in Sections 2.1.2 and 2.1.3 were refrigerated at 2-4°C on AmiesTM Agar Gel swabs 
generally within 48 hr. If storage was required for greater than one week, they were subcultured onto 
5% sheep blood agar (Oxoid, Hampshire) or tryptose agar (Difco, Franklin Lakes) and incubated at 37°C 
for 18-24 hr. Isolates were either processed directly after incubation or were refrigerated at 2-4°C for 
up to two months. Within two months of subculturing, all isolates underwent phenotypic testing as 
outlined in Section 2.2 and then underwent cryopreservation as follows. 
 Cryopreservation of Staphylococcus spp. isolates 
Isolates from the aforementioned surveillance and carriage studies were prepared for storage at -80°C 
using a 2:1 mixture of brain heart infusion broth (BHIB):glycerol. BHIB was provided as a substrate and 
sterile 65% glycerol was used as the cryoprotectant. After overnight incubation at 37°C on sheep blood 
or tryptose agar, approximately 30-50 colonies were inoculated into the BHIB:glycerol mixture. The 
suspension was then thoroughly mixed using gentle pipetting. The isolates were prepared as 
duplicates and then transferred to two separate -80°C freezers. Sterile 1.8mL CryoPure tubes were 
used for storage (Sardsedt, Germany). 
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2.1.5 Freeze-dry storage and retrieval of archived Staphylococcus spp.  
Chapter 7 examined biocide tolerance amongst a mixed collection of staphylococci that included an 
archival collection of MRSP. These isolates originated as submissions made to the Veterinary Pathology 
Diagnostic Service (VPDS) at the University of Sydney between 1952 and 2008 that had been freeze 
dried and stored by the Faculty of Veterinary Science. To prepare isolates for freeze drying, colonies 
of Staphylococcus isolates were grown on sloped plates of 5% sheep blood agar (Oxoid, Hampshire) or 
tryptose agar (Difco, Franklin Lakes) and incubated at 37°C for 18-24 hr. The agar slopes were then 
washed with sterile skim milk and the colonies were emulsified with the milk by gentle pipetting. 
Approximately 100μL of the mixture was placed into sterile glass ampoules before being snap frozen 
in dry ice and plugged with cotton wool. The plugged ampoules were freeze dried overnight and then 
vacuum sealed to create a small pellet of skim milk and bacteria at the base of the ampoule. Multiple 
identical vials were made for each bacterial isolate. The ampoules were stored at 4°C or at room 
temperature. To retrieve the isolates, the freeze dried plugs were resuspended in 100μL of sheep brain 
heart infusion broth and placed on tryptose agar. The isolates were incubated at 37°C for 18-24 hr. 
Following incubation, single colonies were subcultured onto 5% sheep blood agar and incubated at 
37°C for 18-24 hr. The subcultured isolates underwent phenotypic tests to check for purity and 
contamination (Gram staining, catalase and coagulase (slide clumping factor and tube coagulase 
tests)). Several colonies of the subcultured isolates were then prepared for cryopreservation for future 
use, as described in 2.1.4.1. 
 Species determination of Staphylococcus isolates 
2.2.1 Phenotypic tests 
To confirm the species of staphylococci in all studies, isolates underwent phenotypic tests and matrix 
assisted laser desorption ionisation time of flight mass spectrometry (MALDI-TOF MS). All isolates were 
subcultured onto 5% sheep blood agar and incubated at 37°C for 18-24 hr prior to testing. Isolates 
were either inoculated directly from transport swabs, subcultured from storage agar plates or 
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retrieved from cryopreserved samples. Isolates underwent Gram staining, catalase testing and tube 
coagulase testing as outlined below. Gram-positive, catalase-positive isolates underwent MALDI-TOF 
MS as described in Section 2.2.2.   
 Gram stain 
Hucker’s modification of the Gram stain was performed as follows. A flamed loop was used to emulsify 
a small portion of a colony within a drop of water that had been placed on a glass slide. The 
emulsification was spread to a thin layer and allowed to air dry. Once dry, the slide was heat-fixed by 
briefly passing the slide through a Bunsen flame. The fixed slide was flooded with Hucker’s Crystal 
Violet (Merck, Darmstadt) for 1 min, and then washed with water. The slide was flooded with Gram’s 
iodine for 1 min and washed with water. Decolourisation with 95% ethanol was performed until the 
slide produced a clear run off. Safranin (Fluka, Castle Hill) was used to counterstain the slide for 10 sec. 
Safranin was washed off with water; the slide was blotted dry and examined under oil emersion at 
1000X magnification. 
 Catalase test 
The catalase test was used to differentiate Staphylococcus spp. from Streptococcus spp. A sterile 
platinum loop was used to emulsify a single colony into a droplet of 3% hydrogen peroxide on a glass 
slide. The presence of instant bubbling was indicated the presence of catalase (228). 
 Tube coagulase test 
A sterile loop was used to colonies into a sterile test tube containing 0.3mL sterile EDTA rabbit plasma 
(Sigma Aldrich, USA). The tubes were then incubated at 37°C for 4 hrs, with visual checks at 1, 2 and 4 
hrs. Formation of a clot in the rabbit plasma within the 4 hrs was deemed a positive result, and no 
further observation was undertaken if a positive result was received within 4 hrs. If the isolates had 
not produced a clot after 4 hrs of incubation, they were left at room temperature overnight. Samples 
were observed after 18-24 hr at room temperature. Samples that had produced a solid clot that did 
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not dislodge when the tube was inverted at 4 or 24 hr were deemed coagulase-positive, while those 
that produced no clot were coagulase-negative. 
2.2.2 Matrix-assisted laser desorption/ionisation- time of flight (MALDI-TOF MS) mass 
spectrometry  
The species of all Gram-positive, catalase-positive isolates was confirmed using matrix assisted laser 
desorption ionisation time of flight mass spectrometry, which was undertaken using the BD™ Bruker 
MALDI Biotyper in positive linear mode (m/z = 2000–20,000). Isolates were subcultured onto tryptose 
agar and incubated at 37°C overnight prior to testing. A small amount of a single colony of each pure 
culture was transferred to a FlexiMassTM target well using a disposable loop, overlaid with 0.5μL of 2,5-
dihydroxybenzoic acid matrix solution (DHB; 10 mg/mL in acetonitrile/0.1% trifluoroacetic acid 1:1) 
and air-dehydrated within 1–2 min at 24–27C° before being placed in the spectrometer. If no 
dendrogram peaks were obtained in the first run, isolates were again transferred to the target but 1μL 
20% formic acid was applied to the isolate prior to the matrix solution being applied. All isolates were 
run in duplicate and results with a confidence score above 1.8 were deemed acceptable for speciation. 
All Staphylococcus spp. underwent antimicrobial susceptibility testing as follows. 
 Antimicrobial susceptibility testing  
All Staphylococcus spp. collected in the surveillance study (Chapters 3 and 4) underwent antimicrobial 
susceptibility testing by both manual broth microdilution and disk diffusion according to the Clinical 
Laboratory Standards Institute (CLSI) guidelines (173), as outlined in Sections 2.3.1 and 2.3.2. As 
previously described (229), when CLSI guidelines for animals were not available, human CLSI guidelines 
were used (174) or data was interpreted based on European Committee on Antimicrobial Susceptibility 
Testing guidelines and/or using ECOFFinder (230).  Isolates were tested against 18 antimicrobials from 
nine drug categories. Rather than using antimicrobial ‘classes’ to classify organisms as multi-, 
extensive- or pan-drug resistant, we used the drug ‘category’ system previously described (231). This 
method of classification groups antimicrobials into broader ‘categories’ than the traditional system of 
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antimicrobial ‘classes’. Magiorakos et al. (231) argued that the use of categories is more valid for 
epidemiological studies than the class system, as pathogens such as MRSA and MRSP are automatically 
multidrug-resistant when defined by the class system, due to their resistance to almost all β-lactam 
classes. The following antimicrobial categories (231) were tested, with the drugs from each category 
in parentheses: anti-staphylococcal β-lactams (oxacillin, cefoxitin, amoxicillin-clavulanic acid, 
cephalothin, cefovecin, ceftriaxone); aminoglycosides (gentamicin, amikacin); ansamycins 
(rifampicin); fluoroquinolones (enrofloxacin, ciprofloxacin, marbofloxacin, pradofloxacin); folate 
pathway inhibitors (trimethoprim-sulfamethoxazole); lincosamides (clindamycin); macrolides 
(erythromycin); phenicols (chloramphenicol) and tetracyclines (tetracycline). Most antimicrobials 
were tested by both disk diffusion and broth microdilution. However, for the macrolides, erythromycin 
(ERY) was tested by disk diffusion only. For the aminoglycosides, gentamicin (GEN) was tested by disk 
diffusion and amikacin (AMK) was tested by broth microdilution. Antimicrobials were obtained from 
Sigma Aldrich (Australia) and Zoetis (Australia). S. aureus ATCC 25923 and ATCC 29213 were used as 
quality control strains. Isolates defined as ‘Intermediate’ according to CLSI guidelines were defined as 
resistant in this study. S. pseudintermedius isolates were classified as phenotypically methicillin-
resistant if their oxacillin MIC was ≥0.5mg/L and/or disk diffusion diameter ≤17mm. S. aureus isolates 
were classified as methicillin-resistant if cefoxitin resistant (MIC ≥ 8mg/L and/or disk diffusion 
diameter ≤21mm). Methicillin-resistance was confirmed by detection of the mecA or mecC gene (174) 
as determined by whole genome sequencing. 
While Chapters 3 and 4 used the method described above, isolates in all other studies underwent 
automated broth microdilution antimicrobial susceptibility testing using Vitek 2TM (bioMerieux, USA), 
according to the manufacturer’s instructions. 
2.3.1 Broth microdilution 
The minimum inhibitory concentration (MIC) of antimicrobials was determined using the broth 
microdilution according to the CLSI guidelines (173, 174, 229). Antimicrobials were obtained from 
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Sigma Aldrich (USA) and Zoetis (Australia). S. aureus ATCC 25923 and ATCC 29213 were used as control 
strains. MICs were performed in cation-adjusted Mueller-Hinton broth (Becton, Dickinson and 
Company, USA) and serially diluted antimicrobial agents. MIC was defined as the lowest antimicrobial 
concentration that completely inhibited bacterial growth and was determined after 16-20 hr 
incubation at 35°C.  
2.3.2 Disk diffusion 
Antimicrobial disk diffusions was undertaken using the direct colony suspension method according to 
the CLSI guidelines for bacteria isolated from animals (173). Prior to testing, isolates were subcultured 
onto tryptose agar and incubated at 37°C overnight. Three to five colonies were then suspended in 
sterile saline and inoculum density was adjusted until suspension turbidity visually matched the 0.5 
McFarland standard (approximately 1.5 x 108 CFU/mL).  The suspension was inoculated onto 100mm 
Mueller-Hinton agar plates using sterile cotton swabs to streak the entire plate. Antimicrobial disks 
were then placed onto the Mueller-Hinton agar plates using a commercial disk applicator device (BD, 
Sparks). Three or four disks were placed on each plate. The plates were incubated at 37°C for 18-24 hr 
after which the zones of inhibition were viewed and measured. All disks were BD brand (BD BBLTM 
Sensi-DiskTM, Sparks) except cefovecin (Oxoid, Basingstoke). All phenotypically methicillin-resistant S. 
aureus and S. pseudintermedius underwent whole genome sequencing and in silico analysis, as well as 
all S. felis isolates collected in the surveillance study. 
 Whole genome sequencing 
Whole genome sequencing was used as an analytic tool in every study of this thesis. DNA was extracted 
from staphylococcal samples using the Qiagen DNA MiniAmp kit (Qiagen, Valencia, USA), with 
modifications. To prepare for DNA extraction, isolates were subcultured onto tryptose agar and 
incubated overnight at 37°C. Between four to eight colonies were then inoculated into 10mL sterile 
plastic tubes containing a 6mL lemcose broth and incubated for a further 18-36 hr at 37°C. Cell pellets 
were prepared from the broth by centrifuging the tubes at 8000xrpm for 10min. The supernatant was 
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removed except for 50µl liquid, then the cell pellet and liquid were transferred to 1.5mL 
microcentrifuge tubes before being centrifuged a second time at 8000xrpm for 5 min. Cell pellets were 
then frozen at -20°C. To achieve cell wall lysis, frozen cell pellets were resuspended in 180μL lysozyme 
200mg/mL (Sigma Aldrich, USA) and incubated at 37°C for 1 hr. DNA extraction then continued 
following the Qiagen DNA MiniAmp protocol for Gram-positive bacteria. DNA yield and purity 
(A260/A280) were measured using the Nanodrop 1000 spectrophotometer (Thermo Scientific, Delaware, 
USA). Only DNA samples with a A260/A280 purity ratio over 1.8 were used for further analysis. DNA 
extractions with lower purity ratios underwent repeat extraction. DNA concentration was verified 
using the QuBit dsDNA kit (Thermo Scientific, Delaware, USA) and standardised to 0.2ng/µl by dilution 
with sterile distilled water. DNA library preparation was then performed according to the 
manufacturer’s instructions of a commercial DNA library preparation kit (Nextera, Illumina, San Diego, 
USA). Whole genome sequencing was performed using the NextSeq 500 Desktop Sequencer, according 
to the manufacturer’s instructions (Illumina, San Diego, USA). Whole genome sequencing yielded 
250bp paired-end reads as fasta and fastq files.  
 In silico analysis  
The molecular epidemiology of sequenced isolates was determined largely by in silico analysis. De novo 
assembly of Illumina sequence files was carried out using CLC Genomics Workbench computer 
software under default settings (Qiagen, Valencia, USA). When the following basic local alignment 
search tool (BLAST) analyses were performed, sequences required at least 90% homology to the 
reference sequence unless otherwise stated. 
2.5.1 Genomic confirmation of species and methicillin-resistance 
Confirmation of staphylococcal species was determined by identification of the species-specific 
thermonuclease (nuc) gene in assembled contigs. This was achieved by downloading the nuc genes of 
S. aureus, S. pseudintermedius and S. felis from the National Centre for Biotechnology Information 
(NCBI) database (https://www.ncbi.nlm.nih.gov; accession numbers:  GU129659.1, AB327164.1 and 
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AB465335.1 respectively). A local BLAST database of nuc sequences was created and blasted against 
de novo contigs. BLAST results required >99% homology with the respective nuc sequence to be 
deemed a particular species. Detection of mecA and its homologues was similarly performed by 
downloading the relevant sequences and creating a local BLAST database of mecA, mecB and mecC 
(Accession numbers: CP003166.1, NG_047953.1 and FR821779.1 respectively). 
2.5.2 Multilocus sequence typing  
MecA or mecC-positive S. aureus and S. pseudintermedius isolates from the surveillance study 
underwent manual MLST, while isolates from all other studies underwent automated MLST using an 
online bioinformatics platform. For manual MLST, a local BLAST database was created in CLC Genomics 
Workbench by downloading the alleles listed from the MLST databases for S. aureus 
(http://saureus.mLst.net) and S. pseudintermedius (https://pubmLst.org/spseudintermedius/). As per 
the relevant databases, the seven loci used for MLST were arcC, aroE, glpF, gmk, pta, tpi and yqiL for 
S. aureus and ack, cpn60, fdh, pta, purA, sar and tuf for S. pseudintermedius. Downloaded MLST alleles 
were blasted against de novo assembled contigs. Isolates were assigned an MLST type by entering 
allelic profiles into the respective MLST websites for S. aureus and S. pseudintermedius. The previously 
described seven allele MLST schemes were used S. aureus (183) and S. pseudintermedius (185). In 
2016, an online bioinformatics platform became available in Australia that was capable of providing 
the MLST of S. aureus and S. pseudintermedius (https://cge.cbs.dtu.dk/services/MLST/) (232). 
Consequently, MRSP and MRSA from all studies except the surveillance study underwent MLST using 
this platform. De novo contigs were loaded onto the respective MRSA and MRSP online MLST 
platforms, which provided the allelic profile and multilocus sequence type of each isolate. 
2.5.3 SCCmec typing 
SCCmec typing was performed by downloading the mec gene complex and ccr elements of SCCmec 
from the NCBI online database (http://www.ncbi.nlm.nih.gov/), according to the SCCmec elements 
described by the International Working Group on the Staphylococcal Cassette Chromosome (193). A 
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local BLAST database was created and SCCmec element sequences were then blasted against de novo 
contigs.  
2.5.4 Spa typing  
For MRSA isolates, spa types were obtained by uploading fasta files onto the online bioinformatics 
platform https://cge.cbs.dtu.dk/services/spatyper/ (233). For MRSP, no online spa typing platform 
currently exists. Consequently, manual spa typing was performed on fastq files using CLC Genomics 
Workbench. Spa repeat codes described for S. pseudintermedius (90) were downloaded from the spa 
typing website, http://www.pse-spa.org/. As contigs from de novo assembly tend to cleave at repeat 
regions, 250bp fastq raw read files were analysed. Fastq files were searched for spa repeat codes and 
neighbouring regions were searched for subsequent spa repeats. Spa types were assigned according 
to spa repeat sequence profiles described by Moodley and colleagues (90). 
2.5.5 Dru typing 
Similar to spa typing in S. pseudintermedius, no online dru typing platform for MRSA or MRSP currently 
exists. Consequently, dru typing was performed manually using CLC Genomics Workbench. Dru repeats 
were downloaded from the dru typing website, http://dru-typing.org/site/ (190) A local BLAST 
database of dru repeats was made and contigs were examined to determine order of dru repeats, 
starting with the 5a repeat sequence. Contig segments required 100% homology with a repeat 
sequence to be deemed positive for that dru repeat. Dru types were assigned by entering the dru 
repeat succession onto the dru typing website. 
2.5.6 Resistance and virulence gene screening  
Isolates were screened for virulence and/or resistance genes in several of the studies in this thesis. To 
achieve this, the nucleotide sequences of antimicrobial resistance and resistance genes were 
downloaded from the open-access bioinformatics websites, ResFinder 
(https://cge.cbs.dtu.dk//services/ResFinder/) (234) and VirulenceFinder 
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(https://cge.cbs.dtu.dk/services/VirulenceFinder/) (235) respectively. A BLAST database was created 
in CLC Genomics Workbench and the study sequences were then blasted against de novo contains. 
Most studies also screened for additional elements not contained within the ResFinder and 
VirulenceFinder databases, the details of which can be found in each of the following chapters. 
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Chapter 3. Molecular characterisation of methicillin-
resistant Staphylococcus aureus isolated from 
Australian animals and veterinarians 
The content of this Chapter is published in two journal articles, as follows: 
Worthing KA, Coombs GW, Pang S, Abraham S, Saputra S, Trott DJ, Jordan D, Wong HS, 
Abraham RJ, Norris JM. (2016) Isolation of mecC MRSA in Australia. Journal of Antimicrobial 
Chemotherapy 71, 2348-2349 
Worthing KA, Abraham S, Pang S, Coombs GW, Saputra S, Jordan D, Wong HS, Abraham RJ, 
Trott DJ, Norris JM. (2017) Molecular characterisation of methicillin-resistant Staphylococcus 
aureus isolated from Australian animals and veterinarians. Microbial drug resistance: Doi: 
https://doi.org/10.1089/mdr.2017.0032 (accepted and online June 17th, 2017) 
 Abstract 
This study aimed to determine the frequency and molecular epidemiology of methicillin-resistant 
Staphylococcus aureus (MRSA) from Australian animals and to determine whether animal-derived 
MRSA was similar to that from Australian veterinarians. A total of 1080 coagulase-positive clinical 
Staphylococcus isolates from Australian animals were collected during 2013. Sixteen (4%) of 360 S. 
aureus isolates were MRSA. Most MRSA came from companion animals, while none came from the 
203 dairy cattle examined. MRSA isolates were characterised using whole genome sequencing. ST22-
IV (EMRSA-15) was the most common clone in dogs and cats. CC8 was most common in horses. Most 
ST22-IV isolates were resistant to ciprofloxacin. Animal-derived MRSA genomes were interrogated for 
the presence of host-specific genetic markers (scn, chp, sak, sea and vwb). A subset of MRSA genomes 
previously collected from Australian veterinarians was also interrogated. There was no clear pattern 
in the distribution of host-specific markers amongst animal and veterinarian isolates. Animal and 
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veterinarian-derived MRSA were intermingled in the phylogenetic tree. The absence of MRSA in 
Australian dairy cattle is in contrast with its presence in dairy cattle from other countries. Possible 
explanations include Australia’s geographic isolation, the absence of live animal importation into 
Australia and the restrictions placed on the use of antimicrobials of critical importance in Australian 
livestock. 
 Introduction 
Methicillin-resistance has been detected in several staphylococcal species, but methicillin-resistant S. 
aureus (MRSA) is the foremost Staphylococcus species in human medicine. Since its first isolation in 
the 1960s (38), MRSA has become a major nosocomial pathogen in human hospitals around the world 
and is a common cause of community-acquired skin and soft tissue infections (39). MRSA is also a 
veterinary pathogen, with a recent study from Germany noting an MRSA frequency of 52% amongst 
canine, equine and feline S. aureus wound infections (35). In other European countries, Asia and the 
Americas, MRSA has also been identified in bovine mastitis samples, food-producing animals and 
companion animals (32-34, 236, 237). There is evidence that animals may act as a reservoir for MRSA 
in humans via contamination of the food chain (238) or via transmission between humans, pets (52) 
and farm animals (32). However, the epidemiology of MRSA in veterinary medicine is yet to be fully 
elucidated. 
S. aureus is thought to readily adapt to various host species, and several studies have investigated 
specific markers for host adaptation (11-15). Five potential markers have been described, all located 
on mobile genetic elements. They include the staphylokinase gene (scn), staphylococcal complement 
inhibitor gene (sak), chemotaxis-inhibiting proteins gene (chp), enteroxin A gene (sea) and Von 
Willebrand Factor binding protein gene (vwb). The presence of bacteriophage-mediated scn, sak, chp 
and sea are thought to be markers of adaptation towards humans because of their specificity to the 
human immune cascade (11, 12, 14, 239). vwb is located both in the core genome and on mobile S. 
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aureus pathogenicity islands (SaPIs) (15). Variation of SaPI vwb alleles is thought to enable S. aureus 
adaption towards ruminants or horses by facilitating host-specific coagulation activity (15).  
MRSA in animals appears to have a defined clonal distribution, with certain MRSA clones found in 
particular populations of animals and in their human contacts.  For example, the international 
epidemic healthcare-associated ST22-IV clone, colloquially known as EMRSA-15, is the most frequently 
isolated MRSA clone in dogs and cats (33-35, 210) and in their veterinarians (210, 214, 240). Australian 
equine veterinarians are more likely than other veterinarians to carry clonal complex 8 MRSA (240), 
an MRSA clonal complex (CC) which has also been reported in Australian horses (241). In the Australian 
porcine industry, CC398 MRSA, typically deemed a livestock-associated lineage associated with pigs 
(32), has recently been isolated at low frequency in Australian pigs (242) and from an Australian pig 
veterinarian (240). It appears that there is an association between human contact with certain animal 
species and the likelihood of not only carrying MRSA, but of carrying a particular clone of MRSA. 
Several studies have documented the presence of MRSA in animals and veterinarians (210, 238) but 
only sporadic reports of MRSA in animals in Australia exist (241, 242), and the frequency and molecular 
epidemiology of MRSA in Australian animals is currently unknown. Australia is geographically isolated 
from the rest of the world, does not import livestock and has unique antimicrobial prescribing 
regulations for food producing animals. These differences make Australia an interesting comparison 
to previous surveillance reports from the rest of the world. Previous studies have used genetic markers 
of host specificity to infer the origin of staphylococcal isolates (11, 12, 14, 15, 239), but no study has 
specifically searched for these markers in veterinarian and animal isolates. Consequently, the aims of 
this study were to 1) determine the frequency of MRSA amongst clinical submissions of Staphylococcus 
spp. from animals in Australia; 2) determine the molecular epidemiology of MRSA from clinical disease 
in Australian animals; and 3) determine whether the presence or absence of host immune adaptation 
markers amongst isolates from Australian animals and veterinarians could elucidate patterns of host 
adaptation in MRSA isolates.  
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 Materials and methods 
3.3.1 Sample acquisition and speciation 
Animal-derived Staphylococcus aureus isolates were collected during the first national Australian 
survey into antimicrobial-resistant coagulase-positive staphylococci (CPS) in animals (229). Samples 
were collected from January 2013 to January 2014 from all 22 Australian veterinary diagnostic 
laboratories (VDLs) as outlined in Section 2.1.1. S. aureus isolates were identified by routine 
phenotypic laboratory methods and by the BD™ Bruker MALDI Biotyper™, as per Section 2.2.2. The 
genomic sequences of nineteen human-derived MRSA were also examined, originating from a 
previously reported collection of carriage samples retrieved from the anterior nares of Australian 
veterinarians in 2009 (213, 240). The 19 veterinarian-derived MRSA isolates had previously been 
sequenced to determine their MLST type, and were deemed to be representative of a larger collection 
of 44 isolates, as described in the report by Grove and colleagues (240).  
3.3.2 Phenotypic antimicrobial resistance profiling 
The phenotypic antimicrobial resistance profile of each animal-derived isolate was determined by 
broth micro-dilution and disk diffusion, according to the CLSI guidelines as outlined in Section 2.3.  For 
disk diffusion, erythromycin was additionally used and gentamicin was used instead of amikacin as an 
aminoglycoside. If there was discrepancy between broth micro-dilution and disk diffusion results, 
assignment was made based on the presence or absence relevant resistance genes. Genetic resistance 
markers were not used for rifampicin and ciprofloxacin, so the micro-dilution result was used in 
preference to disk diffusion to determine the phenotypic resistance status for these antimicrobials. An 
isolate was classified as methicillin-resistant if phenotypically cefoxitin-resistant and it harboured the 
mecA or mecC gene in whole genome sequenced data. 
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3.3.3 Whole genome sequencing  
Whole genome sequencing was performed on all phenotypically methicillin-resistant CPS. DNA was 
extracted from overnight lemcose broth cultures using the Qiagen DNA MiniAmp kit, according to the 
manufacturer’s instructions for Gram-positive bacteria (Qiagen, Valencia, USA) as described in Section 
2.4. DNA library preparation was performed using the Nextera XT DNA genomic library preparation kit 
(Illumina, San Diego, USA). Whole genome sequencing was performed using the MiSeq System 
according to the manufacturer’s instructions (Illumina, San Diego, USA). De novo and reference 
assembly was performed using CLC Genomics Workbench computer software (CLCbio, Qiagen, USA).  
3.3.4 In silico analysis 
Molecular typing and resistance/virulence gene detection was performed on whole genome sequence 
data using the bioinformatics program, CLC Genomics Workbench (CLCbio, Qiagen, USA). MLST, 
SCCmec-, spa-, and dru typing were undertaken as described in Section 2.5. Resistance and virulence 
gene screening was also undertaken as per Section 2.5.6. In addition to resistance and virulence genes, 
MRSA isolates were also screened for immune evasion genes. Human immune evasion genes were 
downloaded from the open-access bioinformatics websites, 
(https://cge.cbs.dtu.dk/services/VirulenceFinder/) (235). The nucleotide sequence for chp, an immune 
evasion cluster gene not included in the Virulence Finder database, was downloaded from the NCBI 
database (https://www.ncbi.nlm.nih.gov; accession number: AF285146.1). Similarly, the sequences of 
animal-specific variant vwb alleles (15) were downloaded from the NCBI database (Accession numbers:  
HM211303, HM228919 and HM228920 respectively.)  
3.3.5 Phylogenetic tree construction 
A phylogenetic tree was generated using the online bioinformatics program, CSI Phylogeny 1.4 
(https://cge.cbs.dtu.dk/services/CSIPhylogeny/) (243). Briefly, this program used a Maximum 
Likelihood algorithm to depict inferred phylogeny based on concatenated alignment of high quality 
single nucleotide polymorphisms. To construct the tree, fasta files of all genomes were upload to the 
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online platform, which aligned them to a reference genome (EMRSA-15, accession number: 
HE681097). FigTree 1.4.3 was used to optimise visualisation of the phylogenetic tree. 
 Results 
3.4.1 Proportion of MRSA amongst clinical veterinary submissions 
A total of 1080 unique CPS isolates were collected during the study.  Consecutive samples from the 
same animal were initially received in the study, but only unique isolates from each animal were 
included in sample analysis. Isolates were identified as S. pseudintermedius (n= 669), S. aureus (n= 
360), S. schleiferi (n= 44), S. hyicus (n= 3), S. intermedius (n= 2) and S. delphini (n= 2). Of the 360 S. 
aureus, 203 (56%) came from bovine mastitis samples. The remaining S. aureus were isolated from 
horses (n=53), dogs (n=48), cats (n=18), birds (n=5), pigs (n=3), rabbits (n=2), goats (n= 2), and one 
isolate each from a kangaroo, sheep, wallaby and guinea pig. Animal species was not recorded for 22 
S. aureus isolates. Overall, 4% (16/360) of S. aureus were MRSA (Table 3.1).  
 
Fifteen of the MRSA isolates came from companion animals (six horses, six dogs and three cats). The 
remaining isolate came from a kangaroo. The proportion of methicillin-resistance amongst the 119 
companion animal S. aureus isolates was 13%. None of the 203 bovine S. aureus were methicillin-
Table 3-1. Methicillin-susceptible (MSSA) and resistant Staphylococcus aureus (MRSA) submissions as a 
proportion of 360 S. aureus isolated from animals in Australia, 2013-2014. 
Staphylococcus aureus 
isolates (%) 
Bovine Equine Canine Feline Porcine Other Total 
MSSA 203 (100%) 47 (88%) 42 (87%) 15 (83%) 3 (100%) 34 (97%) 345 (96%) 
MRSA  0 6 (12%) 6 (13%) 3 (17%) 0 1 (3%) 16 (4%) 
Total 203 53 48 18 3 35 360 
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resistant. Fourteen of the 16 MRSA isolates came from different post codes, suggesting MRSA in 
Australian animals is geographically dispersed. Two equine isolates, both ST8-IV, came from a single 
postcode and thus likely originated from the same veterinary clinic. Amongst the remaining 720 CPS 
isolates, methicillin-resistance was only detected in S. pseudintermedius (Chapter 4).  
3.4.2 Molecular epidemiology of animal-derived MRSA 
The molecular epidemiology of the 16 MRSA isolates is shown in Table 3.2. The most frequently 
identified MRSA clone was ST22-IV (n=8), isolated from four dogs, two cats, a horse and a kangaroo. 
Apart from a single ST22-IV isolate, all equine MRSA were CC8 (ST612-IV and ST8-IV). Fifteen of the 
sixteen isolates harboured a type IV SCCmec element. The final isolate, ST425 from a cat, harboured a 
type XI SCCmec cassette, as detailed below (244). The most frequently identified spa types were four 
t379 (associated with ST22-IV) and four t064 (associated with ST612-IV/ST8-IV).  A variety of dru types 
were identified. Two isolates, ST93-IV and ST30-IV both from dogs, were PVL positive. The phenotypic 
and genotypic antimicrobial resistance profile for the animal derived MRSA is shown in Table 3.2. The 
genomic sequences from all MRSA isolates have been deposited as biosamples at GenBank, under the 
accession numbers SAMN04537353 (KW2: ST425 mecC from a cat) and SAMN0654665 to 
SAMN06546698 (all other samples). 
3.4.3 First detection of mecC MRSA in Australia 
While 15 of the 16 MRSA isolates harboured the mecA gene, one harboured a mecC gene. The mecC 
isolate was collected in February 2013 from the mandible of a five year old domestic cat located in a 
semi-urban area of Melbourne, Victoria. The isolate had an oxacillin and cefoxitin MIC of 2 and 32 
mg/L respectively. The isolate was tested using the PBP2a latex agglutination test according to 
manufacturer’s instructions (Oxoid, Thermo Scientific, Basingstoke, UK) and was negative. Although 
resistant to β-lactams, the isolate was susceptible to all other antimicrobials tested including 
ciprofloxacin, marbofloxacin, pradofloxacin, enrofloxacin, tetracycline, chloramphenicol, rifampicin 
and trimethoprim-sulfamethoxazole. MecA was not detected in whole genome sequence data. The 
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isolate was characterised as MLST ST425 with an SCCmec type XI element. De novo contigs were 
blasted against a SCCmec type XI reference (mecC MRSA LGA251, GenBank accession number: 
FR821779.1) (147), which allowed identification of the mecC type 8 ccr (ccrA1 and ccrB3) genes. The 
mecC gene had 96% and 100% sequence similarity to the mecC described in S aureus LGA251 (147) 
and S. sciuri GVGS2 (245) respectively.  
3.4.4 Phylogenetic analysis 
Phylogenetic tree construction showed clustering of MRSA isolates according to MLST type, with 
animal isolates sharing clustering with veterinarian isolates (Figure 3.1).  All ST22-IV isolates, including 
those from both animals and veterinarians, clustered within a single clade. Equine- and human-derived 
ST8-IV and ST612-IV isolates also clustered within the CC8 same clade. ST425-XI, ST30-IV and ST93-IV 
were distantly related to each other and to the other isolates.  
3.4.5 Host-specific adaptation markers amongst animal- and veterinarian-derived MRSA 
isolates 
Eleven animal-derived MRSA isolates harboured at least one human immune evasion complex (IEC) 
gene.  None of the animal-derived isolates possessed the ruminant or equine-associated variant of 
vwb (Table 3.3). Meanwhile, 15 of the 19 veterinarian-derived MRSA isolates harboured IEC-associated 
genes and one isolate (ST398) harboured the ruminant-associated variant of the vwb gene, vwb-sb04. 
The ST398 MRSA was isolated from a pig veterinarian (240), and did not harbour any human IEC-
associated genes. 
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Table 3-2. Genotypic and phenotypic characterisation of 16 methicillin-resistant Staphylococcus aureus isolates from animals in Australia, 2013-2014 
Isolate Vet clinic region Origin MLST SCCmec Spa type Dru type Resistance phenotype Resistance genotype 
KW8    QLD Cat, skin ST22 IV t379 dt8h FOX, CIP blaZ, mecA 
KW1 Unknown  Cat, skin ST22 IV t3457 dt10j FOX, CIP blaZ, mecA 
KW4 NT Dog, surgical site ST22 IV t379 dt10a FOX, CIP blaZ, mecA 
KW12 QLD Dog, surgical site ST22 IV t790 dt9ah FOX, CIP blaZ, mecA 
KW3 QLD Dog, surgical site ST22 IV t845 dt9ah FOX, CIP blaZ, mecA 
KW13 Vic Dog, surgical site ST22 IV t2122 dt10e FOX, CIP blaZ, mecA 
KW6 NSW Kangaroo, surgical site ST22 IV t379 dt10a FOX, CIP blaZ, mecA 
KW5 NSW Horse, corneal ulcer ST22 IV t1302 dt10az FOX, CIP, ERY blaZ, mecA, ermC 
KW10 Vic  Horse, skin ST612 IV t064 dt7d FOX, ERY, TET, CHL, SXT, RIF, GEN blaZ, mecA, ermC, tetK, cat(pC221,) dfrA, 
aac(6')-aph(2'') 
KW11 NSW Horse, joint ST612 IV t723 dt7d FOX, TET, SXT, RIF, GEN blaZ, mecA, tetK, dfrA, aac(6')-aph(2'') 
KW16 Unknown Horse, catheter site ST612 IV t064 dt9z FOX, TET, SXT, RIF, GEN blaZ, mecA, tetK, dfrA 
KW7 NSW Horse, catheter site ST8 IV t064 ND FOX, ERY, TET, SXT, RIF, GEN blaZ, mecA, ermC, tetK, dfrA, aac(6')-aph(2''), 
aadD 
KW9 NSW Horse, surgical site ST8 IV t064 dt10g FOX, ERY, TET, SXT, RIF, GEN blaZ, mecA,ermC, dfrA, aac(6')-aph(2''), aadD 
KW14 NT Dog, skin ST93 IV t10656 dt9ah FOX blaZ, mecA 
KW15 Vic Dog, surgical site ST30 IV t019 dt10m FOX mecA 
KW2 Vic Cat, mandible ST425 XI t6292 ND FOX blaZ, mecC 
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ND, determined. Vic= Victoria, NSW= New South Wales, QLD= Queensland, NT= Northern Territory. FOX= cefoxitin, ERY= erythromycin, TET= tetracycline, SXT=  trimethoprim-sulfamethoxazole, RIF= 
rifampicin, GEN= gentamicin, CHL= chloramphenicol 
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Figure 3-1. (Page 47). Phylogenetic tree of animal- and veterinarian-derived methicillin-resistant 
Staphylococcus aureus isolates, generated using a Maximum Likelihood algorithm constructed by 
CSIPhylogeny 1.4 and optimised using FigTree v1.4.3. Length of branches indicates the approximate 
number of single nucleotide polymorphisms (SNPs). EMRSA-15 (ST22, accession number: HE681097) 
was used as the reference genome. Shapes indicate the species of animal from which the MRSA was 
isolated, or the species of animal treated by the veterinarian. Square= horse, circle= dog or cat, 
diamond= pig, star= kangaroo, triangle= mixed practice. Hollow shapes indicate isolates from 
veterinarians, black shapes indicate isolates from animals. 
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Table 3-3. Host-specificity markers in methicillin-resistant Staphylococcus aureus isolates from animals 
and veterinarians in Australia 
Isolate Origin MLST Human immune evasion 
cluster genes 
Animal variant vwb gene 
KW1 Cat ST22 0 0 
KW8 Cat ST22 0 0 
KW2 Cat ST425 0 0 
KW3 Dog ST22 sak, chp 0 
KW4 Dog ST22 sak, chp, scn 0 
KW13 Dog ST22 0 0 
KW12 Dog ST22 0 0 
KW14 Dog ST93 sak, chp, scn 0 
KW15 Dog ST30 sak, chp, scn 0 
KW6 Kangaroo ST22 sak, chp, scn 0 
KW5 Horse ST22 sak, chp, scn 0 
KW10 Horse ST612 scn, sea 0 
KW11 Horse ST612 sak 0 
KW16 Horse ST612 scn 0 
KW7 Horse ST8 scn, sea 0 
KW9 Horse ST8 sak, scn, sea 0 
VET1  Human ST59 sak, chp, scn, sea 0 
VET2 Human ST22 sak, chp, scn 0 
VET3 Human ST22 sak, scn, sea 0 
VET4 Human ST22 0 0 
VET5 Human ST22 0 0 
VET6 Human ST22 sak, chp, scn 0 
VET7 Human ST22 sak, chp, scn 0 
VET8 Human ST5 0 0 
VET9 Human ST8 sak, scn, sea 0 
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 Discussion 
This study found 4% of clinical veterinary S. aureus isolated in Australia in 2013 were methicillin-
resistant. The frequency of MRSA varied, depending on animal species.  No MRSA was identified in 
cattle, while 13% of S. aureus isolated from companion animals were methicillin-resistant. The 
frequency of MRSA amongst companion animals was lower in this study than in previous studies from 
Europe and the USA (35, 60), but due to differences in study design and sample population, the current 
results cannot be directly compared to previous reports. For example, a study from Germany reported 
52% of S. aureus wound infections from dogs, cats and horses were methicillin-resistant (35). While 
this is a high rate of MRSA infection, bacterial wound infections in companion animals are more likely 
to be due to MRSA than other types of infections (246). Thus, the population of animals in the German 
wound infection study (35) would have an intrinsically higher proportion of MRSA than other 
populations.  
As reported in previous studies of MRSA in companion animals, the most frequently isolated MRSA 
clone in this study was ST22-IV (EMRSA-15) (33-35, 210). In Australia and elsewhere, ST22-IV is also 
the most frequently carried clone amongst small animal veterinarians (214, 240), is the most common 
clone isolated from hospital-onset MRSA bacteraemia in Australia (247) and colonises Australian 
VET10 Human ST8 sak, scn, sea 0 
VET11 Human ST8 sak, chp, scn, sea 0 
VET12 Human ST8 sak, scn, sea 0 
VET14 Human ST8 sak, scn 0 
VET13 Human ST612 sak, scn, sea 0 
VET15 Human ST612 sak, scn, sea 0 
VET16 Human ST78 sak, scn 0 
VET18 Human ST398 0 vwb-sb04 
VET17 Human ST78 sak, scn 0 
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human healthcare workers with a greater frequency than other MRSA clones (248). Conversely, ST22-
IV carriage was not detected in two Australian studies that sampled healthy humans with no known 
association to hospitals (249, 250). Previous reports have suggested veterinary personnel may be the 
source of MRSA infections to their patients (209). However, a common population of MRSA can 
circulate between companion animals and humans (34), so pet owners should be considered an 
additional potential source of MRSA for their pets, particularly if the owner is a health care worker 
(208) or has a history of hospitalisation (134). Regardless of the directionality of transmission of MRSA 
between companion animals and humans, ST22-IV MRSA is over-represented in hospital settings, and 
this clearly extends to veterinary hospitals.  
Just as isolates from dogs and cats in this study came from similar clonal MRSA types as Australian 
companion animal veterinarians, the predominance of CC8 MRSA lineages ST612-IV and ST8-IV 
amongst the equine isolates in this study mirrors previously reported carriage of these clones by 
Australian equine veterinarians (240). This is in contrast to the low incidence of CC8MRSA in the rest 
of the Australian population (247). All six of the MRSA from horses were multidrug-resistant, with 
resistance to at least three classes of antimicrobials. With the exception of one equine ST22 isolate, 
the equine isolates demonstrated a common pattern of resistance to cefoxitin, tetracycline, 
trimethoprim-sulfamethoxazole, gentamicin and rifampicin. A similar pattern of resistance amongst 
CC8 isolates was seen in MRSA from Australian equine veterinarians (240). Four equine isolates also 
harboured the ermC gene and were resistant to erythromycin. ermC was not detected in any other 
MRSA isolates. This could reflect a difference in selection pressure between horses and other 
companion animals, because erythromycin is commonly combined with rifampicin to treat 
Rhodococcus equi-associated pneumonia in foals but it is seldom used in dogs and cats. Alternatively, 
the ermC-positive isolates could have been associated with humans more recently than the ermC-
negative isolates, as ermC has previously been flagged as marker of human-associated infections (34). 
As in-contact humans were not sampled in this study, the true relationship of animal and veterinarian-
derived ST22-IV and ST612-IV MRSA isolates cannot be fully elucidated. Nevertheless, the mirroring of 
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MRSA clonal lineages in animals in this study with carriage by Australian veterinarians (240) adds to 
the mounting evidence that MRSA may be shared between humans and animals and that clonal niches 
may be present within different veterinary environments. 
In contrast to MRSA in companion animals, there were no MRSA isolates amongst the 203 bovine 
mastitis submissions. To date, the only report of MRSA in Australian dairy cattle is of a single dairy cow 
where reversed zoonotic transfer of a human-derived clone was suspected (251). The paucity of bovine 
mastitis MRSA reports and the results of the present study strongly suggest that the frequency of MRSA 
in Australian dairy cattle is currently very low. MRSA has been isolated from bovine samples in Europe 
(237) and around the world including Australia’s close neighbour, New Zealand (236), so the absence 
of MRSA in Australian dairy cattle is somewhat surprising. However, dairy farm management practices 
could have contributed to the apparent lack of MRSA in Australian dairy cattle. It is common for cows 
with refractory S. aureus mastitis to be culled from the herd so refractory mastitis cases, potentially 
caused by MRSA, may not have been sent to the laboratory or subsequently included in this study 
(252). The absence of MRSA amongst Australian bovine samples could also be due to the current low 
frequency of livestock-associated CC398 MRSA within Australia.  Although CC398 was not detected in 
the current study, it has recently been identified in pigs (242) and a pig veterinarian in Australia (240). 
Pigs can act as a reservoir for CC398 MRSA carriage (238) and infection (32) in humans. CC398 is also 
becoming an increasingly common cause of bovine mastitis (237). A recent study determined that the 
CC398 isolates found in animals in the United Kingdom likely came from mainland Europe (253), so 
importation of animals may be a risk factor for the presence of CC398 LA-MRSA within a country. The 
strict quarantine of Australian pig farms aims to prevent contact between cattle and pigs. This lack of 
contact between cattle and pigs and the ban of live importation of pigs and cattle into Australia could 
also explain why CC398 MRSA has not yet been detected in the Australian dairy cattle population.  
The absence of MRSA in dairy cattle in this study could also be influenced by the antimicrobial 
prescribing practices for food-producing animals in Australia. Unlike much of the rest of the world 
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(254), fluoroquinolones have never been registered for use in food-producing animals in Australia and 
third-generation cephalosporin use is restricted (255). Ceftiofur is the only third generation 
cephalosporin registered for cattle in Australia, and its labelled use is restricted to treatment of 
bacterial respiratory infections due to Mannheimia haemolytica, Pasteurella multocida and Histophilus 
spp. in individual cattle (ExcenelTM, Pfizer Animal Health, Australia). In contrast to food-producing 
animals, fluoroquinolones and third generation cephalosporins are registered and regularly used in 
dogs and cats in Australia (256). In horses, ceftiofur is registered for use in Australia while 
fluoroquinolones are used off label and are listed as a third line or ‘last resort’ antimicrobial for horses 
by the Australian Veterinary Association (256). In humans, treatment with fluoroquinolones has been 
shown to increase the risk of MRSA carriage and nosocomial MRSA infections (257, 258). In the absence 
of fluoroquinolone exposure amongst livestock, there may be less selection pressure for MRSA 
amongst Australian dairy cattle when compared to cattle exposed to fluoroquinolones. Meanwhile, 
selection pressure may be one reason why the ST22-IV MRSA isolates, which were primarily obtained 
from dogs and cats, were resistant to β-lactams and all fluoroquinolones tested but susceptible to 
other drugs. Holden et al.(259) suggested that the acquisition of fluoroquinolone resistance by ST22-
IV was one of the main drivers in its success as a nosocomial pathogen. The patterns of antimicrobial 
resistance in this study appeared to divide along MRSA clonal lines as well as by animal species, likely 
reflecting a complex epidemiology driven by clonal adaptation towards particular hosts and differing 
antimicrobial usage patterns between animal species. 
The distribution of host-specific genetic markers amongst the MRSA from animals and veterinarians 
was variable. Four of the veterinarian-derived isolates did not harbour human IEC genes, while none 
of the animal-derived isolates harboured the animal-associated vwb variant. The previously reported 
ST398 from a pig veterinarian (240) harboured the animal-associated vwb variant, sb04-vwb and was 
IEC-negative. This is in keeping with the reputation of ST398 as a livestock-associated MRSA lineage 
and provides further evidence that humans can carry such lineages (238). Three of the animal-derived 
and two human-derived ST22-IV isolates were IEC-negative, which is unusual because IEC genes are 
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highly conserved amongst ST22-IV isolates (259). The absence of IEC genes in a human-associated 
clone such as ST22-IV could indicate a move away from human adaptation in certain isolates, assuming 
that the phage-mediated IEC genes are lost when they no longer conferred a biological advantage to 
the isolate. Alternatively, the absence of IEC genes in human-derived ST22-IV isolates could suggest 
that S. aureus can still successfully colonise humans without harbouring these genes and thus, IEC 
genes may not be a reliable marker of human adaptation. Nevertheless, the finding that human- and 
animal-derived MRSA isolates had variably distributed host-adaptation markers is still noteworthy, 
because it shows ‘human-associated’ and ‘livestock-associated’ MRSA lineages do not necessarily stay 
within their assumed host species.  
Despite the veterinarian- and animal-derived MRSA samples being collected four years apart (2009 
and 2013 respectively), phylogenetic analysis showed that veterinarian and animal MRSA isolates 
shared the same clusters within the phylogenetic tree. Similar intermingling was found in phylogenetic 
analysis of ST22-IV from humans and companion animals in the UK (34). In this study, there was 
separation of isolates into a dog/cat-associated- ST22-IV cluster and an equine- associated CC8 cluster, 
further demonstrating how specific MRSA lineages may circulate within specific veterinary 
environments. 
Two isolates, ST93-IV and ST30-IV each from dogs, were PVL-positive. PVL-positive ST93-IV is the major 
cause of community-acquired MRSA infections in Australia (260). This is the first report of ST93-IV in a 
dog. Isolation of ST425-XI mecC MRSA in Australia was also a novel finding (244). ST425-XI MRSA is 
typically thought of as a livestock-associated MRSA lineage previously found only in Europe, but in this 
study it was isolated from a cat in semi-rural area of Victoria. The ST425-XI-t6292 lineage and absence 
of human immune evasion genes suggest the isolate could be linked to the dairy industry in the UK. 
Unfortunately, we were not able to obtain further epidemiological information about the cat, its origin, 
or its human contacts. Nevertheless, the detection of ST425-XI is pertinent because it demonstrates 
the often unexpected manner in which MRSA lineages may spread around the globe. The observed 
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disparity between cefoxitin and oxacillin susceptibility in the mecC isolate is consistent with previous 
reports (261, 262) and could serve as a flag for laboratory technicians that mecC-mediated methicillin-
resistance may be present. The negative result on PBP2a assay is also in keeping with other mecC-
positive isolates (263), showing the superiority of MIC testing over PBP2a detection as a phenotypic 
test for mecC-mediated resistance. The presence of a mecC isolate in this study highlights the 
importance of including mecA homologues such as mecC when using molecular assays for methicillin-
resistance amongst staphylococci. Finally, while human-associated methicillin-susceptible S. aureus 
clones have previously been reported in Australian macropods (264), this is the first report of MRSA in 
a kangaroo.  
The isolates in this study originated from clinical samples sent by private and government veterinarians 
and as a result, isolate submission may have been subject to a number of sampling biases. Firstly, 
financial cost may have discouraged animal owners to permit the attending veterinarian to send a 
sample for culture and susceptibility testing when it would otherwise have been clinically indicated. 
Secondly, it is possible that this study included more complicated clinical infections that warranted a 
veterinarian to send a sample for further testing, so isolates may be more likely to come from resistant 
infections that are not responding to treatment. Thirdly, although livestock associated CC398 MRSA 
was not detected in this study, this could be due to the very low number of samples from pigs in this 
study (n= 3). It could also be due to the focus of this study on samples collected from animals with 
clinical disease, so carriage of CC398 MRSA in Australian livestock would not have been detected. Given 
that CC398 has been isolated in Australian pigs (242), a focused surveillance study into the prevalence 
of MRSA carriage amongst Australian commercial piggeries is now warranted. Although this study 
demonstrates that some associations exist between MRSA clonal type and host animal species, it is 
limited by the small number of MRSA cases, the lack of detailed epidemiological information about 
each case and the absence of concurrent sampling of in-contact humans. Additionally, the non-
contemporaneous nature of veterinarian and animal sampling means that further associations 
between human and animal MRSA isolates may have been missed. A large-scale longitudinal study 
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investigating carriage and infection amongst animals and all in-contact humans is clearly required so 
that the epidemiology of MRSA in animals and humans in Australia can be more clearly elucidated.  
 Conclusion 
In summary, sixteen out of 360 (4%) clinical S. aureus isolates in this study were MRSA. The presence 
of human-associated MRSA lineages in animal hosts, livestock-associated MRSA in humans, and the 
heterogeneity of host immune markers amongst the isolates in this study add to evidence that MRSA 
can circulate between humans and animals. The presence of MRSA in Australian companion animals 
and veterinarians should serve as a further reminder for human physicians and veterinarians to 
consider all human and animal contacts as potential sources of MRSA. The presence of MRSA in 
Australian companion animals starkly contrasts with its absence amongst cattle and this finding adds 
further weight to the important role that antimicrobial stewardship plays in curbing antimicrobial 
resistance.  
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Chapter 4. Molecular epidemiology of methicillin-
resistant Staphylococcus pseudintermedius in 
Australian animals 
The content of this Chapter is published in the following journal article: 
Worthing KA, Abraham S, Pang S, Coombs GW, Saputra S, Jordan D, Trott DJ, Norris JM. (2018) 
Clonal diversity and geographic distribution of methicillin-resistant Staphylococcus 
pseudintermedius from Australian animals: discovery of novel sequence types. Veterinary 
Microbiology, 213, 58-65 
 Abstract 
This study examined the molecular epidemiology of clinical MRSP isolated from Australian animals. 
Clinical staphylococci submitted to all Australian veterinary diagnostic laboratories were collected 
during 2013 and identified using traditional phenotypic tests and matrix-assisted laser desorption 
ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Phenotypic antimicrobial resistance was 
determined using broth microdilution and disk diffusion. MRSP isolates were characterised by whole 
genome sequencing which included identification of the mecA gene. Phylogenetic relationships were 
inferred by comparison of single nucleotide polymorphisms. Of the 669 S. pseudintermedius isolates 
collected from dogs, cats and cattle samples, 77 (11.5%) were MRSP. Nineteen multilocus sequence 
types (STs) were identified, with most isolates belonging to one of five STs (ST71, ST497, ST316, ST496 
and ST45). Phylogenetic analysis revealed that Australian ST71 appears closely related to ST71 from 
overseas. ST497 and ST496 represented novel sequence types not previously reported outside 
Australia. Most other STs were novel and only distantly related to each other. Geographical clustering 
of STs was observed. All isolates belonging to the five main STs were multi- to extensively drug-
resistant while isolates from singleton STs generally had lower levels of antimicrobial resistance. The 
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frequency of ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin, chloramphenicol and 
tetracycline resistance varied significantly between STs (p<0.01).  Six SCCmec types were identified. 
Oxacillin MIC varied significantly between SCCmec types. We characterised ΨSCCmecKW21, a novel 
pseudo-SCCmec element found in nine geographically-clustered MRSP isolates. Australian MRSP 
isolates are phylogenetically diverse, with a mix of previously unreported and well known international 
MRSP clones that demonstrate geographic clustering and exhibit both multidrug-resistant and 
extensively drug-resistant phenotypes. 
 Introduction  
Methicillin-resistance in S. pseudintermedius (265) is a more recent phenomenon than in S. aureus (38) 
but its frequency has increased remarkably, ranging from 8.7% to 28% of S. pseudintermedius 
infections in dogs overall (59, 162-165) and up to 60% of canine S. pseudintermedius pyoderma cases 
(166). Many methicillin-resistant S. pseudintermedius (MRSP) are also multidrug-resistant (266), 
leaving veterinary clinicians with few treatment options. MRSP can be carried by pet owners (27) and 
veterinarians (29) and is an occasional zoonotic pathogen (30). MRSP appears able to acquire and 
maintain multidrug-resistance (151) (resistant to three or more antimicrobial categories) and extensive 
drug-resistance (susceptibility to two or less antimicrobial categories) (231). Its propensity for 
horizontal transfer of genetic resistance determinants makes it a potential threat to public health (151, 
266).  
MLST has identified several dominant MRSP lineages around the world, including ST71 in Europe and 
Asia (59, 162, 163, 184, 267), ST68 in North America (184, 266) and ST45 in Asia (188, 266). This 
suggests that successful MRSP clones may circulate amongst the dogs in a particular geographic area. 
In addition to a growing body of literature researching the distribution of MLST types amongst MRSP 
populations, recent studies have found that SCCmec typing may provide useful information about the 
epidemiological origin of isolates.  Echoing the epidemiological division of MRSA into hospital-
associated (HA) and community-associated (CA) lineages (268, 269), Kasai et al. (270)  (2016) found 
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that SCCmec II-III isolates may represent HA-MRSP lineages and SCCmec V isolates may represent CA-
MRSP. Although early anecdotal reports of MRSP in Australia coincided with reports from other 
countries, MRSP was not reported in Australia in the scientific literature until 2014 (271, 272). A recent 
study conducted in parallel with this thesis examined 888 clinical Staphylococcus spp. isolates collected 
from Australian companion animals in 2013 and found that 11.8% of S. pseudintermedius submissions 
were MRSP (229). However, the molecular epidemiology of Australian MRSP has not yet been 
examined. Consequently, the current study aimed to determine the molecular epidemiology of 77 
MRSP isolates collected from Australian animals in 2013. 
 Methods 
4.3.1 Sample acquisition, speciation and antimicrobial susceptibility testing 
S. pseudintermedius were collected in 2013 during the first Australian survey into antimicrobial 
resistance in veterinary clinical isolates and involved all 22 Australian veterinary diagnostic laboratories 
(VDLs) (See Section 2.1.1) (229). Preliminary staphylococcal speciation was determined by traditional 
phenotypic tests and confirmed by the BD™ Bruker MALDI Biotyper, as outlined in Section 2.2.2. While 
the previous study focused on the phenotypic antimicrobial resistance profiles of 629 S. 
pseudintermedius collected from dogs and cats in the surveillance study (229), the current study 
screened a larger collection of 669 S. pseudintermedius isolates collected from companion animal, 
food-producing animals and samples where no animal species was recorded. S. pseudintermedius 
samples came from dogs (n= 619), cats (n= 13) and cattle (n= 4). No species were recorded for the 
remaining 33 isolates. Repeat isolates from the same animal, indicated by repeated laboratory 
submission numbers, were removed from the study. 
The phenotypic antimicrobial resistance profile of each isolate was determined by broth microdilution 
and disk diffusion according to the CLSI guidelines, as described in Section 2.3. Most antimicrobials 
were tested by both disk diffusion and broth microdilution. However, for the macrolides, erythromycin 
(ERY) was tested by disk diffusion only. For the aminoglycosides, gentamicin (GEN) was tested by disk 
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diffusion and amikacin (AMK) was tested by broth microdilution. Antimicrobials were obtained from 
Sigma Aldrich (Australia) and Zoetis (Australia). S. aureus ATCC 25923 and ATCC 29213 were used as 
quality control strains. If a discrepancy between broth microdilution and disk diffusion occurred, 
assignment was made based on the presence or absence of the relevant resistance genes. As genetic 
resistance markers were not used for rifampicin and ciprofloxacin, the microdilution result was used 
to determine the resistance status. Isolates defined as ‘Intermediate’ according to CLSI guidelines were 
defined as resistant in this study. An isolate was classified as methicillin-resistant if phenotypically 
oxacillin resistant (oxacillin MIC ≥0.5mg/L and/or disk diffusion diameter ≤17mm) and harboured the 
mecA or mecC gene as determined by whole genome sequencing. 
4.3.2 Whole genome sequencing, in silico typing and resistance gene screening  
Whole genome sequencing was performed on all phenotypically methicillin-resistant S. 
pseudintermedius using the MiSeq System (Illumina), as previously described (273) and outlined in 
Section 2.4. De novo assembly, molecular typing and resistance gene detection were performed using 
the bioinformatics program, CLC Genomics Workbench (CLCbio, Qiagen, USA). Determination of MLST 
spa typing, dru typing and resistance gene screening were undertaken as described in Section 2.5. 
Novel sequence types were assigned by the MLST database curator 
(vincent.perreten@vetsuisse.vbi.unibe.ch). For fluoroquinolone resistance, isolates were screened for 
mutations in the topoisomerase II (gyrA) and IV genes (grlA). Screening was performed by downloading 
gyraA and grlA sequences (Accession numbers: AM262968 and AM262971 respectively), creating an 
alignment in CLC Genomics Workbench and screening for nucleotide polymorphisms associated with 
fluoroquinolone resistance (274). 
4.3.3 SCCmec typing 
SCCmec typing was performed by downloading the sequences of the mec gene complex and ccr 
elements of the SCCmec elements described by the International Working Group on the Staphylococcal 
Cassette Chromosome (IWGSCC) (http://www.sccmec.org/Pages/SCC TypesEN.htmL) from the NCBI 
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online database (http://www.ncbi.nlm.nih.gov/). SCCmec elements previously identified in S. 
pseudintermedius (ΨSCCmec57385 (188), II-III1381 (274), SCCmecAL16 (197), SCCmecNA45 (275) and VII241 
(274)) but not included on the SCCmec working group website were also downloaded. Downloaded 
SCCmec element sequences underwent BLAST against de novo contigs using CLC Genomics 
Workbench™. BLAST results required at least 90% homology to be assigned a particular ccr or mec 
gene complex. If an SCCmec type could not be assigned, contigs were mapped against a scaffold of 
reference SCCmec types (193) and the reference methicillin-susceptible S. pseudintermedius genome, 
ED99 (Accession: CP002478.1). Novel elements were then annotated manually using the BLASTn 
algorithm in CLC Genomics Workbench™, and compared to existing elements using EasyFig (Python, V. 
5).  
4.3.4 Phylogenetic analysis of MRSP isolates 
A phylogenetic tree was generated to infer evolutionary history, by uploading Illumina paired-end 
sequencing reads to the Nullarbor bioinformatic pipeline software 
(https://github.com/tseemann/nullarbor). Single nucleotide polymorphisms (SNPs) in the core 
genome were identified by comparison with a reference genome (ST71 MRSP 081661, Accession 
number: CP16073.1). SNPs in recombination events were removed as previously described (276). A 
phylogenetic tree was constructed by MEGA (v7.0) (http://www.megasoftware.net/), using the 
Maximum Parsimony method (277). In order to infer the relationship of Australian MRSP with MRSP 
isolates from overseas, isolates were assigned to clonal clusters (CCs) using the BURST algorithm from 
the MLST database website, http://pubmLst.org/spseudintermedius/. The STs were compared to the 
entire S. pseudintermedius database, and were included within a CC if they were single- or double-
locus variants of the predicted complex founder.  
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4.3.5 Geographic mapping of isolates 
The postcode of the submitting veterinary hospital and ST of each isolate were mapped against an 
Australian postcode map using a geographic information system (http://www.aus-
emaps.com/postcode finder.php). 
4.3.6 Statistical analysis 
Two commercially available statistical programs were used to analyse the data (GraphPad Prism 6, 
2015 and GenStat 16, 2016). Proportions of antimicrobial resistance in each multilocus sequence type 
were compared using the chi-squared test or Fisher’s exact test as appropriate. Observed proportions 
of MRSP from each state were compared to expected MRSP proportions based on the total number of 
S. pseudintermedius submissions from each state. MLSTs and SCCmec types with more than eight 
isolates were compared as separate entities in analyses; other isolates were grouped together. The 
Kruskal-Wallis test was used to determine whether the median oxacillin MICs differed across SCCmec 
types. The Mann-Whitney U test was then used to assess differences in the median oxacillin MIC 
between SCCmec types. Differences were considered significant if p<0.05. 
 Results  
4.4.1 Diversity of MRSP types  
Seventy seven (11.5%) of the 669 S. pseudintermedius isolates were identified as phenotypically 
methicillin-resistant and harboured the mecA gene. No isolates carried the mecC gene. Although a 
further six isolates were phenotypically methicillin-resistant, no mecA gene or homologue was 
identified and consequently these isolates were excluded from further molecular analysis. Of the 77 
genotypically-confirmed MRSP, 76 isolates were cultured from dogs and one isolated from a cat. 
Details of the molecular characteristics of the 77 MRSP are shown in Table 4.2. Nineteen STs were 
identified amongst the MRSP isolates. Five dominant STs (with more than five isolates) were present: 
ST71, ST497, ST316, ST496 and ST45. ST71 was the most frequently identified MRSP lineage (CC71: n= 
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26, 34% of MRSP isolates). Several sequences types (ST496, ST497, ST498, ST499, ST500, ST501, ST539, 
ST544 and ST547) had previously undescribed allelic profiles and were assigned new sequence types 
by the S. pseudintermedius MLST database curator. One isolate demonstrated a new cpn allele and 
was assigned a new sequence type, ST750. Six spa types were identified. The most frequent spa type 
was t05 (n= 20), followed by types t02 (n= 18), t06 (n = 8), t19 (n= 8), t09 (n = 3) and t15 (n= 1). Nineteen 
isolates did not harbour the spa variable repeat region and therefore could not be assigned a spa type. 
The most frequently identified dru types were dt9a (n= 25), dt11y (n= 10) and dt10t (n= 9).  The 
genomic sequences from all MRSP isolates have been deposited as biosamples at GenBank, under the 
accession numbers SAMN08741554 to SAMN08741522. 
4.4.2 Geographic distribution of MRSP lineages 
MRSP was found in veterinary hospitals from six of the eight Australian states and territories. The 
highest number of total S. pseudintermedius isolates came from the states of New South Wales (n= 
228/669; 34%) and Victoria (n= 159/669; 24%). Amongst the 77 MRSP isolates, 30 (39%) came from 
Victoria, which was significantly higher than the expected proportion of 24% based on total numbers 
of S. pseudintermedius from each state (OR= 2.1, CI= 1.1-4.0; p= 0.02). The frequency of MRSP from 
other states was proportional to the number of S. pseudintermedius submitted from that state. Figure 
4.1 shows the distribution of the major Australian MRSP lineages varied with geography. Isolates from 
Victoria (VIC) tended to be ST71 or ST497, while ST316 and ST496 isolates were primarily identified in 
New South Wales (NSW), and ST45 isolates were from Western Australia (WA). Seven ST71 isolates 
and nine of the eleven ST497 isolates came from neighbouring post codes in inner Melbourne, 
indicating they originated from the same clinic or neighbouring veterinary clinics.   
4.4.3 SCCmec types amongst Australian MRSP 
Table 4.1 shows that six SCCmec types were identified amongst the 77 MRSP isolates and that isolates 
from the same STs tended to harbour the same SCCmec type. Several STs shared the same SCCmec 
type.  
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Genome Finishing Module in CLC Genomic Workbench.  Isolate KW21 yielded a 59,691bp contig 
containing a complete sequence of the novel SCCmec element, described below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-1. SCCmec types and MLST of methicillin-resistant Staphylococcus pseudintermedius from 
animals in Australia, 2013-2014 
SCCmec type Multilocus sequence type 
II-III (n= 34)  ST71 (n= 25) 
ST316 (n= 8) 
ST25 (n= 1) 
V (n= 10) ST496 (n= 8) 
ST64 (n= 1) 
Novel ST (n= 1) 
C1/ccrC6 (n= 9) ST64 (n= 2) 
ST84 (n= 1) 
ST283 (n= 1) 
ST499 (n= 1) 
ST500 (n= 1) 
ST501 (n= 1) 
ST525 (n= 1) 
ST547 (n= 1) 
ΨSCCmecKW21 (n= 9) ST497 (n= 9) 
ψSCCmec57395 (n= 7) ST45 (n= 6) 
ST544 (n= 1) 
IVg (n= 5) ST498 (n= 3) 
ST258 (n= 1) 
ST539 (n= 1) 
Not typable (n= 3) ST497 (n= 2) 
ST71 (n=1)  
C1/ccrC6 harbours a C1 mec complex and ccrC6 element (275).   
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4.4.4 Characterisation of ΨSCCmecKW21, a novel SCCmec element from ST497 MRSP 
isolates 
The mec gene complex of KW21 had 99% homology with several class A mec gene complex sequences 
from the NCBI database, including MRSA N315, methicillin-resistant S. epidermidis RP62A and MRSP 
KM1381 (Accession numbers: BA000018.3, CP000029.1 and AM904732.1, respectively).  The complex 
contained a 1,680bp truncated mecR1 gene that was interrupted by a truncated Tn552-like blaZ-locus 
found in MRSA252 (Accession number: 571856.1) and MSSP ED99 (Accession number: NC017568.1). 
No mecI gene or insertion sequences were found in the area flanking mecR1. Consequently, KW21 was 
deemed to have a class D mec gene complex, which has previously been described in methicillin-
resistant S. caprae (280). The mec D gene complex adjacent to the Tn552-like blaZ-locus, which 
contained a contained a 633bp segment of the blaR gene that overlapped with the end of the truncated 
mecR1 gene. A full copy of the blaI was situated adjacent to truncated blaR/mecR gene. No ccr genes 
were identified in KW21. Ccr-negative SCCmec elements have previously been reported in MRSP (188) 
and are common in coagulase-negative staphylococci (281). BlaI was flanked by a 12 nucleotide 
sequence, ACTAATTTA, that had an inverse repeat adjacent to the orfX gene at the other end of the 
complex. The inverse repeats were presumed to represent the element’s approximate insertion sites. 
The SCCmec elements from the other eight isolates investigated also harboured blaI in lieu of a mecI 
gene, a truncated mecR1, and were void of ccr genes. Consequently, they were considered to have the 
same pseudo-element as KW21. We have designated the 7,802bp element ‘ΨSCCmecKW21’ (Figure 
4.2). 
4.4.5 Variation of oxacillin MIC amongst SCCmec types 
Figure 4.3 shows the oxacillin MIC range for the major SCCmec types. The median oxacillin MIC differed 
significantly depending on SCCmec type (Figure 4.3; p<0.001). The median oxacillin MICs of 
C1mec/ccrC6 isolates (4mg/L) and “other” SCCmec types (1mg/L) were significantly lower than the 
median oxacillin MIC of SCCmec II-III, SCCmec V and ΨSCCmecKW21 isolates (64mg/L; p<0.01). 
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4.4.6 Variation of antimicrobial resistance amongst STs 
The phenotypic and genotypic antimicrobial resistance profiles of the MRSP isolates are shown in Table 
4.2. Except for ansamycins, where genetic markers were not searched for, the presence of relevant 
resistance genes generally corresponded to phenotype (Table 4.3). Mutations in gyraA and grlA 
generally, but not always, corresponded with the fluoroquinolone resistance phenotype. Amongst 
ciprofloxacin-resistant isolates, 98% and 44% were positive for the gyrA and grlA amino acid 
substitutions, Ser84Leu and Ser80Ile respectively. Amongst ciprofloxacin-susceptible isolates, 44% 
isolates (all ST316 isolates) had the aforementioned gyrA and grlA substitutions. Three ST496 isolates 
were phenotypically resistant to chloramphenicol but had no detectable catpC221 plasmid (Table 4.2). 
All isolates belonging to ST71, ST497, ST316, ST496 and ST45 were multi- to extensively drug-resistant, 
as defined in Section 2.3 (231). Forty isolates from the main STs were extensively drug-resistant, with 
resistance to seven to eight of the nine antimicrobial categories tested. Eight isolates, mostly from 
singleton STs and ST64, showed low levels of resistance (resistance to 2 or less drug categories). The 
frequency of ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin, chloramphenicol and 
tetracycline resistance varied significantly between STs (Figure 4.4; p<0.01). Six MRSP isolates were 
resistant to rifampicin and were characterised as ST497 (n= 3), ST71 (n= 2) and ST45 (n= 1). The 
frequency of erythromycin, rifampicin and clindamycin resistance was not significantly different 
between STs (data not shown). Notably, the frequency of ciprofloxacin resistance in ST71 and ST496 
(100%) was significantly higher than in ST316, ST497 and “other” STs (63%, 54% and 32% respectively) 
while the frequency of chloramphenicol resistance in ST71 (8%) was significantly lower than all other 
STs (p<0.01). The frequency of tetracycline resistance in ST71 (32%) was also significantly lower than 
the 100% resistance seen in ST316, ST497 and ST496 (p<0.05). 
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Table 4-2. Molecular epidemiology of methicillin-resistant Staphylococcus pseudintermedius from animals in Australia, 2013-2014 
Clonal complex (CC) MLST  Spa type Dru type Resistance phenotype Resistance genotype 
CC71 ST71 (n= 26) t02   (n= 7) dt9a (n=6),  NT (n=1) OXA-ERY-CLI- CIP-SXT (n= 7), GEN (n= 6), 
TET (n= 2), CHL (n= 2),  RIF (n= 1) 
mecA, erm(B), aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia, dfr(G), aph(3ʹ)-III (n= 6),  
tet(K) (n= 2), catpC221 (n= 2) 
t05   (n= 13) dt9a (n=12), dt8b (n=1) OXA-ERY-CLI- CIP-SXT (n=13), GEN (n=12) mecA, erm(B), aph(3ʹ)-III,  dfr(G) (n= 13) aac(6ʹ)-Ie–aph(2ʹ)-Ia (n= 12), ant(6)-
Ia (n= 12) 
t06   (n= 6) dt9a OXA-TET-ERY-CLI-GEN-CIP-SXT (n= 6), RIF 
(n= 1) 
mecA. tet(K), aac(6ʹ)-Ie–aph(2ʹ)-Ia ,aph(3ʹ)-III, ant(6)-Ia,  dfrG (n=6),  erm(B) 
(n= 5)     
CC309 ST497 (n= 11) t02 (n=8 ) dt10t OXA-TET-ERY-CLI- CHL (n= 8)-GEN (n= 4), 
CIP (n= 4), RIF (n= 2) 
mecA, tet(M), erm(B), aph(3ʹ)-III, aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia, catpC221 
t05   (n= 1) dt10t OXA-TET- CLI-GEN-CHL-CIP 
t06   (n= 2) dt11y OXA-TET-ERY- CLI-CIP-CHL-RIF 
ST525 (n= 1) N/A dt9a OXA  mecA  
CC84 ST84  (n= 1) N/A dt11af OXA-ERY-CLI -GEN mecA, erm(B), aph(3ʹ)-III,  ant(6)-Ia 
CC45 ST45  (n= 6) t09   (n= 3), 
NT   (n= 3) 
 dt11cb (n=1), NT (n=5) OXA-TET-ERY-CLI-GEN-CIP (n= 6),CHL (n= 5), 
SXT (n= 3), RIF (n= 1) 
mecA, tet(M), erm(B), aph(3ʹ)-III , aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia (n=6),  
catpC221 (n= 5), dfr(G) (n= 3) 
CC258 ST498 (n= 3) N/A dt10as OXA-ERY-CLI-GEN mecA, erm(B), aph(3ʹ)-III, ant(6)-Ia (n= 3), aac(6ʹ)-Ie–aph(2ʹ)-Ia  (n= 1) 
 ST258  (n= 1) N/A dt10h OXA-TET-SXT mecA, tet(M), dfr(G) 
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ST316 (n= 8) t19  dt11y OXA-TET-ERY-CLI-GEN-CHL-SXT (n= 8), CIP 
(n= 5) 
mecA ,tet(M), erm(B),   aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia,  aph(3ʹ)-III, dfr(G) (n= 
8),  catpC221, (n= 7) erm(C) (n= 1) 
ST496 (n= 8) t02 (n=2) dt10a 
OXA-TET- ERY-CLI -GEN- CIP-CHL-SXT 
mecA , tetM, ermB,aph(3ʹ)-III, aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia, dfr(G) (n= 8), 
catpC221 (n= 5) 
t05 (n= 6) dt10a (n=2), dt4h (n= 2), NT (n=2) 
ST64  (n= 3) N/A dt11af  OXA- GEN (n= 3) ERY (n= 1) mecA, aac(6ʹ)-Ie–aph(2ʹ)-Ia, (n= 3), erm(C) (n= 1) 
ST25  (n= 1) N/A dt11a  OXA-TET-ERY-CLI-GEN-CIP-CHL-SXT mecA, tet(M), erm(B), aph(3ʹ)-III , aac(6ʹ)-Ie–aph(2ʹ)-Ia , catpC221, dfr(G) 
ST499 (n= 1) N/A dt11bn OXA mecA 
ST500 (n= 1) t15 dt11bn   OXA-ERY-CLI -GEN mecA ,tet(M), erm(B), aph(3ʹ)-III, aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia  
ST501 (n= 1) N/A NT   OXA-ERY-CLI -GEN   mecA ,tet(M), erm(B), aph(3ʹ)-III, aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia 
ST539 (n= 1) N/A dt10h OXA-GEN-SXT mecA, aac(6ʹ)-Ie–aph(2ʹ)-Ia, dfr(G)   
ST547 (n= 1) N/A dt11a OXA mecA 
ST750 (n= 1) N/A dt11a OXA-TET-ERY-CLI -GEN   mecA ,tet(M), erm(B), erm(C), apha(3), aac(6ʹ)-Ie–aph(2ʹ)-Ia  
ST283  (n= 1) t02 dt11a OXA-ERY-CLI -GEN mecA , erm(B), apha(3), aac(6ʹ)-Ie–aph(2ʹ)-Ia,  ant(6)-Ia 
ST544  (n= 1) N/A dt11a OXA mecA 
Bold and underlined text denotes that not all isolates were phenotypically resistant to that antimicrobial or harboured that gene: the number of isolates in which resistance was present is indicated in parentheses. 
Plain texts denotes that all isolates were phenotypically resistant or harboured the resistant gene. OXA= oxacillin, ERY= erythromycin, CHL= chloramphenicol, CIP= ciprofloxacin, CLI= clindamycin, GEN= gentamicin, 
RIF= rifampicin, SXT= trimethoprim-sulfamethoxazole, TET= tetracycline. Resistance genes: mecA= alternate penicillin binding protein 2 gene; tet(K) and tet(M)= tetracycline resistance gene; aph(3ʹ)-III = 
aminoglycoside phosphotransferase (neomycin/kanamycin resistance) gene;  aac(6ʹ)-Ie–aph(2ʹ)-Ia = aminoglycoside adenyl-/phosphotansferase (gentamicin/tobramycin resistance) gene;   ant(6)-Ia = 
aminoglycoside nucleotidyltransferase (streptomycin resistance) gene; catpC221= chloramphenicol acetyltransferase gene;   dfr(G)= dihydrofolate reductase gene  mediating trimethoprim resistance; erm(B) and 
erm(C)= rRNA methyltransferase genes associated with macrolide/lincosamide resistance. NT= new dru type 
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Figure 4-5. (Page 72) Phylogenetic tree of methicillin-resistant Staphylococcus pseudintermedius from 
Australian animals, 2013-2014, derived from Maximum Parsimony analysis. Analyses were conducted in 
MEGA v7.0, from 3,603 SNPs in the core genome of 76 isolates. ST71 MRSP 081661 was used as the 
reference genome (Riley et al., 2016). Tip annotations provide Isolate ID, State (region) isolated and 
clade. NSW= New South Wales, VIC= Victoria, QLD= Queensland, SA= South Australia, WA= Western 
Australia, TAS= Tasmania. Vertical lines next to State indicate that the isolates were from the same post 
code. 
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 Discussion  
This study found that Australian MRSP are phylogenetically diverse and geographically clustered. The 
most frequently identified MRSP lineage was ST71, which is consistent with reports from other 
countries (59, 162, 163, 184, 267). In contrast to European ST71 isolates, where spa type t02 is most 
frequently identified, (184)  the most frequent spa type in ST71 isolates from the present study was 
t05. The difference most likely reflects localised evolution of ST71 within Australia. Although isolates 
within ST71 and ST497 were delineated by t02, t05 and t06 spa types (Figure 1), all three spa types  
share a similar pattern of repeat sequences, suggesting they are closely related (90) and therefore 
these sequenced types (STs) are more homogenous than the varied spa types would suggest. Three 
major novel STs were identified that have not previously been reported: ST497 (n=11), ST316 (n=8) 
and ST496 (n=8). The fifth major lineage in this study, ST45 (n=6), is frequently reported in dogs Asia 
and Israel (165, 188, 266) and has been isolated from veterinary personnel in Thailand (215). One of 
the six ST45 isolates was dru type dt11cb, which has previously been associated with ST45 isolates 
from Thailand (188) and canine pyoderma patients in Western Australian (272). Four new dru types 
were found amongst the remaining five ST45 isolates which clustered into two closely related groups 
that varied by one to two dru repeats per group, suggesting microevolution of this clone.  
Geographic clustering of MRSP clones was found in this study, particularly ST497 which mostly 
clustered in a small area in Victoria. A group of seven ST71 isolates also originated from the same 
postcode, indicating they came from the same veterinary clinic. Such clustering of ST497 and ST71 
could suggest an outbreak occurred during the sample period; as has occurred with ST71 in a Finnish 
veterinary hospital (282) or could simply be that ST497 was established within clinics with a high 
sampling intensity during the study period. The nature of this surveillance study means that the 
collection was likely affected selection bias which must be taken into account. For example, the cluster 
of ST497 may have come from a referral practice where patients could have been drawn from a wider 
geographic range than one would expect for a primary accession clinic. Nevertheless, the potential for 
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such sample biases would have been present across all geographic areas in the study, so the finding of 
geographic clustering of MRSP clones is still noteworthy. Specific MRSP clonal lineages have previously 
been associated with particular regions, for instance ST71 first in Europe and subsequently much of 
the rest of the world, ST68 in North America and ST45 in Asia (184, 266). Geographic clustering within 
a country was also reported in MRSP isolates from Norway (283). Australia is a large country with an 
area exceeding Western Europe and with the majority of the population living on the coastal-periphery 
in cities typically separated by over 1000km. Therefore, it is not surprising that a geographically diverse 
clonal pattern was identified. 
In addition to geographic clustering by STs, MRSP isolates also formed clades within the phylogenetic 
tree that aligned with their ST. This suggests that MLST is a useful method of inferring phylogenetic 
groupings. ST71 formed a particularly homogenous clade in the phylogenetic tree, with only 39 SNP 
differences between the 26 isolates. Similar phylogenetic homogeneity amongst ST71 isolates has 
previously been reported (151). Isolate KW33, (ST71-t02-II-III) demonstrated only one SNP difference 
to the ST71 reference isolate (275). This suggests that Australian ST71 MRSP is closely related to ST71 
from overseas, rather than originating via convergent evolution. Introduction of ST71 into Australia 
could have occurred via importation of an infected or carrier dog, or via owner or veterinarian (29, 
284). Similarly, travel of people and animals between South East Asia and Australia could explain why 
ST45 MRSP has been found in Thailand and Australia.  
BURST analysis showed that Australian MRSP clones formed five clonal complexes (CC71, CC45, CC258, 
CC84 and CC309) and 12 singleton that did not belong to any clonal complex. The high genetic diversity 
seen in the current study echoes what has been reported in recent studies in Europe (162, 267, 285) 
and Asia (165). Dos Santos and colleagues analysed 503 STs from the MLST database and found the 
MRSP population was only weakly clonal (266), in contrast to the highly clonal methicillin-resistant S. 
aureus  (MRSA) population (286). They hypothesised that this may be due to the greater diversity of S. 
pseudintermedius lineages that are capable of acquiring SCCmec in comparison to S. aureus (266); 
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which may reflect a higher capacity for horizontal gene transfer in S. pseudintermedius (151, 266). The 
variable presence of mobile genetic elements between staphylococcal species and S. pseudintermedius 
lineages could be due to species and lineage-specific restriction-modification systems that create a 
variable propensity for horizontal gene transfer (151, 287-289).  
Several SCCmec types were identified in this study, including the novel pseudo-SCCmec element, 
ΨSCCmecKW21. This element harbours a class D mec complex, no ccr genes and mecI has been 
replaced by blaI as the putative repressor gene of mecA. To the authors’ knowledge, this is the first 
time a mec D gene complex has been described in a coagulase-positive Staphylococcus species. The 
absence of a mecI gene but presence of a mecR gene could indicate that the ΨSCCmecKW21 element 
is an evolutionarily immature cassette, as it appears mecR gene arose in ancestral SCCmec elements 
before the occurrence of mecI genes (281). Although mecA can be repressed by either mecI or blaI, 
mecI is a stronger repressor of mecA (290). All ΨSCCmecKW21 isolates displayed high-level phenotypic 
oxacillin resistance, with a median oxacillin MIC of ≥64mg/L (interquartile range (IQR) = 8-64mg/L). The  
oxacillin resistance phenotype of ΨSCCmecKW21 isolates is in keeping with previous reports that MRSP 
isolates with the blaI gene demonstrate higher inducible mecA expression in isolates compared to 
isolates harbouring either mecI or mecI and blaI (291). ΨSCCmecKW21 was typed using locally 
assembled alignments in the bioinformatics program, CLC Genomics. While this method successfully 
revealed the structure of the element, a more streamlined approach would involve analysis of a single 
sequence rather than assembled contigs. Consequently, isolate KW31 is currently undergoing further 
analysis by long range PCR and future studies will determine whether the method described here is 
equal to long range PCR in its accuracy. 
Oxacillin MIC varied significantly between SCCmec types. Recently, Kasai and colleagues (270) similarly 
reported differences in oxacillin MIC based on MRSP SCCmec types. Specifically, they found that 
isolates with SCCmec II-III generally had higher oxacillin MICs than isolates with SCCmec V and that 
SCCmec II-III isolates were more often associated with suspected hospital-acquired infections than 
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SCCmec V isolates. Analogous to MRSA in human medicine, they concluded that oxacillin MIC may give 
clues as to an isolate’s epidemiological origin; where a high oxacillin MIC may indicate an MRSP isolate 
is from a successful ‘healthcare-associated’ clone, while isolates with lower MICs may represent 
‘community-associated’ clones (270). Veterinary patients with ‘healthcare-associated’ MRSP SCCmec 
II-III lineages share some risk factors with humans patients that harbour healthcare-associate MRSA, 
such as a history of hospitalisation and surgery (270, 292). However, there are key differences between 
the healthcare systems of human and veterinary hospitals including longer hospitalisation times for 
humans, the presence of long term indwelling medical devices such as intravenous catheters being less 
common in animals  and the fact that humans are more readily diagnosed with, and treated for, serious 
nosocomial infections such as bacteraemia (247, 292). Therefore, while there are similarities in the 
epidemiology of MRSA in humans and MRSP in veterinary medicine, more work is needed to truly 
define what is meant by ‘healthcare’ and ‘community’ environmental niches in veterinary medicine. 
There was insufficient epidemiological data available in the present study to infer whether 
epidemiological origin could predict the SCCmec type of an isolate. These results nevertheless show 
that oxacillin MIC varies significantly depending on SCCmec type and that isolates from the same STs 
almost always harbour the same SCCmec type. Thus, it follows that different MRSP lineages will 
demonstrate different oxacillin MICs. 
Our broader research group previously reported that methicillin-resistance amongst Australian S. 
pseudintermedius was significantly associated with resistance to clindamycin, fluoroquinolones, 
tetracycline and trimethoprim-sulfamethoxazole (229). These findings can now at least be partly 
explained by the finding here that significant differences in antimicrobial resistance profiles exist 
between Australian MRSP multilocus sequence types. ST71 isolates showed a pattern of 
fluoroquinolone resistance with tetracycline and chloramphenicol susceptibility, which is often seen in 
ST71 (266), although the frequency of tetracycline resistance in ST71 varies with geography (293). The 
most common subgroup of ST71 isolates in this study was tetracycline-susceptible spa type t05. This 
is in contrast to Europe, where tetracycline-resistant spa type t02 isolates are most common (184). 
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Geographic differences in ST71 tetracycline-susceptibility are most likely attributable to lineage-
specific acquisition of the tetK gene (294). Analogous to the most prevalent clones of MRSA in humans 
(259), widespread fluoroquinolone resistance identified in ST71 could in part explain its apparent 
dominance. However in epidemiological studies such as the present study, the effect of selection bias 
towards fluoroquinolone-resistant isolates cannot be discounted. Enrofloxacin, marbofloxacin and 
pradofloxacin are the three fluoroquinolones registered for systemic use in dogs and cats in Australia 
and may be used for a range of different infections, sometimes inappropriately, by clinicians as a 
second line treatment when empirical β-lactam therapy fails (295). Given sending a sample for culture 
and susceptibility testing is usually done at the expense of the pet owner, veterinarians rationalise 
their decision to perform microbiology culture on a cost-benefit basis. Consequently, second line 
therapy may be given in lieu of testing; creating a sample bias towards fluoroquinolone-resistant MRSP 
clones, because testing might only be performed when second line therapy has failed. Therefore, 
although fluoroquinolone resistance does appear more frequently in ST71 than in other clones, this 
observation may be affected by sample bias. It is nevertheless noteworthy that the major clonal groups 
in this study were all multi- to extensively drug-resistant, while singleton isolates generally had lower 
levels of resistance. This suggests that multidrug resistance adds to the competitive fitness of MRSP 
clones, at least in a clinical setting where antimicrobial selection pressure is present. Differing 
antimicrobial resistance patterns could also reflect different clonal propensities to maintain various 
resistance elements, or could reflect regional antimicrobial usage patterns (266).  In contrast to 
fluoroquinolone resistance, rifampicin resistance is still at a low level amongst Australian MRSP. 
Nevertheless, widespread resistance to fluoroquinolones and sporadic resistance to critically 
important antimicrobials such as rifampicin is alarming as it suggests that, when faced with multidrug 
resistance, veterinarians may be contributing to selection pressure by usage of these important 
antimicrobials. 
Like the previous study described in Chapter 3, this study is limited by the selection bias towards 
refractory conditions that is inherent in clinical submission surveys and the lack of more extensive 
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epidemiological data available for each isolate. Future studies into region-specific carriage of MRSP are 
warranted, as are studies investigating factors that may explain the predominance of particular clones 
such as ST71. Future studies are also warranted to determine what correlations exist between MLST 
and SCCmec types, oxacillin MIC and the epidemiological niches of MRSP. Furthermore, screening of 
healthy and diseased animals across Australia is indicated in the future, to determine if ST497- 
ΨSCCmecKW21 continues to be a geographically clustered clone or whether it has disseminated 
further into other states of Australia. 
 Conclusion 
This study demonstrates the utility of surveillance studies in shedding light on the epidemiology of 
MRSP at a national level. International and locally evolved MRSP clones are present in Australia. 
Geographic variation in multilocus sequence types and varying antimicrobial resistance profiles 
according to MLST was observed. The discovery of a novel SCCmec type further shows that 
staphylococci possess a diverse range of methods for acquiring methicillin resistance. Echoing previous 
reports (266), a high frequency of multidrug resistance was found amongst the MRSP isolates. As the 
arsenal of effective, veterinary-licensed, anti-MRSP therapeutics continues to shrink, the bond 
between people and their pets continues to grow. It therefore seems likely that pet owners and 
veterinarians will increasingly reach for critically important human antimicrobials to treat multidrug-
resistant MRSP infections. Consequently, the need for stewardship over the use of critically important 
antimicrobials in veterinary medicine has never been more pressing.  
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Chapter 5. Vets and pets: methicillin-resistant 
Staphylococcus aureus and Staphylococcus 
pseudintermedius in Australian veterinary 
personnel, their pets, patients and the veterinary 
hospital environment  
 
 Abstract 
This pilot study investigated the transmission cycle of methicillin-resistant Staphylococcus aureus 
(MRSA) and Staphylococcus pseudintermedius (MRSP) in companion animal veterinary practice. 
Sampling was undertaken at two small animal veterinary hospitals in Sydney, Australia. Samples were 
collected from 46 veterinary personnel, 79 veterinary-owned dogs and cats, 151 healthy canine 
hospital admissions and 25 environmental sites in one of the hospitals. Nasal swabs were collected 
from veterinary personnel. Nasal, oral and perineal swabs were collected from animals. Methicillin 
resistance was detected by growth on BrillianceTM MRSA 2 Agar and confirmed by cefoxitin and 
oxacillin broth microdilution for S. aureus and S. pseudintermedius, respectively. MRSA and MRSP 
isolates were characterised using whole genome sequencing including mecA gene screening and 
multilocus sequence typing. MRSA was isolated from four (8%) veterinary personnel but no animals. 
MRSP was isolated from 11/151 (7%) of canine hospital admissions and 4/53 (8%) of veterinary 
personnel-owned dogs but no veterinary personnel or cats. No MRSA or MRSP was isolated from the 
environment. The main MRSP clone carried by canine patients (ST496) was distinct to that carried by 
veterinary-owned dogs (ST64). One veterinary nurse, who carried Panton Valentine leucocidin-positive 
ST338 MRSA, also owned a ST749 MRSP-positive dog. Besides MRSP-positive dogs from the same 
household sharing the same clone of MRSP, MRSA and MRSP were not shared between humans, 
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animals or environment. Therefore, in the non-outbreak setting of this study, there was limited MRS 
transmission between veterinary personnel, their pets, patients or the veterinary environment. 
 Introduction 
As outlined in Chapters 3 and 4, MRSA and MRSP can both be found in clinical infections of companion 
animals. Chapter 3 described how the clones of MRSA found in Australian animal species are similar to 
those found in Australian veterinarians treating these animal species (240, 273). It appears that MRSA 
can move between humans and animals in a bi-directional manner and veterinarians are a group 
particularly at risk of MRSA carriage (213, 214). It has been established that MRSA can be shared 
between humans and animals, but the epidemiology of S. pseudintermedius transmission between 
animals and humans is less understood. MRSP and multidrug-resistant S. pseudintermedius can 
certainly be carried by healthy pets (296), dog owners (297) and veterinarians (29), and it can cause 
infections in immune-compromised people (30). Although studies have documented concurrent 
carriage of MRSP and MRSA in veterinary dermatologists and their own pets (298), no studies have 
assessed Staphylococcus carriage by non-dermatologist veterinarians and their own pets. Veterinary 
personnel often bring their pets to their place of work, thereby potentially exposing them to 
environmental and patient-associated organisms. Given that veterinary hospital visits and having an 
owner who works in human healthcare are respective risk factors for MRSP and S. aureus carriage in 
dogs (206, 208), it follows that pets owned by veterinary personnel may also be at increased risk of 
MRSA and MRSP carriage. Consequently, the first aim of this study was to determine the concurrent 
carriage rates of MRSP and MRSA in a range of veterinary personnel and their pets and as well as 
subsequent determination of whether veterinarians carried similar clones to those carried by their 
pets.  
The prevalence of methicillin-resistant Staphylococcus (MRS) carriage in veterinary patients is variably 
reported. The prevalence of MRSA and MRSP carriage in dogs sampled in their homes in USA was 8% 
and 1% respectively (299) while carriage of MRSP in canine hospital admissions in Portugal was 6.2% 
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(300). MRSP carriage rate is much higher in dogs with clinical pyoderma, with reports ranging from 
33% in USA (60) to over 60% in reports from Japan (166). A 2006 Australian study found two of 252 
surgical admissions were MRSA carriers while none were MRSP carriers (301). A second smaller study 
found no MRSP amongst 21 clinical S. (pseud)intermedius samples collected from Sydney dogs 
between 2004 and 2007 (302). Most recently, a 2016 study found two of 117 canine obedience school 
attendees were MRSP carriers but none were MRSA carriers (296). It is clear that the prevalence of 
resistant Staphylococcus carriage is dependent on study design and sample population, which makes 
comparison between studies difficult. Nevertheless, regardless of exact methodology, study 
population or country of origin, most veterinary studies show a steady upward trend of antimicrobial 
resistance in S. pseudintermedius as time progresses (40). Given that there was no MRSP amongst 
Australian veterinary clinical submissions in 2004 to 2007 and this frequency rose to 11.5% in 2013 
(Chapter 4), a study is now indicated to determine whether there has been a similar increase in MRSP 
carriage. Consequently, this study’s second aims were to estimate the current frequency of MRSP and 
MRSA carriage in Australian canine hospital admissions and to determine if MRS carried by hospital 
admissions was related to clones carried by veterinarians and their pets. 
Previous studies have demonstrated that MRSA and MRSP can be found in the veterinary hospital 
environment (27, 210), and molecular typing has shown that MRSA found in the environment can be 
highly similar to that carried by veterinary personnel and patients  (210). There is a growing body of 
literature investigating the transmission cycle of MRS in veterinary practice. However, no studies have 
concurrently examined MRSA and MRSP carriage in veterinary personnel, their pets, patients and the 
veterinary hospital environment. Therefore the third and final aim of this study was to screen the 
veterinary hospital environment for MRS contamination and to determine the relatedness of MRS 
isolated from veterinary personnel, their pets, patients and the veterinary hospital environment. 
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 Materials and methods 
5.3.1 Sampling 
Sample collection involved two veterinary hospitals in Sydney, Australia: a primary accession clinic 
(Hospital A) and a multi-disciplined small animal referral hospital (Hospital B), located 10km apart from 
each other, as outlined in Sections 2.1.2 and 2.1.3. Samples were collected from veterinary personnel, 
veterinary-owned pets, canine hospital admissions and environmental sites within the veterinary 
hospital. All aspects of this study were approved by the Human and Animal Ethics Committees at the 
University of Sydney (Project numbers 2016/837, 2016/1072 and 2015/866, respectively). The details 
of sampling procedures are outlined below. 
  Veterinary personnel and their pets 
Sampling of veterinary personnel and their pets (dogs and/or cats) was undertaken over a two-week 
period in February 2017 (Hospital A) and April 2017 (Hospital B). Veterinary personnel included 
veterinarians and support staff (veterinary nurses, kennel hands and administrative staff). Personnel 
were invited to participate whether or not they had pets at home. Personnel were given written 
instructions on how to take samples, then took samples from themselves and their pets, undertaking 
sampling in their own home. For veterinary personnel, a single sterile swab was used to sample the 
nares. For pet dogs and cats, personnel took three separate swabs: one each from the anterior nares 
(large dogs) or nasal planum (small dogs and cats), oral cavity and perineum. For multipet households, 
sampling was limited to three dogs and/or three cats. Personnel wore gloves during the procedure and 
refrigerated samples immediately after the procedure. All swabs were collected using AmiesTM Agar 
Gel swabs (Copan Diagnostics, USA).  
 Canine hospital admissions 
Swab were taken from the nares/nasal planum, oral cavity and perineum of canine hospital admissions 
from both veterinary hospitals. Convenience sampling of canine hospital admissions occurred in two 
sampling periods in August 2015 and August 2016 for Hospital A while sampling was sporadic from 
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April 2016 to April 2017 for Hospital B. To minimise sampling from dogs with known MRSP carriage risk 
factors such as recent hospitalisation or antimicrobial treatment (206), dogs had to meet the following 
selection criteria: a) they had not been in the hospital for more than 10 minutes at the time of 
sampling; b) they were admitted for an elective procedure (for example: non-emergency surgery, 
routine blood tests, imaging, dentistry, boarding); c) they were deemed systemically well by the 
attending clinician; and d) they had no visible skin lesions suggestive of pyoderma.  
 Hospital environment 
Environmental sampling was undertaken at Hospital A only, on the same day in February 2017 that 
samples were collected from personnel and their pets. Twenty-five swabs were taken from the 
following areas: cage floors and walls, waiting room chair legs and seats, door handles into the 
consultation, treatment, pharmacy, bathroom, radiology and boarding rooms, and computer 
keyboards and computer mice in the consulting, treatment and radiology rooms. Samples were taken 
by pre-moistening AmiesTM Gel agar swabs with sterile saline, then rolling the swab across the 
environmental surface for 10sec. Although MRSP-positive carriers and patients with MRSP-infected 
wounds were known to have been in the hospital within the last month, no known MRSP carriers or 
patients were present at the time environmental sampling. Therefore, it was assumed that 
environmental sampling was indicative of a non-outbreak setting for the hospital. 
5.3.2 Phenotypic methicillin-resistance screening 
Human, animal and environmental swabs were all processed as follows. Samples were initially 
enriched by inoculation onto Columbia sheep blood agar (Oxoid, UK) and overnight incubation at 37°C. 
After the enrichment step, a sterile microbiological loop was streaked across the blood agar plate to 
collect many colonies which were then subcultured onto the selective medium, BrillianceTM MRSA 2 
Agar (Oxoid, UK) and incubated overnight at 37°C (Horstmann et al., 2012). Samples that grew as blue 
colonies on the BrillianceTM agar underwent catalase and tube coagulase testing as described in Section 
2.2.1. Coagulase-positive BrillianceTM-positive isolates underwent species confirmatory testing with 
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MALDI-TOF mass spectrometry (BDTM Bruker MALDI BiotyperTM) as previously described (Worthing et 
al., 2018b). Phenotypic methicillin resistance was confirmed using the Vitek 2TM automated 
antimicrobial susceptibility testing (AST) system (bioMerieux, USA). Methicillin resistance in S. aureus 
was identified by cefoxitin screening and detection of the modified pbp2a protein. In S. 
pseudintermedius, phenotypic methicillin resistance was identified by an oxacillin MIC of ≥0.5mg/L by 
Vitek screening. Isolates also underwent testing by Vitek 2TM to the following antimicrobials: 
benzylpenicillin, enrofloxacin, erythromycin, gentamicin, clindamycin, tetracycline, chloramphenicol, 
rifampicin and trimethoprim-sulfamethoxazole. Clindamycin testing included screening for inducible 
clindamycin resistance and measurement of MIC by Vitek 2TM. 
5.3.3 Molecular characterisation of methicillin-resistant isolates 
Methicillin-resistant S. aureus and S. pseudintermedius underwent whole genome sequencing (WGS) 
using the MiSeq system (Illumina, USA) as previously described (273). In silico characterisation of 
isolates was undertaken as outlined in Section 2.5. A rooted phylogenetic tree of MRSP isolates was 
generated using CSI Phylogeny 1.4 (https://cge.cbs.dtu.dk/services/CSIPhylogeny/) (243). Briefly, this 
program used a Maximum Likelihood algorithm to depict inferred phylogeny based on concatenated 
alignment of high quality single nucleotide polymorphisms. To construct the tree, fasta files of all MRSP 
genomes were uploaded to the online platform which aligned them to a reference genome (ST71 MRSP 
081661, Accession numbers: CP16073.1). FigTree 1.4.3 was used to optimise visualization of the 
phylogenetic tree. 
5.3.4 Statistical analysis 
Power analysis was conducted to determine the ideal sample size required to determine the frequency 
of MRSP carriage amongst Sydney canine hospital admissions. Based on previously reported MRS 
carriage rates amongst Australian dogs of around 1% (296, 301) and an anticipated frequency of 11.5%  
based on the frequency of clinical MRSP from dogs in NSW (303), power analysis suggested a sample 
size of at least 164 would be required to predict MRS carriage frequency with 95% confidence 
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(http://clincalc.com/stats/Sample Size.aspx). Categorical comparisons were undertaken by 
constructing contingency tables and performing Fishers exact test (GraphPad Prism 7, USA). Results 
were considered significant if p<0.05.  
 Results 
5.4.1 MRSA and MRSP in humans, animals and environment 
Samples were collected from 46 veterinary personnel (veterinarians, n= 19; support staff, n= 27 
(nurses= 22, receptionists= 2, kennel hands= 3), 79 veterinary-owned pets, 151 canine hospital 
admissions and 25 environmental sites. This consisted of 191 convenience samples from Hospital A 
(118 canine hospital admissions, 21 veterinary personnel, 13 veterinary-owned pet dogs, 14 
veterinary-owned pet cats and 25 environmental sites) and 110 samples from Hospital B (33 canine 
hospital admissions, 25 veterinary personnel, 40 veterinary-owned pet dogs and 12 veterinary-owned 
pet cats). MRS was isolated from 4/46 veterinary personnel (8%), 11/151 (7%) canine hospital 
admissions, and 4/53 veterinary-owned pet dogs (8%). MRS was not isolated from cats or the 
veterinary environment. The MRS carriage rate in veterinary-owned dogs (8%) was not significantly 
different to veterinary-owned cats (0%; p= 0.3). MRS frequency was proportional to sampling intensity 
from each hospital and was not significantly different between Hospital A and B (p= 0.91). 
Consequently, results from both hospitals were combined for analyses. Table 5.1 shows the 
proportions of MRSA and MRSP isolated from veterinary personnel, canine hospital admissions and 
veterinary-owned pets. No MRSA was isolated from animals nor MRSP from humans. The phenotypic 
antimicrobial resistance profile of all isolates is shown in Table 5.2. MRSP isolates were resistant to 
significantly more antimicrobial classes than MRSA (p<0.001). All personnel- and animal-derived MRS 
samples underwent WGS and in silico molecular characterisation (Table 5.3). Two Brilliance-positive 
isolates (one S. aureus (KW8) and one S. pseudintermedius (KWBH2)) were positive for the mecA gene 
but methicillin-susceptible on Vitek 2 screening. It was assumed that a methicillin-susceptible 
subpopulation had been inadvertently subcultured for AST testing and thus these two isolates were 
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still included in further analyses. No MRSP or MRSA was isolated from the 25 environmental sites 
sampled. Although one catalase-positive isolate grew on BrillianceTM 2 agar, it was coagulase-negative 
and therefore not characterised further.  
 
 
Table 5-1. Methicillin-resistant coagulase-positive staphylococci (MRS) isolated from veterinary 
personnel, canine hospital admissions, veterinary-owned pets and the veterinary hospital 
environment 
Group Number sampled Number of carriers (%) 
  MRSA MRSP 
Veterinary personnel    
Veterinarians 19 3 (16%) 0 
Support staff 27 1 (4%) 0 
Total personnel 46 4 (8%) 0 
Dogs    
Hospital admissions 151 0 11 (7%) 
Personnel-owned  53 0 4 (8%) 
Total dogs 204 0 15 (8%) 
Cats    
Personnel-owned 26 0 0 
Hospital environment    
Waiting room chairs 2 0 0 
Door handles 8 0 0 
Computer keyboards 3 0 0 
Cage door handles 3 0 0 
Cage interiors 9 0 0 
Total environment 25 0 0 
Total samples 301 4 (1%) 15 (5%) 
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5.4.2 Characterisation of MRSA from veterinary personnel  
Of the four MRSA isolates from veterinary personnel, three were from veterinarians and one was from 
a veterinary nurse. The difference in MRSA carriage amongst veterinarians (16%) was not significantly 
different to support staff (4%; p= 0.29). Three of the four MRSA isolates were susceptible to all non-β-
lactam antimicrobials. The fourth isolate, ST338 from a veterinary nurse (Table 3), was additionally 
resistant to tetracycline. One veterinarian from each of the hospitals carried ST59-IV MRSA. The two 
isolates were different spa types (t316 and t976). One MRSA isolate, ST338 SCCmec type V isolate from 
a veterinary nurse, harboured the Panton-Valentine leucocidin gene (pvl); the remaining isolates were 
pvl-negative. The final MRSA isolate, ST81 from a veterinarian, was phenotypically susceptible to 
oxacillin but harboured the mecA gene. Post-hoc power analysis found that with a sample size of 46, 
previously reported Australia-wide veterinarian MRSA carriage rate of 4.8% (213) and observed MRS 
frequency rate of 8%, the personnel-sampling component of the study was underpowered (power= 
23%). A sample size of 409 would have been required to obtain 80% power in the veterinary personnel 
component of the study. 
Table 5-2. Frequency (%) of antimicrobial resistance in methicillin-resistant Staphylococcus aureus 
(MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) from veterinary hospitals 
Group PEN ENR ERY CLI TET CHLOR RIF TMS 
MRSP (n= 19) 100 37 32 16 58 42 0 37 
MRSA (n= 4) 100 0 0 0* 25 0 0 0 
PEN= benzylpenicillin, ENR= enrofloxacin, ERY= erythromycin, CLI= clindamycin, TET= tetracycline, CHLOR= 
chloramphenicol, RIF= rifampicin, TMS= trimethoprim sulfamethoxazole. *Susceptible to clindamycin by MIC testing and 
by screening for inducible clindamycin resistance using Vitek 2TM. 
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Table 5-3. Molecular epidemiology MRSA and MRSP isolated from veterinary personnel, personnel-
owned dogs and canine hospital admissions in Sydney, Australia 
Isolate Year 
isolated 
Source Species Isolation site Phenotypic 
methicillin 
resistance § 
MLST SCCmec Spa 
type 
Dru 
type 
HOSPITAL A          
KW12 2017 Veterinarian MRSA Nares + ST59 IV t316 None 
KW1606a 2015 Dog (H) MRSP Nares and perineum + ST496 Vt t05 dt10a 
KW1610a 2015 Dog (H) MRSP Nares, oral cavity 
and perineum 
+ ST496 Vt t05 dt10a 
KW1608 2015 Dog (H) MRSP Perineum + ST496 Vt t05 dt10a 
KW1614 ±   2015 Dog (H) MRSP Perineum + ST525 Vt t09 dt9bd 
KW1613 ± 2015 Dog (H) MRSP Oral cavity + ST68 Vt t23 New 
KW1607 2015 Dog (H) MRSP Nares + ST64 C1/ccrC6 None dt7ae 
KWAH3 2016 Dog (H) MRSP Oral cavity + ST496 Vt t05 New 
KWAH4 2016 Dog (H) MRSP Oral cavity and 
perineum 
+ ST496 Vt t02 New 
KWAH1 2016 Dog (H) MRSP Oral cavity + ST64 C1/ccrC6 None dt11af 
KWAH2 2016 Dog (H) MRSP Oral cavity + ST64 C1/ccrC6 None dt10cj 
KW5 2017 Dog (P) MRSP Nares - ST749 IV None NT 
HOSPITAL B          
KW7c 2017 Veterinary nurse MRSA Nares + ST338 V t441 NT 
KW8 2017 Veterinarian MRSA Nares - ST81 IV t177 dt7f 
KW3 2017 Veterinarian MRSA Nares + ST59 IV t976 dt7f 
KWBH2 ¥ 2016 Dog (H) MRSP Oral cavity and 
perineum 
+ ST751 NT None NT 
KW1 2017 Dog (H) MRSP Nares and oral cavity + ST496 Vt t02 dt7f 
KW10b 2017 Dog (P) MRSP Nares + ST64 C1/ccrC6 None New 
KW11b 2017 Dog (P) MRSP Oral cavity + ST64 C1/ccrC6 None dt7f 
KW6c 2017 Dog (P)  MRSP Nares, oral cavity + ST64 C1/ccrC6 None New 
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5.4.3 Characterisation of MRSP from veterinary-owned pets and canine hospital 
admissions 
The MRSP carriage rate between veterinary-owned pet dogs (8%) and canine hospital admissions (7%) 
was not significantly different (p= 0.77). Most dogs that carried MRSP at more than one site carried 
the same clone at each site. However, one dog had two different clones isolated; ST525 from the 
perineum and ST68 from the oral cavity. Two main MRSP clones were isolated: ST496 (n= 6) and ST64 
(n= 6). ST496 was the most common clone amongst canine hospital admissions (6/12 dogs; 50%) but 
was not carried by any veterinary-owned dogs. ST64 was the most common clone amongst veterinary-
owned dogs (three dogs from two households) and was carried by all three veterinary-owned dogs at 
Hospital B. ST496 was carried by two dogs from the same household who were hospital admissions to 
Hospital A and ST64 was carried by two veterinary-owned dogs from the same household at Hospital 
B. Within each of the hospitals, none of the veterinary-owned dogs carried the same clone as hospital 
admissions to that hospital. Figure 5.1 shows the phylogeny of MRSP isolated from canine hospital 
admissions and veterinary-owned dogs at both hospitals. Isolates from both hospitals were generally 
interspersed throughout the tree, suggesting a general lack of geographic clustering.  
 
 
and perineum 
§ Phenotypic methicillin resistance as determined by Vitek2 testing: cefoxitin screening and PBP2a test for MRSA isolates; oxacillin MIC testing for 
MRSP isolates. ± Isolates 1613 and 1614 originated from the same dog but were different MLST types.   ¥ Both isolates from dog KWBH2 underwent 
phenotypic and genotypic testing and both isolates were mecA positive but one isolate was resistant to oxacillin (MIC= 0.5mg/L) while the other was 
susceptible (MIC<0.25mg/L). a, b, c Isolates with the same superscript letters originated from the same household.  Dog (H)= canine hospital admission; 
Dog (V)= personnel-owned dog. NT= not typable. Unless indicated, dogs that were positive at multiple sites carried the same MLST type at all sites.  
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5.4.4 Shared MRS carriage in veterinary personnel and their pets  
Of the 46 veterinary personnel that were sampled, 38 also had their pets sampled. Of the 38 personnel-
pet groupings, concurrent MRS carriage was identified in one veterinary nurse and one of the two dogs 
owned by that nurse. The isolate from the nurse was ST338 MRSA with SCCmec type V while the nurse’s 
pet dog carried ST64 MRSP with a mec complex type C1/ccrC6 SCCmec element. Besides both SCCmec 
elements carrying a type C1 mec gene complex, the nurse- and pet- derived MRS samples did not 
appear related. Two pairs of dogs from the same household were both MRSP carriers. The first pair 
were personnel-owned dogs from Hospital B. Both dogs carried ST64 which clustered closely in the 
phylogenetic tree. The dog’s owner, a veterinarian, was not a MRS carrier. The second MRSP-positive 
pair were hospital admissions at Hospital A, admitted on the same day for routine dental care. The 
ST496 MRSP isolated from this pair clustered closer to each other than other ST496 isolates.  
 
 Discussion  
This study simultaneously sampled veterinary personnel, their pets and patients, and the veterinary 
hospital environment and detected MRSA from humans and MRSP from dogs but did not find MRSP 
carriage in humans, MRSA carriage in animals, or any MRS in the environment. The absence of MRSA 
in animals and MRSP in humans supports the notion that S. aureus is generally more host-adapted to 
humans and S. pseudintermedius to dogs (67). Four of 46 veterinary personnel (8%) were MRSA 
carriers, which is a higher rate of carriage than the previously reported rate of 4.9% in Australian 
companion animal veterinarians (213). These results add to evidence that the rate of MRSA carriage in 
veterinary personnel, like human healthcare workers, is higher than what is reported in the general 
population (213, 214, 304, 305). The veterinary-specific risk factors for MRSA carriage are not yet 
known, but it is possible that veterinary personnel have similar occupational risk factors to workers in 
healthcare such as caring for patients with MRSA-infected wounds (306). However, MRSA appears to 
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be much more prevalent amongst human hospital patients than veterinary hospital patients, so it is 
likely that additional risk factors exist for veterinarians such as the handling of antimicrobial drugs (298, 
305), or environmental exposure to biocides and patient-excreted antimicrobials. It is clear that an 
extensive prospective cross-sectional study is warranted to better define the occupational risk factors 
for MRSA carriage in veterinary personnel. 
The rate of MRSP carriage amongst veterinary-owned dogs (8%) was not significantly different to 
canine hospital admissions (7%), indicating that dogs of veterinary personnel are not at increased risk 
of MRSP or MRSA carriage compared to canine hospital admissions from the same geographic area. 
Previous studies have found that pets owned by human healthcare workers are at increased risk of 
carrying methicillin-susceptible S. aureus (MSSA) (208), but there are conflicting reports as to whether 
or not dogs owned by healthcare workers are at increased risk of MRSA carriage (208, 307). Future 
studies that directly compare the relative risk of MRSA and MRSP carriage amongst pets owned by 
veterinary personnel, human healthcare workers and non-healthcare workers are now warranted. All 
three MRSP-positive veterinary-owned dogs at Hospital B carried ST64 which closely clustered on the 
phylogenetic tree and differed by less than 10 SNPs, suggesting that ST64 had circulated amongst 
veterinary-owned pets in this hospital. Despite this, it was not isolated from any dogs admitted to the 
same hospital. Sampling of dogs upon discharge would have helped to determine whether canine 
hospital admissions subsequently acquired MRSP clones carried by veterinary-owned pets in the same 
hospital. 
The rate of 7% MRSP carriage we found amongst canine hospital admissions is similar to some overseas 
studies (206), but higher than the 1% MRSP carriage rate in another Australian study that examined 
healthy dogs at an obedience school in regional Victoria (296). The difference could reflect increased 
local prevalence in Sydney compared to regional Victoria or increased prevalence amongst dogs 
attending veterinary hospitals compared to obedience school. ST496, a multidrug resistant MRSP 
strain, was the most common clone carried by canine hospital admissions in this study and was also 
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the most common clone amongst clinical MRSP from dogs in greater Sydney in 2013 (303).  ST496 has 
not been reported outside Australia, but it appears that ST496 has become a common clone in Sydney 
that has evolved and diversified, evidenced by a greater diversity of dru types in this study compared 
to the 2013 surveillance study (303). Concurrent carriage of ST496 MRSP by two canine hospital 
admissions from the same household suggested intra-household transmission had occurred. Although 
neither patient showed signs of skin disease at the time of sampling, inspection of both patients’ 
records revealed that one of the dogs had a long history of intermittent antimicrobial use associated 
pyoderma secondary to flea allergy dermatitis. It is likely that the dog with a history of skin disease 
acted as a source of MRSP for the asymptomatic dog in the same household (27, 308). While clear risk 
factors for MRSP carriage and infection such as previous antimicrobial use, frequent veterinary visits 
and a history of hospitalisation have already been identified (204, 206), veterinarians should be aware 
that apparently healthy dogs can also carry MRSP, particularly if they live with an MRSP carrier.  
It is noteworthy that the MRSP isolates in this study displayed a significantly higher level of 
antimicrobial resistance than the MRSA isolates, with 37% resistance to fluoroquinolones and 
trimethoprim-sulfamethoxazole and 32% resistance to erythromycin amongst MRSP compared to no 
resistance to these classes amongst MRSA isolates. While MRSP is not a major zoonotic pathogen, the 
expansion of multidrug-resistant MRSP clones such as ST496 still presents a public health concern 
because such clones may act as a reservoir for genetic resistance determinants that could be 
horizontally-transferred to important human pathogens. Animal-derived staphylococci can be the 
source of resistance determinants in human S. aureus (281), but the extent to which S. 
pseudintermedius contributes to the resistance gene pool in human pathogens such as S. aureus is not 
fully determined (309) and could thus be examined in future genomic studies.  
Besides concurrent MRSA carriage in a veterinary nurse and MRSP carriage in the nurse’s pet dog, this 
study found no shared MRS carriage in veterinary personnel and their pets. The lack of MRSP isolation 
from veterinary personnel in this study likely reflects the general lack of human host tropism by MRSP 
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but could also reflect the small sample size and the fact that animals with overt skin disease were 
intentionally omitted from this study. Dogs with skin disease are more likely to carry MRSP than dogs 
with healthy skin (310), and transmission of MRSP from animals to owners is more commonly reported 
when the animal has clinical disease (27). Certain MRSP clones such as ST71 appear better able to 
colonize human corneocytes than MSSP or other MRSP clones and thus may have better zoonotic 
potential (311). It is therefore possible that the lack of human MRSP carriage in this study reflects the 
lack of ST71 in the animal population sampled. Although ST71 is a dominant MRSP clone in Europe 
(184) and represents 34% of clinical MRSP in Australia overall (303), it was not isolated from any dogs 
in this study and was isolated from only 1/24 (4%) clinical MRSP cases around Sydney in 2013 (303). 
Overall, it appears that MRS carriage by veterinary personnel is influenced by their role within the 
veterinary hospital and the local prevalence and clonal distribution of MRS in their respective patient 
population.  
MRSP was not isolated from the veterinary hospital environment. This could be attributed to the low 
sample size, the lack of longitudinal sampling or the fact that Hospital A had developed a hospital 
protocol for the management of known MRS-infected patients which was initiated six months prior to 
this study. Successful reduction of environmental MRSA was reported in a human hospital that revised 
its hospital infection control protocols to address an increase in MRSA cases (312), but lack of 
longitudinal sampling pre- and post-cleaning protocol prevents us from assessing whether the absence 
of MRSP was truly due to a successful infection control program. Although the moistened swab method 
has been used in previous veterinary studies of hospital environmental sampling (210, 313), the wipe-
rinse method of environmental sampling is now recommended for hospital infection control protocols 
(314). The larger surface area of wipes compared to swabs may have afforded greater sensitivity to 
the environmental sampling in this study, and thus the study method could have been improved by 
the use of the wipe-rinse method for environmental sampling.   
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 Conclusion 
In conclusion, this pilot study provides valuable insights into the molecular epidemiology of MRS within 
two veterinary hospitals. The clonal types of MRSP and MRSA found in veterinary personnel, 
veterinary-owned pets and hospital admissions were distinct from each other. This suggests that 
limited MRS transmission occurs between these groups, at least in a non-outbreak setting as was 
examined in this study. The rate of MRS isolation was not significantly different between the tertiary 
referral hospital and a primary accession hospital, nor between personnel-owned dogs and hospital 
admissions. MRSP carriage was not detected amongst veterinary personnel. However, it is apparent 
that clonal types of MRSP vary with geography, so sampling of dogs and veterinary-personnel in areas 
such as Victoria, where ST71 MRSP is common (303), would provide valuable comparative results for 
this study. Contrasting with the lack of MRSP carriage in the current study, MRSP carriage has been 
twice documented in veterinary dermatologists (29, 298). A study that simultaneously compares MRSP 
carriage amongst dermatologist and non-dermatologist veterinarians is warranted to evaluate 
whether specialty-specific risk for MRSP carriage exists amongst veterinarians. Lastly, like Chapter 3, 
the current study adds to existing literature in reporting that veterinarians have a higher rate of MRSA 
carriage than the general population. A large-scale case-control study is thus warranted to further 
investigate the occupational risk factors for MRSA carriage in veterinarians.  
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Chapter 6. Characterisation of clinical 
Staphylococcus felis from cats: detection of 
coagulase positive isolates and genetic virulence 
determinants 
 Abstract  
This study used phenotypic tests and whole genome sequencing to characterise a collection of 38 
clinical Staphylococcus felis isolates from cats. Samples were isolated from cats with a range of 
diseases including feline lower urinary tract disease (n = 15) and otitis externa (n= 14). Isolates were 
identified using MALDI-TOF MS and by identification of S. felis-specific rpoB and nuc genes in whole 
genome sequenced contigs. Phenotypic antimicrobial resistance was determined using disk diffusion 
and broth microdilution. Coagulase activity was assessed using feline and rabbit plasma. Contigs were 
screened for putative virulence and antimicrobial resistance genes using the sequences of known 
genes from other staphylococcal as homologous references. A preliminary multilocus sequence typing 
scheme was developed using five housekeeping genes. Phylogenetic relationships were further 
inferred by comparison of single nucleotide polymorphisms. Two isolates were coagulase-positive 
when tested against feline plasma while all isolates were coagulase-negative against rabbit plasma. 
Both coagulase-positive isolates harboured homologues of the Staphylococcus aureus coagulase gene 
while coagulase-negative isolates did not. A range of other putative virulence genes were found 
amongst isolates including genes associated with adhesion, toxin production and immune evasion. All 
isolates displayed low levels of phenotypic antimicrobial resistance which was reflected by a general 
absence of resistance genes. Fourteen sequence types were present in the collection. Isolates 
generally clustered in the phylogenetic tree according to their sequence type. The presence of 
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coagulase-positive S. felis isolates and widespread putative virulence genes suggests that S. felis is a 
potentially pathogenic species that warrants further research. 
 Introduction 
The previous chapters of this thesis contain sporadic cases of MRSP and MRSA infections in cats, but 
perhaps the most significant disease causing staphylococcal species for cats is Staphylococcus felis. 
First identified as a new species in 1989 (68), S. felis is coagulase-negative when tested using rabbit 
plasma and produces incomplete haemolysis on sheep blood agar (68). Due to its phenotypic similarity 
to other coagulase-negative staphylococci such as S. simulans (68) and S. sciuri  (69), the prevalence 
of S. felis may have been underestimated in studies prior to 1989 or in studies where advanced 
molecular methods were not utilised. Although it is generally agreed that S. felis is a common part of 
the normal flora of cats, its role as a feline pathogen is more contentious (71-74, 315). S. felis-positive 
urine samples have significantly higher pH than other culture-positive urine and are significantly more 
likely to contain urine crystals (71). Like many staphylococcal species, S. felis produces urease (68), 
which is the likely cause of the alkalinised urine seen in S. felis-positive urine. As a skin commensal, S. 
felis could be dismissed as a contaminant of urine samples, but Lister et al. (71) concluded that its 
urease production and resultant alterations in urine pH were sufficient virulence factors to deem it a 
potential urinary pathogen of cats. A subsequent study examined a single S. felis isolated from a cat’s 
subcutaneous wound and found virulence factors such as biofilm and proteolytic enzyme production, 
demonstrating its potential as a skin pathogen (315). Besides a handful of studies (68, 71, 315), there 
is a scarcity of literature regarding the epidemiology and potential virulence factors of S. felis in cats.  
There are divergent reports of the antimicrobial susceptibility profile of S. felis in the peer reviewed 
literature. As antimicrobial resistance continues to rise in other Staphylococcus spp. such as S. aureus 
and S. pseudintermedius, one would expect resistance to be increasing in S. felis as well. However, 
while methicillin-resistance and multidrug-resistance has been found amongst S. felis isolates (9, 316), 
other studies have identified low levels of antimicrobial resistance amongst S. felis (71, 72). With the 
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rise of antimicrobial resistance in S. aureus and S. pseudintermedius, it is not surprising that much 
research has been directed at further characterising these two species. MLST has already shed light 
on the population structure of S. aureus (183) and S. pseudintermedius (185) but no such scheme 
exists for S. felis, so its population structure is currently unknown. Given the current scarcity of 
research characterising S. felis, the three aims of this study were to 1) investigate potential virulence 
factors that may aid S. felis in its colonisation and formation of opportunistic infections; 2) investigate 
the phenotypic and genotypic antimicrobial resistance profiles of a range of clinical isolates of S. felis 
and 3) use MLST to infer the population structure of S. felis among Australian cats. 
 Methods 
6.3.1 Collection and identification of S. felis isolates 
Isolates were collected as part of the first Australian survey into antimicrobial resistance in veterinary 
staphylococcal clinical isolates, as described in Chapters 2, 3 and 4 (229). Isolates were collected from 
veterinary diagnostic laboratories located in all Australian states and mainland territories. Although 
laboratories were instructed to forward only coagulase-positive Staphylococcus spp. to the 
researchers, 172 isolates from coagulase-negative species were received. Samples were isolated from 
a range of animal species, including 74 isolates from cats. For each isolate, the geographic postcode 
of origin, clinical syndrome (as recorded by the submitting veterinarian) and site of isolation were 
recorded. Samples from the urinary bladder, urinary catheters or free catch urine samples were all 
recorded as feline lower urinary tract samples. Preliminary staphylococcal speciation was determined 
by traditional phenotypic tests (Gram stain, catalase and coagulase testing) and confirmed by the BD™ 
Bruker MALDI Biotyper™ with all isolates run in duplicate and results with a confidence score above 
1.8 deemed acceptable for speciation.  
All presumptive S. felis isolates underwent whole genome sequencing as previously described (Section 
2.4) (273). DNA was extracted from staphylococcal samples using the Qiagen DNA MiniAmp kit 
according to the manufacturer’s instructions for Gram positive bacteria, with lysozyme used as the 
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cell lysis agent (Qiagen, Valencia, USA). DNA yield and purity (A260/A280) were measured using the 
Nanodrop 1000 spectrophotometer (Thermo Scientific, Delaware, USA). DNA concentration was 
verified using the QuBit dsDNA kit (Thermo Scientific, Delaware, USA). DNA library preparation was 
performed according to the manufacturer’s instructions (Nextera, Illumina, San Diego, USA). Whole 
genome sequencing was performed using the NextSeq 500 Desktop Sequencer, according to the 
manufacturer’s instructions (Illumina, San Diego, USA).  De novo assembly of sequenced data was 
undertaken using a commercial bioinformatics program (CLC Genomics Workbench 10, Qiagen, USA). 
The identity of presumptive S. felis isolates was confirmed by identification of the species-specific 
genes, thermonuclease (nuc; Accession number: AB465335.1) (317) and RNA polymerase subunit-B 
(rpoB; Accession number: AF325878.1) (318) in whole genome sequenced contigs. Contigs underwent 
BLASTn analysis in CLC Genomics Workbench and had to display homology of >98% with the S. felis 
nuc gene and rpoB reference sequences to be deemed a true S. felis isolates.  
6.3.2 Coagulase testing 
The tube coagulase test was conducted using sterile EDTA-treated rabbit plasma (Sigma Aldrich, USA) 
and EDTA-treated feline plasma collected from residual blood samples sent to the University of Sydney 
Veterinary School’s diagnostic laboratory for routine haematology, using the technique outlined in 
Section 2.2.1. The slide agglutination test was used to assess the presence of clumping factor using 
rabbit and feline plasma. S. aureus ATCC 29213 was used as a positive control for all coagulase and 
clumping factor tests. 
6.3.3 Antimicrobial susceptibility testing 
Two methods of phenotypic antimicrobial susceptibility testing (AST) were performed. Antimicrobial 
disk diffusion was undertaken using the direct colony suspension method according to the Clinical and 
Laboratory Standards Institute (CLSI) guidelines for bacteria isolated from animals, as outlined in 
Section 2.3. Isolates were deemed susceptible or resistant based on CLSI guidelines for veterinary 
coagulase-negative staphylococci, where available (173). If animal-derived data was not available, 
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human data from the CLSI guidelines were used (174). The following antimicrobials were tested by 
disk diffusion: amoxicillin-clavulanic acid, cephalothin, cefoxitin, cefovecin, oxacillin, penicillin, 
trimethoprim-sulfamethoxazole, ciprofloxacin, enrofloxacin, marbofloxacin, pradofloxacin, 
clindamycin, gentamicin, chloramphenicol, rifampicin, azithromycin and tetracycline. All disks were 
BD brand (BD BBLTM Sensi-DiskTM, Sparks) except cefovecin (Oxoid, Basingstoke).  Automated AST was 
carried out by broth microdilution using the Vitek 2TM system (bioMerieux, USA), according to the 
manufacturer’s instructions. The following antimicrobials were tested: benzylpenicillin, oxacillin, 
enrofloxacin, erythromycin, gentamicin, clindamycin, tetracycline, chloramphenicol, rifampicin and 
trimethoprim sulfamethoxazole. Minimum inhibitory breakpoints for coagulase-negative 
staphylococci were used, as outlined in CLSI guidelines for humans (174). 
6.3.4 Resistance gene screening 
Isolates were screened for resistance genes by uploading their fasta files onto the open-access 
bioinformatics website, ResFinder (https://cge.cbs.dtu.dk//services/ResFinder/) (234). Sequences 
required >90% homology do be deemed positive for a particular gene. 
6.3.5 Virulence gene screening 
Putative S. felis virulence genes were searched for using BLASTn in CLC Genomics. A local blast 
database was created by downloading the sequences of virulence genes for S. aureus from the open 
access-bioinformatics website, VirulenceFinder (https://cge.cbs.dtu.dk/services/VirulenceFinder/) 
(235). S. felis sequences with >60% homology to the Virulence Finder gene sequences were then 
screened for homology to sequences from other staphylococcal species using the BLASTn function of 
the NCBI website. The following additional sequences that are described as staphylococcal virulence 
factors but not available from VirulenceFinder were downloaded from the NCBI website: biofilm-
associated surface protein, bap (106), lysozyme-resistance determinant, peptidoglycan O-
acetyltransferase, oatA (80), S. (pseud)intermedius exfoliative toxin, siet (319), autolysin/adhesion, atl  
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(89), capsular polysaccharide synthesis locus, cap (320), and coagulase, coa (321), (Accession 
numbers: AY220730.1, CP009046.1, AB099710.1, D17366.1, U81973.1 and X17679.1 respectively). 
6.3.6 Development of a multilocus sequence typing scheme  
Five genes were chosen as loci for the multilocus scheme, based on the housekeeper genes previously 
described in the MLST schemefor S. pseudintermedius (57, 185). The sequences of the S. felis heat 
shock protein gene, cpn60, and elongation factor Tu gene, tuf, were downloaded from the National 
Center for Biotechnology Information (NCBI) website (Table 6.1). As no S. felis sequences were 
available for the remaining five housekeeper genes from the NCBI website, the other loci were 
downloaded from the MLST website for S. pseudintermedius (Table 6.1). All downloaded sequences 
were placed in a local BLASTn database in CLC Genomics Workbench. Each sequence was then used 
as a template and blasted against de novo S. felis contigs to find the S. felis sequences. BLASTn 
homology was used to determine allele number: blast results that shared the same homology with 
the template sequence were given the same allele number.    
 Table 6-1. Details of loci and alleles used in multilocus sequence typing of Staphylococcus felis 
 
6.3.7 Phylogenetic analysis 
A phylogenetic tree was generated using the online bioinformatics program, CSI Phylogeny 1.4 
(https://cge.cbs.dtu.dk/services/CSIPhylogeny/) (243). This program used a Maximum Likelihood 
Locus Origin of template 
sequence 
Location of template 
sequence/accession number  
Template 
sequence 
length 
(bp) 
S. felis 
sequence 
length (bp) 
Alleles present in 
this study 
cpn60 S. felis AF242282.1 553 553 5 
tuf S. felis  HM352941.1 615 615 3 
ack S. pseudintermedius S. pseudintermedius MLST website 564 564 6 
fdh S. pseudintermedius S. pseudintermedius MLST website 259 258 6 
pta S. pseudintermedius S. pseudintermedius MLST website 492 497 9 
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algorithm to depict inferred phylogeny based on concatenated alignment of high quality single 
nucleotide polymorphisms. To construct the tree, fasta files of all genomes were upload to the online 
platform, which aligned them to a reference genome. As no reference genome is currently available 
for S. felis, both S. aureus NCTC8325 (Accession number: NC_007795.1) and S. pseudintermedius ED99 
(Accession number: NC_017568.1) were trialled as reference genomes for construction of the tree. A 
higher percentage of the S. pseudintermedius genome (5.9%) was covered by all S. felis isolates than 
the S. aureus genome (2.3%), so S. pseudintermedius ED99 was chosen as the final reference genome 
for phylogenetic tree construction. FigTree 1.4.3 was used to optimise visualisation of the 
phylogenetic tree. 
 Results 
6.4.1 Identification of S. felis isolates 
Of the 74 isolates received from cats, 18 were coagulase positive staphylococci (CPS) and 56 were 
coagulase negative (CNS). Thirty-eight isolates were presumptively identified as S. felis using MALDI-
TOF MS, which accounted for 51% of the total 74 staphylococcal isolates received from cats in the 
surveillance study. The remaining isolates were S. aureus (n= 18), S. pseudintermedius (n= 10), S. 
epidermidis (n= 3), S. haemolyticus (n= 2) and S. warneri (n= 1) No species could be identified in two 
coagulase-negative isolates, despite the isolates undergoing MALDI-TOF MS in triplicate. These 
isolates were removed from the study. S. felis were isolated from cats with a range of diseases 
including feline lower urinary tract disease (FLUTD; n= 15), otitis externa (n= 14), ocular disease (n= 
2), and pyoderma (n= 1). For the remaining six cats, one had acute renal failure, two had neurological 
signs, and a clinical diagnosis was not recorded for three cats (Table 6.3).  
Despite all 38 S. felis isolates undergoing DNA extraction, sufficient DNA purity (A260/A280 >1.8) could 
not be obtained from nine isolates despite repeated attempts at extraction. Therefore, 29 of the 38 
isolates underwent successful DNA extraction and whole genome sequencing.  All isolates had their 
identity confirmed by demonstrating >98% homology with the S. felis-specific nuc gene in whole 
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genome sequence data. All isolates except F11 displayed 99.81% homology with the rpoB gene from 
S. felis (Accession: AF325878.1). F11 displayed 100% homology to a 91% long fragment of the S. felis 
rpoB gene but also displayed a second copy of rpoB that had 100% homology to a 91% length sequence 
of S. aureus.  
6.4.2 Multilocus sequence typing of S. felis isolates  
Fourteen sequence types were present amongst the 29 S. felis isolates analysed (Table 6.2). The most 
common sequence types were ST6 (n= 7), ST4 (n=3) and ST10 (n= 3). The allelic profiles of each ST are 
shown in Table 6.2. Sequence types did not cluster according to clinical syndrome or geographic origin 
(Table 6.3).  
6.4.3 Antimicrobial resistance amongst S. felis isolates  
Table 6.3 shows that isolates had a very low level of antimicrobial resistance. Automated Vitek AST 
detected tetracycline resistance (MIC>1mg/L) in one isolate while all other isolates were susceptible 
to all antimicrobials tested. Meanwhile, disk diffusion detected tetracycline resistance (zone diameter 
<14mm) in a further isolate and penicillin resistance (zone diameter <28mm) in three isolates. 
Resistance genes were rare, with blaZ being present in 2 of 29 isolates screened (7%) isolates and tetK 
in 1 (3%) isolate. Table 6.3 shows that disk diffusion results showed greater agreement with gene 
screening: both blaZ-positive isolates were also phenotypically penicillin-resistant on disk diffusion 
but susceptible on Vitek screening. Unfortunately, whole genome sequencing was not performed on 
one penicillin-resistant isolate and one tetracycline-resistant isolate, so the phenotype and genotype 
could not be compared for these two isolates. 
6.4.4 Virulence factors 
Two isolates (7%) (F11 and F33) were coagulase-positive when tested using feline plasma; the 
remaining isolates were negative (Table 6.4). The two coagulase-positive isolates were negative at 4 
hr but positive at 24 hr. No isolates were coagulase-positive when tested with rabbit plasma. 
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All isolates were negative for the clumping factor test using rabbit and feline plasma. Both isolates 
that were coagulase-positive on feline plasma were positive for a homologue of the coagulase gene, 
coa (Table 6.3). Isolate F11 harboured a contig with a 1428bp sequence with 95% homology to the 
reference coa sequence, while isolate F33 harboured several smaller contigs that displayed between 
81 to 95% homology with S. aureus coa. All isolates harboured putative homologues of the gene 
sequences for β-haemolysin (hlb), biofilm-associated protein (bap), the lysozyme-resistance 
Sequence type Loci and corresponding alleles 
 ack pta tuf fdh cpn60 
1 1 4 2 1 3 
2 1 4 2 2 1 
3 1 4 2 6 4 
5 2 3 1 1 3 
6 2 8 1 1 3 
7 3 5 2 4 6 
8 3 7 1 5 3 
9 3 9 1 1 3 
10 4 7 1 5 3 
11 5 6 3 5 3 
12 5 1 1 5 1 
13 2 4 1 1 3 
14 3 7 1 5 2 
15 6 7 1 5 2 
16 1 4 1 5 1 
Table 6-2. Allelic profiles and sequence types of clinical Staphylococcus felis isolates from cats in 
Australia 
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determinant, O-acetyltransferase (oatA), autolysin/adhesion (atl), exfoliative toxin (siet) and capsular 
polysaccharide synthesis protein, capO (Table 6.4). Additionally, 20/29 (69%) of isolates including all 
ST4, ST6 and ST8 isolates possessed a putative gene with 74% sequence homology to the second S. 
pseudintermedius exfoliative toxin gene, exi. None of the isolates harboured homologues of the 
enterotoxins from the VirulenceFinder database. 
6.4.5 Phylogenetic analysis 
In the phylogenetic tree, isolates generally clustered with other isolates from their sequence type 
(Figure 1). Isolates did not cluster according to disease syndrome or geographic origin (Data not 
shown). Isolate F11, a coagulase-positive isolate, formed a branch that was separate to all other 
isolates in the tree. F11 was more closely related to other S. felis isolates than S. pseudintermedius or 
S. aureus.  
 
Chapter 6  
Kate Alice Worthing thesis - March 2018   107 
Isolate Site of 
isolation 
Clinical syndrome Geographic 
origin 
Sequence 
Type 
Resistance 
phenotype: 
VITEK MIC 
Resistance 
phenotype: disk 
diffusion 
Resistance 
genes 
F2 Ear Otitis externa SA 1 0 0 0 
F11 Ear Otitis externa SA 3 0 PEN blaZ 
F8 Ear Otitis externa NSW 4 0 0 0 
F10 Ear Otitis externa SA 5 0 0 0 
F4 Ear Otitis externa Unknown 6 0 0 0 
F15 Ear Otitis externa NSW 6 0         0 0 
F12 Ear Otitis externa NSW 9 0         0 0 
F13 Ear Otitis externa Victoria 10 0            0 0 
F30 Ear Otitis externa NSW 12 0           0 0 
F27 Ear Otitis externa NSW 15 0           0 0 
F23 Ear Otitis externa SA ND 0        PEN ND 
F28 Ear Otitis externa NSW ND 0          0 ND 
F36 Ear Otitis externa NSW ND 0          0 ND 
F38 Ear Otitis externa NSW ND 0          0 ND 
F14 Ear Neurological signs NSW 8 0          0 0 
F18 Ear Neurological signs NSW 11 0          0 0 
F25 Ear Not recorded NSW 6 0         0   0 
Table 6-3. Characterisation of clinical Staphylococcus felis isolates from cats in Australia, 2013-2014 
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F1 Eye Corneal stromal abscess NSW 12 0         0 0 
F17 Eye Corneal ulcer NSW 8 0         0 0 
F35 Skin pustule Pyoderma QLD ND 0         0 ND 
F5 Urine Acute renal failure Victoria 6 0         0 0 
F21 Urine FLUTD NSW 2 0         0 0 
F6 Urine FLUTD Victoria 4 0         0 0 
F22 Urine FLUTD NSW 6 0         0 0 
F24 Urine FLUTD NSW 6 0         0 0 
F20 Urine FLUTD NSW 7 TET     PEN, TET blaZ, tetK 
F16 Urine FLUTD NSW 10 0        0 0 
F19 Urine FLUTD NSW 10 0        0 0 
F29 Urine FLUTD NSW 13 0        0 0 
F34 Urine FLUTD NSW 14 0        0 0 
F33 Urine FLUTD NSW 16 0        0 0 
F3 Urine FLUTD SA ND 0        0 ND 
F31 Urine FLUTD QLD ND 0        0 ND 
F32 Urine FLUTD Victoria ND 0        0 ND 
F37 Urine FLUTD NSW ND 0       TET ND 
F7 Urine  FLUTD QLD 6 0        0 0 
F9 Urine Not recorded Unknown 4 0        0 0 
F26 Urine Not recorded Victoria 14 0        0 0 
Chapter 6  
Kate Alice Worthing thesis - March 2018   109 
FLUTD= feline lower urinary tract disease; QLD= Queensland, NSW= New South Wales; SA= South Australia; ND= not determined 
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Table 6-4. Putative virulence genes in clinical S. felis isolates from cats in Australia, 2013-2014 
 
Gene name Product name Putative 
function 
Reference sequence and S. 
felis homology to reference 
(%) 
Number S. felis (%) 
isolates with gene 
Exoenzymes     
Coa Staphylcoagulase Coagulation of 
host tissues 
S. aureus 8325-4 (81-95%) 2 (7%) 
Sak Staphylokinase Proteolysis of 
host tissues 
S. aureus Mu50 (70%) 1 (3%) 
Exotoxins     
Exi/expA Exfoliative toxin Proteolysis of 
host epidermis 
S. pseudintermedius 
AB489850.1 (74%) 
20 (69%) 
Siet Exfoliative toxin Proteolysis of 
host epidermis 
S. pseudintermedius ED99 
(70%) 
29 (100%) 
Hlb Beta-haemolysin Destruction of 
red blood cells 
S. epidermidis ATCC 12228 
(67%) 
29 (100%) 
LukD/LukE Leukotoxin Destruction of 
white blood 
cells 
S. aureus Mu50 (72%) 2 (7%) 
Adhesins     
IcaA Intercellular adhesion 
protein A 
Biofilm 
production 
S. aureus Mu50 (100%) 1 (3%) 
Bap Biofilm -associated 
surface protein 
Biofilm 
formation 
S. aureus V329 (61-64%) 29 (100%) 
Atl Autolysin/adhesin Autolysis, 
adhesion and 
erythrocyte 
agglutination 
S. pseudintermedius ED99 
(76%) 
29 (100%) 
Others     
CapO Capsular 
polysaccharide 
synthesis protein O 
Capsule 
production 
S. pseudintermedius ED99 
(76%) 
29 (100%) 
OatA O-acetyltransferase Lysozyme 
resistance 
S. epidermidis 12228 (68%) 29 (100%) 
Scn Staphylococcal 
complement inhibitor 
Host immune 
evasion 
S. aureus Mu50 (69%) 29 (100%) 
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schleiferi in dogs (322, 323) and S. agnetis from production animals (324, 325). It is interesting that 
both coagulase-positive isolates were only positive when tested with feline plasma. Thus, they would 
still be deemed coagulase-negative if tested using the rabbit plasma that is traditionally used in 
diagnostic laboratories. Variation in coagulation activity against different host species’ plasma has 
previously been observed in staphylococcal von Willebrand factor-binding protein (vWbp), which is 
one of the two coagulases produced by S. aureus (326). The finding of a novel coagulase homologue 
in two phenotypically coagulase-positive S. felis isolates shows that it can possess host-specific 
virulence determinants towards their main host species, cats. 
Staphylococcal virulence factors are generally divided into four categories: exoenzymes, exotoxins, 
adhesins and others (76, 77). The S. felis isolates in this study demonstrated two or more gene 
homologues from each of these categories. Consistent with previous reports, the most common 
infections amongst S. felis isolates were urinary tract infections and otitis externa (68, 72, 73). 
Genomic analysis showed that most S. felis isolates harboured homologues of putative virulence genes 
that have been shown to play a role in cystitis and skin infections caused by other staphylococcal 
species. Specifically, 100% and 69% of isolates harboured homologues of siet and exi respectively, 
which are exfoliative toxin genes implicated in blister formation in staphylococcal dermatoses (117). 
Additionally, all isolates harboured a homologue of the atl gene which, in addition to conferring host 
blood cell agglutination in S. aureus isolates (327), is implicated in adhesion to uroepithelium by the 
human urinary pathogen, S. saprophyticus (328, 329). These results add further evidence to the notion 
that S. felis is a true urinary pathogen of cats, as suggested by Litster et al. (71). 
Lysozyme is a host-produced enzyme that causes bacterial cell lysis (80). Bera et al. (80) examined a 
group of staphylococci from several different species and noted that those species with phenotypic 
lysozyme resistance were also those that are demonstrated pathogens in humans, while those that 
were sensitive to lysozyme were not known pathogens of humans. Thus, the authors concluded that 
lysozyme resistance is a marker of pathogenicity amongst Staphylococcus spp.. All S. felis isolates in 
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this study had a homologue of the OatA gene, which has been postulated to be the main determinant 
of lysozyme resistance in staphylococci (80). S. felis is a commensal of feline skin and is found in saliva 
(9, 10), both of which produce lysozyme (109). Any observer of cats will note their tendency for 
fastidious grooming, characterised by repetitive licking of their fur with lysozyme-laden saliva. It is 
therefore unsurprising that S. felis would require lysozyme-resistance to survive constant exposure to 
host lysozyme. Although phenotypic assays of lysozyme-resistance were not taken in this study, the 
fact that adequate DNA purity could not be obtained in 9/38 isolates could potentially be explained 
by the use of lysozyme as the cell lysis agent in the DNA extraction protocol, and lysozyme-resistance 
may have hampered cell lysis in these nine isolates. Future studies are required to determine whether 
the putative virulence gene homologues identified in the current study confer phenotypic virulence in 
vitro.  
The isolates in this study had low levels of phenotypic antimicrobial resistance and very few harboured 
antimicrobial resistance genes. This is in contrast to other staphylococcal species collected from cats 
in the same surveillance study (229). Namely, 10% of the S. pseudintermedius and S. aureus collected 
from cats in the same surveillance study were methicillin-resistant and 12% of feline S. aureus isolates 
were resistant to fluoroquinolones (229).  When methicillin-resistant S. felis has been reported 
previously, it has been from carriage rather than clinical isolates (10, 316). The current findings are in 
keeping with other studies that have found low levels of antimicrobial resistance amongst clinical S. 
felis isolates (71, 72). Possible reasons for lack of antimicrobial resistance amongst clinical S. felis 
isolates include: a fitness cost for resistant isolates allowing them to be outcompeted by more virulent 
pathogens, or the presence of other phenotypic virulence determinants that, at the site of an 
infection, result in failure of in vivo antimicrobial therapy despite in vitro susceptibility. Such 
determinants could include biofilm (106) and capsule formation (320), both of which the presence of 
putative gene homologues amongst the isolates in this study would suggest that S. felis is capable of 
producing. The practice of screening for occult urinary tract infections in cats, which entails sending a 
pre-antimicrobial sample of cystocentesed urine for culture and susceptibility as part of a diagnostic 
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work-up (330), may also create a selection bias that is in reverse to other clinical samples from 
surveillance studies, where samples are generally more likely to be submitted if refractory to 
antimicrobial treatment. A larger study that compares the antimicrobial susceptibility profiles of pre- 
and post-treatment feline urine samples would help to determine if S. felis truly has lower levels of 
resistance than other bacterial species.  
MLST and analysis of single nucleotide polymorphisms were used to infer phylogeny amongst this 
group of S. felis isolates because both techniques are sequence based and therefore repeatable. 
Consequently, although the sample size is too small to give a detailed picture of the population 
structure of S. felis, clustering in the phylogenetic tree and the presence of several isolates from the 
same sequence types (e.g. ST6) suggest that S. felis may exhibit a clonal population structure similar 
to S. aureus, where successful strains arise from variation attributable to point mutations rather than 
recombination (286). The MLST scheme is admittedly preliminary, and will be benefited by analysis of 
a broader population of phenotypically characterised S. felis isolates. If validated, it is hoped that 
future studies can use this MLST scheme to examine carriage and infection isolates from wild and 
domesticated cats, allowing a deeper understanding of the S. felis population structure. Of note is the 
coagulase-positive isolate, F11, which formed its own branch in the phylogenetic tree and showed 
rpoB sequence homology to both S. felis and S. aureus. Staphylococcus pseudintermedius ED99 was 
used as a reference genome for the phylogenetic tree. However, as only 5.9% of the core genome was 
covered by the analysis, there may be some SNPs that were missed in the analysis. The closest 
phylogenetic relation of S. felis appears to be a coagulase-positive species isolated from otters, 
Staphylococcus lutrae (331). No whole genome sequence for this species was available at the time of 
analysis, but it has recently become available (332). Therefore, phylogenetic tree construction using 
this genome as a reference would be useful to confirm the phylogenetic structure of S. felis. Further, 
analysis of the 16s rRNA gene homology (331) may help to determine whether the outlying isolate F11 
represents a novel coagulase-positive species or subspecies. 
Chapter 6  
Kate Alice Worthing thesis - March 2018   115 
This study is limited by the fact that details regarding the initial culture conditions of each isolate were 
not recorded by the referring laboratory. We therefore cannot determine whether isolates came from 
heavy, pure cultures which would indicate that S. felis was truly the causative agent of the infections 
seen in this study. There is a chance that isolates came from mixed or light growth cultures, which 
would make it difficult to determine whether S. felis was the causative agent or merely a contaminant. 
Future studies would benefit from recording the quality of cultures received from infectious samples 
to provide a stronger aetiologic link between S. felis and the diseases seen. Secondly, besides 
phenotypic testing of the presence of coagulase, we did not confirm the putative functions of virulence 
genes homologues by undertaking phenotypic testing. Consequently, subsequent studies should 
compare genotype with phenotype to show whether S. felis does indeed possess the necessary 
virulence factors to be considered a true pathogen of cats. Lastly, the S. felis isolates in this study were 
collected as part of a surveillance study that requested veterinary diagnostic laboratories to submit 
coagulase-positive staphylococci to our research team. It is therefore possible that we selected for an 
atypical collection of S. felis that may have either appeared coagulase-positive during initial testing or 
eluded accurate speciation by the submitting laboratories. Nevertheless, these results again show the 
utility of surveillance studies in unearthing unexpected information about rarely-studied species such 
as S. felis. 
 Conclusion 
In conclusion, this study examined a population of 38 S. felis clinical isolates from Australian cats and 
found that two were coagulase-positive when tested against feline-plasma, suggesting that host-
specific coagulation can occur in this species. A preliminary five allele multilocus sequence typing 
scheme was developed, which found 14 sequence types amongst 28 typed isolates. Isolates mostly 
came from urinary tract infections and otitis, and all isolates demonstrated sufficient putative 
virulence genes to indicate they are capable of causing disease in these body systems. Overall, the 
findings of this study suggest that S. felis has the capacity to be a pathogen of cats.  
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Chapter 7. Biocide tolerance in methicillin-resistant 
Staphylococcus aureus and Staphylococcus 
pseudintermedius from animals 
The content of this Chapter is published as a journal article, as follows: 
Worthing KA, Marcus, A, Abraham S, Trott DJ, Norris JM. (2018) Qac genes and biocide tolerance in 
clinical veterinary methicillin-resistant and methicillin-susceptible Staphylococcus aureus and 
Staphylococcus pseudintermedius. Veterinary Microbiology. 216: 153-158 
 Abstract 
Quaternary ammonium compound genes (qac genes) are associated with tolerance to certain 
veterinary biocides such as chlorhexidine and benzalkonium chloride. This study aimed to evaluate 
whether qac genes were present in a collection of 125 clinical veterinary-derived methicillin-resistant 
Staphylococcus aureus (MRSA) and methicillin-resistant and susceptible S. pseudintermedius (MRSP 
and MSSP), and to determine whether the isolates displayed phenotypic biocide tolerance. All isolates 
underwent whole genome sequencing, multilocus sequence typing and were screened for qac genes. 
A subset of 31 isolates underwent minimum bactericidal concentration (MBC) testing using 
chlorhexidine gluconate and benzalkonium chloride. MBC testing was conducted with and without the 
addition of bovine serum albumin (BSA) as an in vitro substitute for organic matter contamination. 
Two of 17 MRSA isolates (12%) harboured qacA/B genes; both isolates were ST8 from horses. QacJ, 
qacG and smr genes were identified in 28/90 (31%) MRSP and 1/18 (6%) MSSP isolates. ST71 isolates 
were significantly more likely to harbour qac genes than other MRSP clones (p<0.05).  The presence 
of qac genes was not associated with increased phenotypic biocide tolerance. In the absence of bovine 
serum albumin, the MBC values for all isolates were well below the recommended usage 
concentration for each biocide. However, the presence of BSA significantly increased the median MBC 
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values of both chlorhexidine and benzalkonium chloride. Given that ST71 is the most common clone 
of MRSP in the world, further research is required to investigate why there is high qac gene prevalence 
amongst Australian ST71 isolates. 
 Introduction 
Chapter 4 described how MRSP from Australia, like much of the rest of the world (184, 266), are 
generally multi- to extensively drug-resistant. The rise of multidrug and methicillin-resistant MRSP has 
led to heightened interest in the use of topical biocides as treatment for canine skin conditions (219, 
333-335). In vivo (217, 218, 334) and in vitro (333, 335) studies have shown promising results for 
topical treatment of methicillin-susceptible and -resistant S. pseudintermedius infections with biocides 
such as chlorhexidine. However, there is growing concern in the human medical literature about the 
presence of genetic determinants of biocide tolerance in Staphylococcus species. One such genetic 
determinant is the quaternary ammonium compound (qac) resistance gene group (336, 337). 
Quaternary ammonium compound (QAC) resistance proteins are inducible efflux pumps encoded by 
plasmid-borne genes (227). QAC proteins appear to aid extraction of toxic cationic compounds and 
can protect against certain host-derived antimicrobial peptides (336, 338-341). QAC proteins are 
found in several bacterial genera including Staphylococcus spp. and can be divided into two broad 
groups: the Major Facilitator Family, which includes qacA and qacB, and the Small Multidrug 
Resistance protein family, which includes qacG, qacH, qacJ and qacC/smr (338). The prevalence and 
distribution of qac genes varies with geography, Staphylococcus species, and the clinical origin of the 
isolate (338).  
In vitro studies have shown that qac genes can increase biocide tolerance amongst Staphylococcus 
isolates, but efflux capability varies depending on their specific qac gene and the compound being 
tested (226, 227). QacA-positive isolates have higher tolerance for biocides than qacB while isolates 
housing qacJ show increased biocide tolerance compared to qacG and smr-positive isolates (227). The 
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quaternary ammonium compound, benzalkonium chloride, and the bisbiguanide, chlorhexidine, are 
two cationic biocides that are commonly used in human and veterinary medicine. Several studies have 
found that S. aureus isolates that house qac genes demonstrate higher tolerance to benzalkonium 
chloride and chlorhexidine, evidenced by a significantly higher minimum bactericidal concentration 
(MBC) in qac-positive isolates compared to qac-negative isolates (342, 343). Although qac genes have 
historically been termed biocide ‘resistance’ genes, most studies have found that while qac-positive 
isolates tend to have a higher MBC than qac-negative isolates, the MBC for all isolates is still much 
lower than the recommended concentrations for practical biocide disinfectant use in hospitals (343, 
346). It is therefore more appropriate to speak in terms of biocide ‘tolerance’ rather than resistance 
because if used at their correct concentration, biocides are generally effective at killing even qac-
positive isolates.  
Biocide tolerance has important implications for infection control, particularly for management of 
difficult to treat organisms like methicillin-resistant Staphylococcus spp in hospitals that use cationic 
biocides such as benzalkonium chloride or chlorhexidine. Several studies in human medicine have 
examined qac genes in MRSA and demonstrated their correlation with in vitro biocide tolerance (225, 
342, 343), but similar studies in companion veterinary medicine are lacking. MRSA with increased 
tolerance to benzalkonium chloride has been found in qac-positive MRSA from pigs (344) and a meta-
analysis of 400 pig herds found that heavy disinfectant use in fattening herds was associated with a 
higher prevalence of MRSA carriage amongst pigs than herds that did not use disinfection (345). Qac 
genes have been found in low numbers of methicillin-susceptible S. pseudintermedius (MSSP) from 
dogs (347) and a range of Staphylococcus species from horses (227, 348, 349) but they have not yet 
been reported in methicillin-resistant S. pseudintermedius (MRSP). Given the rising prevalence of 
MRSP in veterinary medicine (40) and its growing profile as a potential zoonotic pathogen (66), the 
possible presence of qac genes in MRSP needs to be addressed. Consequently, this study searched for 
qac genes in 125 S. pseudintermedius and S. aureus clinical veterinary isolates and examined 
phenotypic benzalkonium chloride and chlorhexidine tolerance in a subset of 31 isolates. 
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 Materials and methods 
7.3.1 Bacterial isolates  
One hundred and eight clinical isolates of S. pseudintermedius (90 MRSP, 18 MSSP) and 17 methicillin-
resistant S. aureus (MRSA) were included in the study. Bacterial isolates were obtained from three 
collections housed at the University of Sydney. Collection A (n= 113) came from a nation-wide 
surveillance study which collected all clinical veterinary isolates of coagulase-positive Staphylococcus 
from January 2013 to January 2014 (Chapters 3 and 4). Collection B (n= 7) were clinical Staphylococcus 
isolates from canine pyoderma cases in Sydney, NSW, that were collected as part of an undergraduate 
research project in 2013. Collection C (n= 5) were freeze-dried archived clinical Staphylococcus isolates 
that had been collected by the Veterinary Pathology Diagnostic Services (VPDS) at the University of 
Sydney. The isolates from Collection C dated from 1999 to 2002. The MRSP originated from dogs (n= 
89) and cats (n= 1) while the MRSA isolates came from dogs (n=7), cats (n=3), horses (n= 6) and a 
kangaroo (n= 1).  The MSSP originated from dogs (n= 16) and cats (n= 2). Isolates from Collection C 
were retrieved from freeze-dry storage as outlined in Section 2.1.5. The speciation of all isolates was 
determined by standard phenotypic tests and MALDI-TOF MS as outlined in Section 2.2, and were 
confirmed via identification of the species-specific thermonuclease gene, nuc, in sequenced data.  
7.3.2 In silico analysis and typing 
All isolates underwent whole genome sequencing and MLST as outlined in Section 2.5 and previously 
described (273). To screen isolates for qac genes, the following nucleotide sequences were 
downloaded from the NCBI database: qacA/B, qacJ, qacG, qacH, and qacC/smr (Accession numbers: 
NC_007931.1, NG_048046.1, NG_051904.1, NC_019081.1, GQ900464.1 respectively). Isolates were 
screened for qac genes using CLC Genomics Workbench (Qiagen, USA). A local BLAST database was 
created and the sequences were blasted against de novo contigs. Isolates required 90% homology with 
the reference nucleotide to be deemed to be positive for that gene. Isolates that were positive for 
qacA/B will be referred to as ‘qacA-positive’ from hereon in.  
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7.3.3 Biocide tolerance testing  
MBC values were determined for two veterinary biocides: 5.4% w/v benzalkonium chloride (F10SC, 
batch number: 170922, Health and Hygiene Pty Ltd, South Africa) and 5% w/v chlorhexidine gluconate 
(Hexacon, batch number: 12355, Apex Laboratories Australia). MBC values were determined as 
previously described (339, 343, 346, 347), with the following modifications. Isolates were subcultured 
onto tryptose soy agar and incubated at 37°C overnight. They were then inoculated into 0.9% saline 
to obtain 0.5 McFarland standard, yielding a suspension with estimated 1.5x108 CFU/mL. Two-fold 
dilutions of chlorhexidine and benzalkonium chloride were prepared in sterile water. The range of 
dilutions tested was 1:50 to 1:25600, which equated to chlorhexidine concentrations of 0.5 – 
1000mg/L and benzalkonium chloride concentrations of 0.5 – 1080mg/L. To expose the bacteria to 
each biocide, 100µl of suspension colony was inoculated into 900µl of each diluted biocide and left at 
room temperature for 5 min. To inactivate the biocide, 100µl of the biocide/bacteria mix was then 
transferred to 900µl sterile neutralizer (3g/L lecithin, 30g/L tween 80 in phosphate buffered saline pH 
7.4 +-0.4) and left at room temperature for 5min. Two 25ul drops of neutralized sample were then 
plated onto sheep blood agar (Oxoid, Basingstoke) and incubated for 24hr at 37°C. Survivors were 
enumerated using the drop plate method as previously described (346). Negative controls used sterile 
saline instead of biocide. MBC was determined by the concentration of biocide that yielded a 5 
logarithmic reduction in bacterial survivors when compared to saline controls. Samples were run in 
duplicate. If duplicates returned a different MBC value, the higher value was designated as the MBC 
for that isolate. Duplicate results that were more than two-fold different from each other were 
repeated in triplicate; the median triplicate result was then recorded. Samples were prepared with 
and without the addition of bovine serum albumin (BSA in 0.9% sodium chloride, final concentration= 
30g/L (3%)) to the biocide/bacteria mix. BSA was used to replicate the effect of protein contamination 
in vitro (343). Therefore, isolates were tested against four biocide preparations: chlorhexidine with 3% 
BSA (chlorhex + BSA); chlorhexidine without 3% BSA (chlorhex – BSA); benzalkonium chloride with 3% 
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BSA (benzalkonium + BSA) and benzalkonium chloride without 3% BSA (benzalkonium – BSA). ATCC S. 
aureus 29213 was used as an internal control strain. 
7.3.4 Statistical analyses 
For comparisons between groups of more than 10, the Mann-Whitney U test was used to assess 
differences in median MBC values (GraphPad Prism 7, USA). Categorical comparisons were undertaken 
by constructing contingency tables and performing Fishers exact test. Results were considered 
significant if p<0.05.  
 Results 
7.4.1 Frequency of qac genes amongst Staphylococcus isolates 
A total of 31/125 (25%) Staphylococcus isolates harboured qac genes, which consisted of 2/17 (12%) 
MRSA, 28/90 (31%) MRSP and 1/18 (6%) MSSP isolates (Table 7.1).  The range of sequence types 
examined, and the qac genes that they harboured, are shown in Table 7.1. MRSA were the only 
isolates that housed qacA/B genes. Both qacA/B-positive isolates were ST8 MRSA isolates from horses. 
The most common qac gene amongst MRSP was qacJ (n= 15, 54%) followed by qacG (n= 8, 29%) and 
smr (n= 2, 7%). MRSP isolates from the same sequence type generally harboured the same qac gene, 
but ST71 MRSP isolates harboured either qacJ (n= 13), qacG (n= 2) or smr (n= 1). ST71 isolates were 
significantly more likely to harbour qac genes than other MRSP sequence types (OR= 6.9, CI= 2.5-19.0, 
p<0.01). Three MRSP isolates (one ST496, two ST45) housed a putative novel qac gene with only 83% 
homology to qacJ. This 324bp qac sequence had 100% homology to the sequence of an unnamed qac 
gene from the S. aureus plasmid, pKH4 (Accession number: U81980.1).  
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7.4.2 Biocide tolerance 
The MBC values for benzalkonium chloride and chlorhexidine were determined for a randomly 
selected subset of 31 qac-positive and qac-negative isolates (Table 7.2). Fourteen of the tested isolates 
were qac-positive (n= 12 MRSP; n= 2 MRSA) while 17 were qac-negative (n= 11 MRSP; n= 6 MRSA). Of 
the qac-positive MRSP isolates that underwent MBC testing, most harboured qacJ (9/12; Table 7.2).  
MLST Number of Qac-positive 
isolates/total number of 
isolates  
Qac genes present 
MRSA   
ST8  2/2 qacA/B 
Others  0/15 None 
MRSP   
ST71  16/26 qacG, qacJ, smr 
ST64  4/4 qacG 
ST45 2/6 Unnamed putative qac gene# 
ST496  1/8 Unnamed putative qac gene# 
ST525  1/5 qacG 
ST498  1/3 smr 
ST25  1/1 qacJ 
ST544  1/1 qacJ 
ST537  1/1 qacG 
ST544  1/1 qacG 
Others  0/34 None 
MSSP   
ST538 1/1 qacJ 
Others  0/17 None 
#Accession number: U81980.1   
Table 7-1. Qac genes and multilocus sequence types (MLST) of coagulase-positive staphylococci from 
Australian animals 
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Table 7-2. Minimum bactericidal concentration (MBC) values of benzalkonium chloride and 
chlorhexidine for methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible 
Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) 
isolates with and without qac genes 
Isolate ID Species MLST Qac gene present MBC (mg/L) 
Benzalkonium chloride  Chlorhexidine 
With BSA* Without BSA With BSA Without BSA 
N13/1/408 MRSA ST8 qacA/B 67.5 16.87 500 125 
N13/1/396 MRSA ST8 qacA/B 135 8.43 500 31.25 
N13/1/17 MRSA ST22 None 135 4.21 250 31.25 
Q13/1/145 MRSA ST22 None 135 2.1 250 62.5 
N13/1/715 MRSA ST22 None 67.5 2.1 250 31.25 
N13/1/648 MRSA ST612 None 135 16.87 250 250 
V13/2/458 MRSA ST612 None 67.5 4.21 500 31.25 
N13/4/96 MRSA ST612 None 33.75 4.21 250 62.5 
ATCC29213 MSSA Control None 135 16.87 500 125 
N13/4/25 MRSP ST25 qacJ 67.5 2.1 125 15.63 
Q13/1/190 MRSP ST496 Unnamed qac# 135 8.43 250 15.63 
V13/2/470 MRSP ST71 qacG 135 8.43 250 7.81 
V13/2/18 MRSP ST71 qacJ 135 16.87 250 31.25 
V13/2/18 MRSP ST71 qacJ 67.5 4.21 500 31.25 
V13/6/4 MRSP ST71 qacJ 135 4.21 250 31.25 
V13/6/5 MRSP ST71 qacJ 67.5 4.21 250 31.25 
N13/1/103 MRSP ST71 qacJ 33.75 2.1 125 15.63 
V13/2/133 MRSP ST71 qacJ 16.87 4.21 250 15.63 
V13/2/152 MRSP ST71 qacJ 135 2.1 125 15.63 
N13/1/480 MRSP ST71 qacJ 67.5 2.1 250 15.63 
Q13/1/311 MRSP ST71 smr 33.75 2.1 250 15.63 
N13/4/115 MRSP ST496 None 135 4.21 250 15.63 
Staphylococci in Australian Animals 
124  Kate Alice Worthing thesis - March 2018 
 
The range of benzalkonium chloride MBC values for MRSP isolates is shown in Figure 7.1. The median 
benzalkonium-BSA MBC of both qac-positive and qac negative MRSP isolates was 4.21mg/L. The 
median benzalkonium+BSA MBC of both groups was 67.5mg/L. Regardless of whether isolates were 
qac-positive or qac-negative, the median benzalkonium+BSA MBC (67.5mg/L) was significantly higher 
than the median benzalkonium-BSA MBC (4.21mg/L; p<0.0001). The range of chlorhexidine MBC 
values for MRSP isolates is shown in Figure 7.2. Like benzalkonium chloride, the median MBC of 
chlorhexidine was not significantly different between qac-positive and qac-negative isolates (p=0.12). 
The median chlorhex+BSA MBC of qac-positive isolates was 250mg/L, which was not significantly 
higher than qac-negative isolates (125mg/L; p= 0.4). The median chlorhex-BSA MBC of both groups 
was 16mg/L. Regardless of whether the isolates had qac genes, the median MBC of chlorhex+BSA 
(250mg/L) was significantly higher than the chlorhex-BSA MBC (15.63mg/L; p<0.0001).  
 
V13/2/83 MRSP ST497 None 67.5 4.21 500 15.63 
V13/2/173 MRSP ST497 None 67.5 67.5 250 15.63 
V13/2/242 MRSP ST497 None 33.75 1.05 125 31.25 
V13/2/92 MRSP ST497 None 16.87 1.05 125 15.63 
V13/2/393 MRSP ST71 None 67.5 2.1 125 7.81 
V13/2/475 MRSP ST71 None 135 4.21 125 7.81 
V13/2/413 MRSP ST71 None 135 4.21 250 7.81 
V13/2/440 MRSP ST71 None 135 4.21 250 7.81 
V13/2/441 MRSP ST71 None 16.87 2.1 250 15.93 
V13/2/488 MRSP ST71 None 135 2.1 125 7.81 
*BSA= 3% bovine serum albumin; #Accession number: U81980.1 
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For MRSA, the benzalkonium+BSA MBC was 67.5mg/L for one qac-positive isolate and 135mg/L for 
the other, while the median MBC was 135mg/L for the qac-negative isolates (range= 33.75mg/L – 
135mg/L). The benzalkonium-BSA MBC was 8.43mg/L for the first qac-positive MRSA isolate and 
16.87mg/L for the other while the median MBC for qac-negative isolates was 4.21mg/L (range= 
2.1mg/L – 16.87mg/L). The chlorhex+BSA MBC was 500mg/L for both qac-positive MRSA isolates while 
the median MBC for qac-negative isolates was 250mg/L (range= 125mg/L – 500mg/L). The chlorhex-
BSA MBC for both qac-positive isolates was 62.5mg/L while for qac-negative isolates, the median MBC 
was 31mg/L (range= 16.87mg/L – 62.5mg/L).   
 Discussion 
Biocide tolerance genes have previously been reported in MRSA from humans (225, 339, 342, 343) 
and MSSP from dogs (347), but this study documents the first instance of qac genes in clinical MRSP 
from dogs and MRSA from horses. Of the 90 MRSP isolates surveyed, 31% harboured either qacJ, qacG 
or smr while 2/17 (12%) of MRSA isolates harboured qacA genes. In vitro testing found no difference 
in the MBC of chlorhexidine or benzalkonium chloride between qac-positive and qac-negative MRSP 
isolates. Like previous reports (225, 342, 343), the MBC values for qac-positive MRSA isolates in the 
current study were generally higher than that of qac-negative isolates, but the sample size was too 
small to assess the statistical significance of this finding (n= 8).  Both qacA-positive MRSA isolates were 
ST8 from horses. The ST8 MRSA lineage is more commonly associated with horses than most other 
MRSA lineages (350, 351) although equine-specific markers have not yet been detected. Screening of 
a larger sample of equine-derived MRSA will help to determine whether ST8 is more likely to carry qac 
genes than other lineages and if so, whether qac genes have phenotypic effects which might explain 
ST8’s dominance amongst equine isolates. 
ST71 MRSP isolates were significantly more likely to harbour qac genes than other MRSP clones.  ST71 
was the most common MRSP lineage in the current study and the surveillance study described in 
Chapter 4, which is consistent with previous reports (162, 184). It would be tempting to suggest that 
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the presence of qac genes has conferred biocide tolerance and a subsequent fitness advantage to the 
ST71 clone, as has been observed in an epidemic clone of qac-positive ST22 MRSA that outcompeted 
other MRSA clones in a human hospital setting (225). However, no difference was observed in MBC 
values between qac-positive and qac-negative isolates suggesting that the presence of qac genes does 
not confer increased biocide tolerance to MRSP isolates in vitro, or possibly that an unidentified 
mechanism exists in all isolates that overrides the effects of qac genes. A previous study found that 
qacJ-positive S. aureus isolates showed a higher benzalkonium chloride MIC than qacJ-negative 
isolates and those with other SMR protein family genes (qacG or smr) (227), but biocide tolerance was 
not assessed by MBC, so it is difficult to compare those results to the current study or to assess the 
practical implications of the previous study. The current sample size precluded comparing the MBC 
values of qacJ-positive isolates with other types of qac genes, so it is possible that significant 
differences exist that could not be detected. Alternatively, qac genes may confer a biological 
advantage to ST71 by mechanisms other than biocide resistance such as conferring resistance to host-
derived antimicrobial peptides (340). QacA-positive S. aureus isolates survived exposure to thrombin-
induced platelet microbicidal protein 1a (tPMP-1), a cationic peptide release by rabbit platelets. In 
acting as cationic compounds that disrupt the bacterial cell membrane (352), host antimicrobial 
peptides may act in a similar manner to cationic biocides like benzalkonium chloride or chlorhexidine 
(224). Staphylococci have been in contact with their hosts’ antimicrobial peptides for many thousands 
of years more than manmade cationic biocides, so it is quite probable that any bacterial efflux effect 
originally evolved in response to exposure to antimicrobial peptides. If the function of qac genes was 
indeed originally to defend against mammalian cationic proteins, it makes sense that their 
coincidental efflux capacity for cationic biocides is variable, depending on the original mammalian 
protein targeted. This could explain why different qac genes appear to vary in their efflux capacity 
against various biocides (226, 227). Future studies could examine whether qac-positive MRSP lineages 
such as ST71 display higher tolerance to canine-derived antimicrobial peptides when compared to 
qac-negative isolates. Screening of archival veterinary staphylococcal isolates could also help to 
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determine whether any evolutionary correlations exist between the occurrence of qac genes and the 
use of biocides in veterinary practice. 
Without the addition of bovine serum albumin (BSA), the benzalkonium chloride and chlorhexidine 
MBC values for MRSP isolates ranged from 1.05-4.2mg/L and 7.8-31.25mg/L respectively, which is 
similar to some previous studies (353) but higher than others (335, 347).  However, detailed 
comparisons between studies cannot be made for a number of reasons. Firstly, the current study is 
the first to examine MRSP isolates with qac genes, so direct comparisons cannot be made. Secondly, 
most papers use different methodologies for MBC testing, with variations including time of exposure 
(353), formulation of chlorhexidine (335, 347), whether or not neutralisation occurred (353) and 
whether or not BSA was added as a study condition (343). The importance of neutralisation was 
exemplified in a recent study that showed without a neutralization step, the killing efficacy of a 
chlorhexidine-based hand scrub was estimated up to one logarithmic difference (354). Although 
standard recommendations exist for the testing of biocides, there are different recommendations 
given by the European and North American guidelines (355), which could explain some of the 
disparate methods used across studies. A single standardised method of MBC testing for staphylococci 
is clearly needed to obtain meaningful comparisons between studies.  
A consistent finding in this study was that the presence of protein increased the MBC of chlorhexidine 
and benzalkonium chloride, regardless of whether isolates had qac genes or not. This study used the 
addition of 3% bovine serum albumin as an in vitro indicator of organic matter contamination that 
would be present on mammalian skin and would likely also be present in the veterinary hospital 
environment, where chlorhexidine and benzalkonium chloride are used as disinfectants. Liu et al. 
(343) compared chlorhexidine MBC values for MRSA isolates with and without 3% BSA, and found that 
the presence of BSA caused a four-fold increase in the chlorhexidine MBC of qacA-positive MRSA 
isolates. The current study also found that the addition of BSA yielded a statistically significant four-
fold increase in the median chlorhexidine MBC for MRSP. A similar pattern of elevated MBC values in 
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the presence of 3% BSA was seen in the results of benzalkonium chloride tests. The labelled 
recommended concentration for HexaconTM 5% chlorhexidine gluconate is 1000mg/L for general 
antisepsis and 5000mg/L for surgical skin preparation (Apex Laboratories, Australia). The 
chlorhexidine gluconate MBC values for MRSP and MRSA reported in this study are clearly below its 
recommended usage concentration and thus all isolates would still be killed if the product is used 
appropriately. Meanwhile, the recommended concentration of F10SCTM benzalkonium chloride is 
labelled as 1:500 (~108mg/L) for general disinfection, 1:250 (~432mg/L) for high level disinfection and 
1:125 (~432mg/L) for resistant viruses such as parvovirus. In the presence of 3% BSA, 50% of MRSA 
isolates and 39% of MRSP isolates had an MBC of 135mg/L, which is above the recommended 108mg/L 
concentration for general disinfection. It is well known that the efficacy of biocides can be reduced by 
the presence of organic matter (343). Bovine serum albumin is merely an in vitro substitute for protein 
contamination, and it is likely that the real organic contamination found in a veterinary environment 
would have more of an effect on biocide efficacy than what was found in the current study. Overall, 
these results reinforce the importance of removing gross contamination and organic matter prior to 
disinfection in order to allow biocidal killing of MRSP and MRSA, particularly with disinfectants such 
as benzalkonium chloride. 
This study used a biocide exposure time of 5 min to replicate the approximate time that a topical 
treatment such as a chlorhexidine-based shampoo may be applied to a dog (218). However, for several 
reasons the results of in vitro biocide testing undertaken here likely do not reflect what happens in 
vivo and thus the significance of these results must not be exaggerated. Firstly, BSA is a poor surrogate 
for the hair, skin cells and debris that would be on the skin of a dog with staphylococcal pyoderma. 
Secondly, compliance of animal owners and even veterinarians is an aspect that affects infection 
control and treatment measures which cannot be tested in in vitro studies such as this. An 
observational study found that veterinarians used a contact time of as low as seven seconds for a 
chlorhexidine-based surgical cleaning product during pre-operative hand scrubbing, despite the 
labelled recommendation being at least two minutes (222). Future studies must take into account the 
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high likelihood that pet owners and even veterinarians may not adhere to scientifically-proven biocide 
contact times, which could explain why topical therapy may fail in anecdotal accounts. More in vivo 
and prospective studies are required before the true efficacy of biocides against MRSP and MRSA can 
be truly known.  
 Conclusion 
This study found that 31% of MRSP and 12% of MRSA isolates harboured qac genes. ST71 MRSP was 
significantly more likely than other lineages to harbour qac genes, raising interesting questions about 
the possible fitness advantages that qac genes may confer to this dominant MRSP clone. Although the 
sample size was larger than other previous studies (335, 347) this study was still limited by the 
relatively small sample size of isolates that underwent MBC testing. Future studies could be 
strengthened by undertaking MBC testing on a large sample size and ideally compare MBC values 
between as well as within clonal types, for example: a comparison of ST71 isolates with qacJ, qacG 
and smr against qac-negative ST71. Now that qac-MRSP isolates have been detected, ongoing 
surveillance studies will no doubt procure more qac-positive MRSP isolates that provide a larger 
sample pool for future studies. These in vitro results suggest that chlorhexidine and benzalkonium 
chloride are effective at killing MRSP and MRSA, provided protein contamination is limited. While in 
vitro studies are unarguably useful in obtaining baseline data about biocides, the clinical relevance of 
such studies must always be taken in the context of the veterinary practice. In such environments, 
biological parameters and human behaviour are equally important in determining the clinical efficacy 
of a biocide. 
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Chapter 8. Conclusions and future directions 
This thesis contains five studies which expand our understanding of the epidemiology of veterinary 
staphylococci in Australia. The first Australian nationwide surveillance study generated a 
comprehensive collection of 1080 clinical Staphylococcus spp. isolates which allowed detailed 
examination of MRSA, MRSP and S. felis in Chapters 3, 4 and 6 respectively. Amongst companion 
animals, the frequency of MRSA and MRSP was 4% and 11.5% respectively. The frequency of resistant 
staphylococci in Australian dairy cattle appears lower than other countries, a key finding that could 
suggest Australia’s strict antimicrobial prescribing practices for food producing animals may decrease 
selection pressure for resistant staphylococci. Chapter 3 also found that human- and ruminant-
associated host adaptation markers can be present in MRSA isolates from both veterinarians and 
animals, highlighting how MRSA can cross the host species divide. Chapter 4 found that the globally 
successful ST71 lineage is the most common MRSP clone in Australia. Although universal 
fluoroquinolone resistance amongst ST71 could be one explanation for its dominance, Chapter 7 
provided unexpected insights into another possibility. Qac genes, which are associated with increased 
biocide tolerance in MRSA, were discovered in MRSP isolates for the first time. ST71 was significantly 
more likely to harbour these genes than other MRSP clones, which raises fascinating questions 
regarding the potential fitness advantage that the presence of qac genes in ST71 may confer. Chapter 
5 contained an interesting pilot study that examined a population of veterinary personnel and their 
patients simultaneously, in order to determine the extent to which transmission of MRSA and possibly 
MRSP occurred between humans and animals in this healthcare setting. A rate of 8% MRSA carriage 
was detected amongst veterinary personnel, but no shared carriage of MRSA or MRSP was found 
between veterinary personnel and their patients or their own pets. Chapter 6 detailed the 
unprecedented result of phenotypic coagulation of feline plasma by two S. felis isolates, a finding with 
significant diagnostic and clinical implications for both microbiologists and veterinarians. Although a 
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PhD is undoubtedly a magnum opus for the researcher who creates it, perhaps what is more 
interesting than the 200 pages of research initially generated are the questions raised and the future 
horizons made visible by the research. Consequently, it is now time to examine the findings of each 
study more thoroughly so that their clinical implications can be addressed and future studies 
envisioned. 
The significance of MRSA as a public health pathogen is highlighted by its listing as one of nine bacteria 
of ‘international concern’ by the World Health Organisation (356). Research into the epidemiology of 
this pathogen is therefore of utmost importance, and consequently this thesis devoted two studies to 
the examination of MRSA in Australian animals and veterinarians. Chapter 3 found that human host-
adaptation markers were present in MRSA isolates from animals, suggesting either that the isolates 
were associated with humans or that these markers are not accurate flags of host adaptation. From a 
clinical perspective, this finding serves to remind veterinarians that MRSA in companion animals, 
particularly wound infections, could well be of human origin (209). The role of veterinary personnel 
and pet owners in this cycle of transmission must consequently be considered in disease management 
plans. Knowledge regarding zoonotic diseases and infection control amongst veterinary personnel is 
generally quite poor (357-359), as is the level of communication about zoonoses between small animal 
veterinarians and their clients (358, 360). In showing that MRSA is most likely shared between 
veterinarians and the patients that they treat, Chapter 3 helps to provide sound evidence that will 
contribute to MRSA infection control guidelines for veterinary personnel. If veterinarians are aware 
that humans are a potential source of MRSA for veterinary patients, they may be more likely to heed 
recommendations for effective MRSA infection control such as hand hygiene (220) and may 
accordingly correctly advise pet owners of such practices.  
To determine the extent to which humans are the source of MRSA wound infections in veterinary 
patients, a future study could undertake longitudinal concurrent sampling and molecular analysis of 
MRSA-infected wounds and carriage isolates from all in-contact humans and their environment. A 
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similar study was recently conducted into MRSP-infected dogs and in-contact dogs from the same 
household, which found that MRSP carriage was shared amongst household members until the index 
case became negative for MRSP carriage (361). An equivalent study in MRSA that includes sampling 
of human contacts might help to identify hotspots of household and hospital MRSA transmission. The 
study could draw on the sample processing and typing methods in Chapter 5. It would also be useful 
to establish whether correlations exist between veterinarian hand hygiene and the rate of nosocomial 
infections seen in practice. This could be achieved via a study that combines recently described direct 
surveillance methods to observe veterinarian hand hygiene behaviour (222) with a prospective 
assessment of the clinical outcomes of patients treated during the observation period.  Such studies 
would ultimately enhance the appreciation for infection control measures and hand hygiene 
compliance in veterinary medicine. 
Since the ground breaking Swann Report of 1969 (362), stakeholders at every jurisdiction level have 
been warned about the role that antimicrobial use in food producing animals may play in the global 
spread of antimicrobial resistance. Accordingly, Australia has taken a conservative stance when it 
comes to antimicrobial prescribing practices in veterinary medicine. Australia’s antimicrobial control 
measures include the classification of antimicrobials as a ‘restricted substance’ that can only be 
supplied via prescription by a veterinarian or other health professional (363), and the prohibition of 
fluoroquinolone use in food producing animals (161, 255). The difference in MRSA frequency between 
companion canimals and cattle seen in Chapter 3, taken with the differences in antimicrobial use in 
Australian companion and food producing animals, provide evidence that antimicrobial usage 
patterns affect the frequency of antimicrobial resistance seen in particular regions and animal groups. 
Future investigations including ongoing surveillance studies can further strengthen the evidence 
regarding the link between Australian antimicrobial prescribing practices and the occurrence of 
antimicrobial resistance in particular animal groups. In particular, a study examining the prevalence of 
MRSA carriage in Australian pigs and cattle is strongly warranted, given that lineages such as CC398 
may well have been missed in the current studies due to their focus on clinical submissions.  In vitro 
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and retrospective human studies have already shown that fluoroquinolone use can select for 
methicillin-resistance amongst S. aureus populations (257, 258, 364). A prospective cross-over study 
that examined fluoroquinolone use and its effect on the microbiome as well as MRSA and MRSP 
carriage and infection in companion animals would be invaluable in providing evidence for the theory 
that fluoroquinolone use correlates with methicillin-resistance in veterinary medicine. Using methods 
featured in this thesis, such a study could involve serial longitudinal sampling of carriage and infection 
sites before and after the administration of fluoroquinolones, with subsequent in silico analysis of 
bacterial isolates comparing the sequence types, resistance genes and genetic mutations present at 
each sampling instance. 
Australian legislation means that antimicrobials can only be prescribed by doctors, dentists and 
veterinarians under a patient-practitioner relationship (363), a practice that seeks to minimise 
inappropriate antimicrobial use in the community. In addition to legislation at a national level such as 
the prohibition of fluoroquinolones in food producing animals (363), antimicrobial usage at the 
hospital and patient level undoubtedly has a role in the selection for methicillin-resistant staphylococci 
in veterinary medicine. Recent studies have examined the antimicrobial prescribing practices of 
Australian veterinarians and found that veterinarians in companion animal and bovine sectors 
commonly demonstrate appropriate drug choice but inappropriate dosage intervals and treatment 
duration (295, 365-367). Thus, future studies must consider not only the effect of drug choice on the 
advent of antimicrobial resistance, but also the effects of inappropriate drug dosing. Given that pet 
owners and farmers are the main administrators of prescribed antimicrobials to outpatient animals, 
it follows that client compliance and the details of outpatient drug dosing are additional pieces of the 
puzzle that should be further investigated to understand the full effects of antimicrobial use on the 
selection of resistant pathogen such as MRSA and MRSP. As has already occurred in studies of 
Australian veterinarians (295, 365-367), a descriptive survey would be a useful start in gauging the 
knowledge and antimicrobial usage practices of Australian pet owners and farmers. 
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The pilot study in Chapter 5 found that 8% of veterinary personnel were MRSA carriers, a rate which 
is higher than that reported for the general population (210, 213, 214, 304, 305). There is now 
substantial evidence that veterinary professionals are at increased risk of MRSA carriage, but the 
occupation-specific risk factors are not yet known. A large multidisciplinary study is indicated to 
determine why veterinarians are at increased risk of MRSA carriage. It seems probable that 
veterinarians are exposed to risk factors that place selection pressure on their nasal microbiome.  
Potential risk factors that could be examined include patient handling techniques, the use of personal 
protective equipment, physical handling of antimicrobials, duration and frequency of exposure to 
biocides and concurrent burden of MRSA in the veterinarians’ work and home environment. In the 
meantime, veterinarians should be aware of their increased occupational risk of MRSA carriage, both 
in terms of their own personal health and the potential risk of transfer to their patients.  
Chapter 6 contained the surprising finding of phenotypic coagulation of feline plasma by two S. felis 
isolates. Given that the initial surveillance study aimed to collect only coagulase-positive 
staphylococci, the presence of 38 S. felis isolates amongst the resultant collection was unexpected. 
This serendipitously led to a study into S. felis, a species that may previously have been viewed by 
microbiologists and veterinarians as a lesser pathogen due to its status as a coagulase negative 
Staphylococcus. Variable coagulase activity has been reported in certain veterinary staphylococcal 
species (322-325), and such variable coagulase production draws into question whether the coagulase 
test is firstly reliable at differentiating staphylococci and secondly whether it truly does delineate 
pathogenic from non-pathogenic species. The finding that some S. felis isolates are able to produce 
host specific coagulase should make veterinarians and microbiologists view this species as a potential 
pathogen rather than discounting it as a contaminant. One coagulase-positive isolate formed a 
separate branch in the phylogenetic tree that was distinct from the other S. felis isolates. Future 
studies involving a larger collection of feline samples could investigate whether other isolates exist 
that are phylogenetically similar to the aberrant coagulase-positive isolate, which could then further 
use single nucleotide polymorphism analysis and DNA-DNA hybridisation to determine if this isolate 
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actually represents a novel species or subspecies. Molecular and phenotypic comparison of 
asymptomatic carriage samples with clinical isolates would also help to determine whether there is a 
difference between commensal S. felis isolates and those that create disease. 
All S. felis isolates in this study originated as clinical submissions made by veterinarians presumably 
investigating a clinically overt disease process in a feline patient. It is therefore intriguing that, in stark 
contrast to the S. pseudintermedius and S. aureus isolates collected in the same surveillance study 
(229), all S. felis isolates displayed a very low level of antimicrobial resistance. It the absence of 
resistance which would cause predictable antimicrobial treatment failure, it seems likely that at least 
some of the isolates displayed sufficient clinical virulence to warrant sample submission by the 
veterinarian. The finding of putative virulence factors in coagulase-positive and negative S. felis is 
timely, given the current paradigm shift that is occurring regarding significance of CNS in veterinary 
medicine. Recently published guidelines for the management of staphylococcal skin and soft tissue 
infections in animals assert CNS can be considered the causative agents of disease as long as consistent 
pyogenic clinical signs are present and correct sample collection technique has been used (219).  
As has been done with other similar studies examining the staphylococcal genome for virulence 
homologues (77, 116), the S. felis genomic study should be followed by an investigation into 
phenotypic expression of putative virulence factors. Such a study could involve isolation of S. felis from 
infectious samples from animals observed to have clinical disease and in vitro studies on these isolates, 
examining phenotypic expression of virulence factors such as lysozyme resistance and biofilm 
formation. The absence of antimicrobial resistance amongst S. felis also warrants further attention. 
Differing staphylococcal species appear to have varying capacity for horizontal gene transfer (151, 
287-289) so comparison of S. felis genomes with other staphylococcal species such as S. 
pseudintermedius would be useful to see if there are differences in systems such as restriction 
modification. The first step in any such a study would be to complete the whole genome of S. felis, a 
feat which will be greatly facilitated by the framework generated from the genomic data in this thesis.  
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A novel finding of Chapter 7 was the predominance of qac genes amongst ST71 MRSP isolates in 
Australia. This is the first time that qac genes have been reported in MRSP. It initially appeared as 
though, in addition to universal fluoroquinolone resistance amongst ST71, the presence of qac genes 
might explain why ST71 is so dominant amongst clinical MRSP isolates. Theoretically, the presence of 
qac genes could elicit a survival advantage to ST71 by conferring biocide tolerance to qac-positive 
isolates. This hypothesis was not realised in the in vitro study of Chapter 7, which did not detect 
significantly increased biocide tolerance amongst ST71 or qac-positive isolates. The sample size for 
biocide testing was admittedly small, so a larger scale study is now warranted to further assess the 
effect of qac genes on biocide in veterinary-derived staphylococci. In addition to testing benzalkonium 
chloride and chlorhexidine, future studies could include newer veterinary products such as 
hypochlorous acid, which has shown promising in vitro results against veterinary staphylococci but has 
not yet been tested against qac-positive MRSP or challenged with protein contaminated test 
conditions (335). A study is currently underway that has screened the carriage isolates collected from 
dogs at Hospital B in Chapter 5 for the presence of qac genes and will now prospectively assess the 
clinical outcomes for qac-positive MRSP carriers and non-carriers undergoing surgery. This will help to 
determine the clinical relevance of qac genes amongst MRSP. As mentioned in Chapter 7, if the study 
finds that qac genes in MRSP do not in fact confer biocide tolerance, they may still confer a fitness 
advantage by yielding resistance to host-derived antimicrobial peptides (340). A future in vitro study 
that examines the bactericidal effect of canine-derived antimicrobial peptides against qac-positive and 
-negative MRSP would be useful to determine if this is the case. Meanwhile, it is heartening to 
remember that chlorhexidine effectively killed all qac-positive and –negative MRSP in vitro, which 
adds to existing in vivo evidence (218) that it remains an effective topical treatment option for 
methicillin-resistant skin infections. 
Chapter 4 found clear geographic clustering of MRSP sequence types amongst clinical isolates from 
Australian animals, adding further weight to the notion that MRSP clones are shared between the 
dogs within a particular population (184, 266, 283). This concept was further supported by the findings 
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of Chapter 5, which found that dogs in the Sydney region mostly carried ST496 and ST64 MRSP. The 
finding that dogs within geographic regions share MRSP has interesting potential implications for 
infection control. While it is appreciated in human and veterinary medicine that many staphylococcal 
infections can be endogenous (201-203), it is also known that they can be exogenous. Indirect 
evidence for exogenous infection was found firstly in Chapter 3, where human-associated ST22 clones 
were the cause of most of the MRSA infections in companion animals. Further evidence for exogenous 
infection was found in Chapter 4, where the close geographic clustering of ST497 and ST71 isolates 
from the same postcode in Melbourne, Victoria, suggested a common external source of infection. It 
cannot be determined whether the MRSP isolates in Chapter 4 were endogenous or exogenous, 
because samples were only taken from clinical lesions and the dogs were not sampled for 
asymptomatic carriage before they developed their infection. To more thoroughly understand the 
epidemiology of exogenous and endogenous staphylococcal infections in companion animals, a large 
scale prospective study including repeated sampling at carriage and infection sites would be required. 
Such a study would need to consider several confounding factors such as sample population, host 
factors, disparate diagnostic criteria for the various staphylococcal diseases, and indeed the definition 
of what constitutes an endogenous or exogenous infection. Until the effects of each of these 
confounders can be extrapolated, such a study be would be logistically complex. A simple preliminary 
study could start by comparing MRSP carriage amongst dogs visiting veterinary hospitals with those 
at dog parks or grooming parlours, as this would help to determine the effects of sample population 
on the rate and molecular epidemiology of MRSP carriage amongst specific dog populations.  
Taken together, Chapters 4 and 5 add to our knowledge about MRSP transmission by showing that 
dogs within the same environment can share the same clone of MRSP, both in carriage and infection 
samples. Dogs with known risk factors for MRSP carriage such as a history of antimicrobial use or skin 
disease (204-206) should thus be treated as potential sources of MRSP for other dogs, including those 
in their own household. Analogous to MRSA in human hospitals (220), appropriate infection control 
protocols and hand hygiene practices would likely play a key role in reducing the transmission of 
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MRSP. Although limited by its small sample size, Chapter 5 contains a very useful pilot study that was 
cost effective and efficient to undertake. Therefore, it is hoped that future studies might now use a 
similar study design to conduct larger scale studies to generate more robust results regarding the 
transmission of MRSP in veterinary practice. 
A clinically relevant finding from Chapter 7 was that the minimum bactericidal concentration (MBC) 
of both chlorhexidine and benzalkonium chloride increased four-fold when bovine serum albumin 
(BSA) was added as an in vitro substitute for organic matter contamination. The addition of BSA caused 
the MBC of benzalkonium chloride to rise above the minimum recommended usage concentration for 
some isolates, indicating that these isolates would not be killed in the clinic environment if the site 
was not first cleared of organic matter. BSA was used as an in vitro substitute for the organic matter 
that is abundant in veterinary practice such as hair, skin, protein and bodily fluids. Although BSA is the 
best available in vitro analogue of organic contamination, it is admittedly a poor substitute for the 
complexity of contamination that would be present in reality. It is therefore likely that organic matter 
contamination would have an even greater detrimental effect on biocide efficacy than was evident in 
this in vitro study. Such a finding is useful to remember when designing guidelines for infection control 
measures and is also pertinent to future studies designed to assess the efficacy of veterinary biocides.  
The design of future biocide studies is complicated by the fact that there is no standardised 
international protocol for biocide testing, making it difficult to compare between studies or to choose 
the best method to use. As noted by Kampf et al. (354), inappropriate methodology when biocide 
testing can cause inaccurate results being reported, leading to the production of misinformed 
infection control protocols and ultimately suboptimal patient care. For this reason, care was taken in 
the biocide study design to include factors such as neutralisation of the biocide and a five minute 
contact time, both of which have been shown to affect the results of MBC testing (339, 354). Short 
contact times might mimic or even exaggerate the time of biocide exposure used in veterinary practice 
(222), but it is unlikely that any in vitro model would ever be able to simulate the organic conditions 
Staphylococci in Australian Animals 
140  Kate Alice Worthing thesis - March 2018 
and underlying patient diseases that would influence veterinary biocide efficacy in vivo, not to 
mention the additional confounds introduced by veterinarian and owner compliance. Nevertheless, a 
standard in vitro methodology would at least permit direct comparisons between studies, something 
which would allow broader conclusions to be drawn and more evidence-based infection control 
guidelines to be created.  
This thesis made extensive use of whole genome sequencing (WGS) to obtain typing and gene 
screening data. When the first MRSP isolate was sequenced in 2014, no online bioinformatics websites 
had been developed and all typing was undertaken using manually curated BLAST databases. 
Consequently, it took approximately one day per isolate to obtain MLST, SCCmec, dru and spa typing 
data. Since that time, several freely accessible online bioinformatics tools have become available such 
as the Center for Genomic Epidemiology website, https://cge.cbs.dtu.dk, which has separate 
automated tools for MLST, spa typing, resistance and virulence gene screening and phylogeny; 
reducing the time of analysis to one to two hours per isolate. Most recently, advances in 
bioinformatics and internet speed have enabled the development of ‘all-in-one’ pipelines such as 
www.goseqit.com that can provide MLST, spa, virulence and resistance gene screening within ten 
minutes. The goseqit website was developed after all bioinformatics analysis in this thesis had been 
completed so it was not used in any studies. Future studies will undoubtedly benefit from having such 
cost effective and rapid typing tools. Such rapidity means that WGS is almost at the stage of being a 
clinically useful tool because sample analysis time could now be as short as 48 to 72 hours. While 
genomic analysis provides invaluable epidemiological information about a bacterial isolate’s likely 
ancestry and virulence potential, it must be remembered that it cannot shed light on two other crucial 
elements of staphylococcal pathogenesis: host factors and phenotypic expression of the bacterial 
genome. If rapid bioinformatics, time and resources had been available, this thesis could have 
benefited from deeper analysis of phenotype and host interactions, such as examining potential 
phenotypic virulence differences between ST71 and other clones of MRSP. Future studies will now 
benefit from rapid, automated, and freely available bioinformatics tools which will allow more time 
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and resources to be focussed on the concomitant examination of host factors and bacterial phenotype 
involved in staphylococcal disease. In the meantime, the studies contained in this thesis have provided 
an invaluable frame work upon which future investigations into veterinary staphylococci can be built. 
To date, the findings of this thesis have been communicated with veterinarians and microbiologists by 
oral presentations at eight peer reviewed conferences, many of which have been followed by flurries 
of interest and offers of collaboration. It is heartening to know that veterinarians ‘at the coal face’ are 
interested and motivated to learn more about the epidemiology of resistant staphylococci in 
veterinary practice. Such interest can only serve to foster better veterinary medicine and ultimately 
better results for patients. Results have been further disseminated by publication of three peer-
reviewed papers, with a further four likely to follow. The findings within this thesis will be most useful 
when shared with other stakeholders in veterinary medicine, such as pet owners and primary 
producers. MRSA clearly creates disease in humans as well as animals and MRSP isolates are a 
potential source of several resistance determinants that could be transferred to human pathogens. 
Staphylococcus felis has not been reported as a human pathogen, but its genome may hold clues that 
could mitigate the acquisition of antimicrobial resistance by other staphylococcal species. While this 
thesis has focussed on staphylococci of veterinary significance, its results are also pertinent to human 
medical physicians and public health experts. In order to effectively understand and manage 
staphylococcal disease, a One Health approach that combines the expertise of human and veterinary 
medicine is therefore truly indicated. 
In the war against resistant bacteria, there is still much to learn before the remarkable Staphylococcus 
genus is fully understood. While we must concede that Staphylococcus is a formidable opponent, this 
thesis makes a valuable contribution to our arsenal in the fight against antimicrobial resistance in 
staphylococci.  
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